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Abstract 
It is thought that stem cells hold promise for use in future therapeutics.  One such application is 
tissue engineering (TE) which aims to repair or replace diseased or damaged organs in 
vitro.  Successful applications of TE, where the tissue is replaced and is functional, could improve 
a patients’ quality of life.  Mesenchymal stem cells (MSCs) are a form of adult stem cell that are a 
precursor for fat, cartilage and bone cells.  Bone is the second most transplanted tissue after blood 
therefore, enabling TE strategies through provision of high quality bone cells to facilitate bone 
repair would be beneficial.  As MSCs are a precursor to bone, their use is attractive. Additionally, 
their proliferative potential and immunoregulatory properties make MSCs an ideal candidate cell 
for TE.  MSCs require behavioural cues in vitro that direct phenotype in a targeted way.  One 
method to direct stem cell behaviour is to utilise materials engineering.  Static materials (examples 
include topography, chemistry and stiffness) have been employed but research has now moved 
towards stimuli responsive technologies to provide dual functionalities for culture and that emulate 
the properties of the stem cell niche.  
It is the intention of the work described in this thesis to utilise an enzyme responsive technology to 
promote MSC self-renewal and stimulate MSC differentiation to bone.  Using solid phase peptide 
synthesis (SPPS) a biomimetic enzyme responsive material was made with the sequence PEG-
GPAG↓LRGD tethered to a glass coverslip.  Due to enzyme action on the sequence, the PEG cap is 
removed to create on demand adhesion to the peptide RGD.  Further, the surface is designed to be 
under the control of cell secreted enzymes, rather than in response to enzymes added in by the user.  
 
The cell secreted enzymes that were investigated for this thesis were the matrix metalloproteases 
(MMPs). Here we confirm that the primary MMP secreted by MSCs was the gelatinase MMP-2 
and a peptide sequence was designed to be cleaved by this MMP.  It is known that redundancy can 
occur in MMP families and the role of MMP-9 was also investigated.  The results show that MMP-
9 is as efficient for surface cleavage, although cell supernatant concentration was 100-fold lower.  
MMP-2 concentration increased at week 3 specifically in response to peptides and so formed the 
original hypothesis that cleavage occurred at that time point.  However, due to the potency of 
MMP-9 this may not be the case.  Due to the limitations of manual synthesis and availability of 
materials, there was not enough evidence of MSC self-renewal.  Further there was some indication 
of osteogenesis, specifically in response to the sequence at 4-6 weeks, however this is too long in 
culture to be therapeutically relevant.  It may be better in the future to employ an enzyme 
responsive surface that can guarantee 100% efficiency of cleavage to ensure a synchronised 
population of end terminal cells. 
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1. Introduction: Mesenchymal Stem Cells 
and Tissue Engineering
  2 
The aim of tissue engineering (TE) is to create off-the-shelf tissues and organs to replace 
those that have become diseased or damaged.  If successful, this would alleviate the 
limitations of current therapeutics but also to aid the crisis in organ donation. The stem cell 
field is central to this work and mesenchymal stem cells (MSCs) have the potential to be at 
the forefront of this technology.  However, the expansion of MSCs in vitro is still 
inadequate due to untargeted differentiation of the cells.  In the past 20 years, there have 
been many materials strategies applied to MSC culture, namely topography, chemistry and 
stiffness.  However, a growing trend in MSC culture is to utilise stimuli responsive 
biomaterials such as light, enzyme, temperature and even electrical stimuli to manipulate 
the material properties at will.  This work aims to continue this theme by utilising cell 
secreted enzymes to remodel the cell-material interface for MSC differentiation.  In this 
chapter, we will explore the nature of stem cells, the use of static and stimuli responsive 
technologies for stem cell culture particularly for the differentiation of MSCs along an 
osteoblastic lineage.  
 
1.1 Stem Cells  
A stem cell is characterised as having the ability to self-replicate and form other cell types.  
The first observation of these types of cells were derived from experiments by Till and 
McCulloch (Till & McCulloch 1961).  Looking at the effects of radiation on the body they 
noted that when bone marrow cells were injected into irradiated mice, it resulted in nodules 
on the spleen that were proportional to the number of cells injected (Till & McCulloch 
1961).  The mass was the product of proliferating colonial cells and there had to be a 
precursor cell that could generate daughter cells (Till & McCulloch 1961).  This 
observation paved the way for future work on precursor cells and the identification of pure 
stem cells (Friedenstein 1976).  Embryonic stem cells were then identified from mouse 
embryos in 1981 (Evans & Kaufman 1981).  Evans and Kaufman established a culture of 
cell lines from mouse blastocysts that had normal morphology and karyotype, which grew 
rapidly and could form teratocarcinomas when injected into a mouse model (Evans & 
Kaufman 1981).  Teratocarcinoma is the generation of tumour like cells that contain 
differentiated cells of all lineages in one cell mass (Evans & Kaufman 1981).  Another 
breakthrough emerged in 1998 when the first human embryonic stem cells were identified 
(Thomson 1998).  In the last few decades, there have been many discoveries in stem cell 
biology including the identification of multiple stem cell niches and the molecular 
mechanisms involved in their regulation (Ehninger & Trumpp 2011).  Since the discovery 
of stem cells, their potential use in healthcare was immediately obvious. However, the use 
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of stem cells has been somewhat controversial particularly in the case of embryonic stem 
cells. 
  
1.1.1 Embryonic Stem Cells (ESCs) 
ESCs are derived from the inner cell mass of the preimplantation embryo and are 
characterised as cells that can form cells of all three germ layers (endoderm, mesoderm and 
ectoderm, Figure 1.1) (Stojkovic et al. 2004).  From these cell types, differentiated cells 
can be obtained.  Embryos are grown to blastocyst stage, then the inner cell mass is 
isolated and removed for culturing (Stojkovic et al. 2004).  For human embryos, the inner 
cell mass is usually derived from fertilised gametes donated from clinical procedures such 
as in vitro fertilisation (IVF) or abortions (although guidelines vary per country) (Dhar & 
Hsi-En Ho 2009).  Those that were accredited for discovery of these cells used tissue from 
both procedures (Thomson 1998).  
 
Figure 1.1 - Stem Cell Lineage.  Embryonic stem cells are isolated from the inner cell mass of the 
blastocyst.  These cells are described as pluripotent and can form every cell in the body.  These cells then 
specialise and become responsible for generation of cells of each tissue layer (endoderm, mesoderm and 
ectoderm). The cells that form these layers are known as multipotent and can form the terminally 
differentiated cells of that tissue. 
 
ESCs have a specific set of requirements for in vitro culture for example, the cytokine 
leukaemia inhibitory factor (LIF) and a feeder layer, (mitotically inactivated murine 
embryonic fibroblast, MEF) are typically used (Odorico et al. 2001).  Differentiation 
occurs when they are removed from the layer and where they differentiate into embryoid 
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bodies (EB) (Odorico et al. 2001).  ESCs express a high level of telomerase activity, 
characteristic of immortal cells and suggests that their replicative capacity is greater than 
that of somatic cells (Thomson 1998). ESCs express few major histocompatibility complex 
(MHC) class I molecules.  This increases with specialisation and therefore differentiation 
results in the presence of more MHC markers (Olivier et al. 2004).  Presentation of these 
markers creates an immune response when implanted into a patient  (Vogel 2002) and so to 
overcome this, the patient would need to be on extremely high doses of 
immunosuppressant’s (Odorico et al. 2001).  There is a further risk in utilising these cells 
in that injection of ESCs to immunodeficient mice does not induce organogenesis, rather 
teratoma formation (Till & McCulloch 1961).  
 
The use of ESCs have great potential for TE purposes as they have the capacity for 
differentiation to clinically relevant cells from a single cell source.  The process of 
donation of human embryos is carefully considered, permitted only with informed consent 
and handled under the appropriate ethical guidelines (Dhar & Hsi-En Ho 2009).  In the 
UK, the use of ESCs for research is governed by the Human Fertilisation and Embryology 
Act (HEFA), which requires stringent measures on consent and research is only permitted 
where significant knowledge on development or disease can be obtained (Dhar & Hsi-En 
Ho 2009). Due to the nature of the cell type and the unanswered question of embryo 
“consciousness” there is a lot of debate surrounding the use of these cells which in the past 
has been influenced even at the political level (in 2001 the Bush administration limited 
federal funding for ESC research 
2
). To use these cells in the clinic, tissue typing could be 
employed or as was suggested in 1998 to genetically engineer the cells to combat immune 
rejection (Thomson 1998).  Technologies such as CRISPR (Clustered Regularly 
Interspaced Short Palindromic Repeats) could be utilised to do this (Zhang et al. 2014). 
 
1.1.2 Induced Pluripotent Stem Cells (iPSCs) 
In 2006, Shinya Yamanaka created an alternative to the destruction of embryos by taking 
somatic cells and reprogramming their behaviour using 4 key genes: Oct3/4, Sox2, c-Myc 
and Klf4 (Takahashi & Yamanaka 2006).  The genes were inserted into MEF cells using a 
retroviral transduction.  The cells, when inserted into nude mice formed teratomas, with 
cells that had differentiated into tissues of all three germ layers (Takahashi & Yamanaka 
2006).  The somatic cells took on a pluripotent role which they then demonstrated was 
                                                 
2
 https://www.newscientist.com/article/dn24970-stem-cell-timeline-the-history-of-a-
medical-sensation/ 
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sufficient to aid embryonic development as they were injected into mouse blastocysts from 
which pups were born  (Takahashi & Yamanaka 2006).  In the next year, this was achieved 
using the same factors but moving from mouse cells to adult human fibroblasts (Takahashi 
et al. 2007).  This was a landmark finding and the potential of this technology for 
healthcare was quickly recognised earning Yamanaka the 2012 Nobel Prize for medicine.   
 
The advantage is that this method generates patient specific cells, cells that could be used 
to alleviate the effects of degenerative diseases.  A group from Harvard applied the 
technique in a bid to help elderly amyotrophic lateral sclerosis (ALS) sufferers (Dimos et 
al. 2008).  ALS is a condition which affects neurons in the spine leading to paralysis over 
time.  One way to treat the condition is by using healthy motor neurons, so the group 
aimed to reprogram fibroblasts from the skin of an 82-year-old patient to produce motor 
neurons and glia (Dimos et al. 2008).  The cells were reprogrammed with various factors 
via retroviral transfection and resulting cells had active cell cycle and normal karyotype.  
They were then induced to differentiate into neuronal cells using an agonist of sonic 
hedgehog (SHH) signalling and retinoic acid that resulted in increased expression of the 
neuronal marker -tubulin IIIb (Dimos et al. 2008).  The result was encouraging 
considering the age and phenotype of the patient.   
 
However, subsequent work on age related iPSCs showed that reprogramming efficiency 
decreased with increasing age of the patient as the cells exhibited shorter telomere lengths 
and increased doubling time indicating cell senescence (Trokovic et al. 2015).  In this case, 
age related disorders may not be effectively treated by autologous iPSCs (Trokovic et al. 
2015).  Further, it has been demonstrated that iPSCs retain DNA methylation signatures 
from the terminally differentiated cell they were obtained from and therefore have a bias 
for that phenotype (Kim et al. 2010).   There are also risks associated with their use due to 
the factors involved in the reprogramming phase (Lai et al. 2011). For example, miRNA 
could be utilised to modify the cells however, this is untargeted and could disrupt the 
regulation of the host cell (Lai et al. 2011).   
 
1.1.3 Adult Stem Cells 
Although cells such as the ESCs and iPSCs have more flexibility as they are pluripotent 
cells, their application to TE, at present, is limited.  This is due to the potential tumorigenic 
potential of the cells, safety concerns (from both transfection agents and non-human feeder 
layers), the potential immune response of the host and the ethical issues associated with 
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their use (Alvarez et al. 2012).  Researchers are turning to adult stem cells to overcome 
these issues.  Adult stem cells are located in specific areas in the body known as niches 
(Ehninger & Trumpp 2011).  While these stem cells are limited in terms of lineage, they 
are equally as capable of forming a large populations of cells through their proliferative 
potential (Beyer Nardi & Da Silva Meirelles 2006).  One such subset of adult stem cells 
that are particularly relevant for therapeutic use are the mesenchymal stem cells (MSCs).  
Although MSCs are derived primarily from the bone marrow niche, other sites have been 
located; adipose, skeletal muscle, teeth and umbilical cord (Baksh et al. 2004).  However, 
there is little phenotypic variation between the cells from these various sources (Kolf et al. 
2007).  This study exclusively utilises MSCs obtained from the bone marrow niche. 
 
1.1.3.1 Mesenchymal Stem Cells  
MSCs were first described in 1968 by Friedenstein et al. where they were noted to be 
precursors for osteogenic cells (Friedenstein et al. 1968).  In culture, MSCs were described 
as colony-forming unit fibroblasts (CFU-F), skeletal like cells with the capacity to form 
colonies (Friedenstein et al. 1968).  Since this initial documentation, there has been further 
characterisation to define the true properties of MSCs.  Firstly, they must be adherent cells 
that are positive in the expression of specific markers (of which there are many that are 
attributed including Stro-1, CD13, CD73, CD106 amongst others) (Jackson et al. 2007), 
notably cells negative for Stro-1 do not form CFU-Fs (Kolf et al. 2007).  For MSCs, the 
expression of these markers does not change with trypsinisation (Pittenger 1999).  The 
cells also form skeletal cell types; osteo-, chondro- or adipocytes (Salem & Thiemermann 
2010). There is also an argument that MSCs can also form other derivatives such as muscle 
and neural cells (Gilbert et al. 2010; Yim et al. 2007).    
 
The use of MSCs for TE purposes has potential for several reasons.  Firstly, the ability to 
obtain bone marrow from a patient is a well-studied and practised procedure consisting of 
aspiration from the iliac crest (Ringe et al. 2002).  In addition, bone is the second most 
transplanted tissue after blood (Shegarfi & Reikeras 2009), therefore as MSCs are 
precursor cells, it would be desirable to have a source of fast growing cells that bone could 
be derived from. They also have potential for TE due to their immunoregulatory ability 
(Aggarwal & Pittenger 2005). MSCs have been shown to have little expression of MHC 
Class I and lack MHC Class II molecules that contribute to immunogenicity (Kode et al. 
2009).  Moreover, MSCs can suppress the T cell response using toll like receptors (TLR), 
specifically TLR-3 ligation to TLR-4 (Liotta et al. 2008).  MSCs have the ability to alter 
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cytokine secretion from natural killer cells (NK) and dendritic cells (DC) namely, reducing 
the expression of pro-inflammatory cytokines tumour necrosis factor (TNF-), interferon-
gamma (IFN-), and interleukins (IL-1, -2 and -12) which are typically characteristics of 
the pathophysiology of Graft-versus-host disease (GVHD) (Aggarwal & Pittenger 2005).  
The reduction of these markers changes the immune response to a more anti-inflammatory 
phenotype and therefore may provide a mechanism for tolerance in response to 
transplanted tissue (Aggarwal & Pittenger 2005).  This innate response of MCSs is 
prevalent in vivo as MSCs have been found to target immune cells to aid the healing of the 
left ventricle after myocardial infarction (MI) when injected intravenously (Luger et al. 
2017).  Using mouse models, Luger et al. found that MSCs engrafted to the heart after MI, 
specifically to the injured site and decreased the number of NK cells and neutrophils 
therefore improving ventricle function (Luger et al. 2017).  For TE, these properties have 
the potential to reduce the risk of GVHD if used as an allogenic source of cells, improving 
the chances of success of the transplant (Becker & Hummelen 2007), this is not the case 
with ESCs or iPSCs. 
 
These qualities have resulted in a sharp increase in the number of publications concerning 
MSCs and its derivatives in the last decade (Figure 1.2).  In 2016, the total number of 
academic papers published regarding MSCs reached just over 5,500, a vast increase since 
the 1990’s (326 papers published in 1999).  This is also true for the differentiated cell types 
generating yearly publications in the thousands, a steady trend in the last 10 years which is 
set to continue in the future. This interest is due to increasing patient populations, 
increased approval for clinical trials and a demand for regenerative medicine.  These 
factors have created a global stem cell market that is worth billions of dollars (USD) and is 
expected to increase to $12.3bn in 2021 at a compound annual growth rate (CARG) of 13.1 
% (Evers 2016). Of this market, it is estimated that MSCs occupy 23 % (Kode et al. 2009).  
However, there are still some barriers to the stem cell market namely ethical approval and 
cost.  Future bioengineering strategies must be cost effective to ensure clinical use. Yet 
with an ageing population and strain on current health care systems it is necessary to 
investigate stem cell technologies in the hope of providing novel therapies.   
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Figure 1.2 - Number of Publications Per Year for MSCs and Its Derivatives.  In the last two decades, the 
number of publications for MSCs and its differentiated cells has dramatically increased.  In the late 1990’s 
publications for each cell type consisted of less than 1000 papers per year. The number of publications 
increased in early 2000s and has steadily increased over time (2009-2016), particularly in the case of MSCs 
and adipose cells.  The increasing amount of research has influenced the increasing value of the stem cell 
market and highlights the potential of this cell type.  Graphs generated from a Web of Science search for the 
number of publications that stated MSCs, osteoblasts, adipose cells and chondrocytes in the title for the years 
stated. 
 
1.2 The Niche 
All stem cells are located in defined specialised areas in the body called niches (Scadden 
2006).   The niche functions to save stem cell populations from depletion but also limits 
excessive proliferation (Scadden 2006).  The stem cell population remains in quiescence 
until there is a need for specialised cells. Stem cells are then activated to form progenitor 
cells (through transit amplification) then by specialisation, a population of terminally 
differentiated cells is created (Watt & Hogan 2000).  The niche is more than a holding site 
for the stem cells as it encompasses supporting cells and extracellular matrix (ECM) which 
regulate cell behaviour (Hartmann 2006; Ehninger & Trumpp 2011).  Adhesion to the 
ECM is critical for this interaction, which is carried out by integrin proteins (section 1.4). 
 
The bone marrow MSC niche is located in the inner cavity of bone (Clarke 2008). 
Anatomically, bone is surrounded by an outer membrane called the periosteum, consisting 
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of blood vessels and nerve endings (Clarke 2008).  Bone can be subdivided to cortical (the 
outer layer that provides strength) and cancellous bone (referred to as “spongy” and exists 
as a network of trabeculae to resist external forces) (Figure 1.3).  The cancellous bone is 
lined by the endosteum, which contains blood vessels and osteoprogenitor cells (Clarke 
2008).  The medullary cavity within the cancellous bone is the is the location of the bone 
marrow.  Bone is a hard material due to the mineralisation of the ECM proteins (with 
calcium, magnesium and phosphate) but not brittle due to the flexible properties of 
collagen  (Clarke 2008). 
 
Bone is dynamic in nature and consists of four cell types (osteoprogenitor cells, 
osteoblasts, osteocytes and osteoclasts) that are in continual regulation.  Osteoprogenitor 
cells produce osteoblasts, the cells that are responsible for the secretion of the bone matrix 
(Clarke 2008).  Osteocytes are mature bone cells derived from osteoblasts that reside in the 
lacuna in a dormant state and osteoclasts are large multi-nucleated cells that resorb the 
bone matrix (Roodman 1996).  The bone tissue is dynamic, the interplay of these cell types 
ensures a balance between bone formation and resorption, changes to this balance leads to 
the development of skeletal disorders such as osteoporosis (Boskey & Coleman 2010).  
 
 
Figure 1.3 - The Bone and the Bone Marrow Niche.  The bone marrow is located within the inner mass of 
the bone.  Bone itself is composed of cancellous and cortical bone that are encased within the periosteum.  
The bone marrow is the home of not only mesenchymal stem cells (MSCs) but also the hematopoietic stem 
cells (HSCs).  Through a myriad of factors, the stem cells are kept in regulation between self-renewal and 
differentiation.  Differentiating cells participate in transit amplification whereby the number of progenitor 
cells increase in number prior to terminal differentiation. The niche is also subjected to an oxygen gradient. 
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The bone marrow consists of multiple cell types, however MSCs only represent 0.01-
0.001% of the bone marrow cell population (Salem & Thiemermann 2010).  That said, 
with expansion, these small numbers of MSCs can generate 50 million cells by passage 2 
from 10 mL aspirates from adult donors (age 19-57 years old) (Pittenger 1999). The bone 
marrow niche is the location of two types of progenitor cells as MSCs occupy the same 
niche as that of the hematopoietic stem cells (HSCs), the progenitor cell for the blood and 
immune system (Figure 1.3).  The niche is also subjected to an oxygen concentration 
gradient, while it is highly vascularised the cells display a hypoxic phenotype (expression 
of hypoxia inducible factor-1-, Hif-1), this is thought to play a role in maintenance of 
quiescence (Spencer et al. 2014) (Figure 1.3).  The interplay of multiple cell types, the 
ECM and the oxygen gradient dynamically regulate stem cell behaviour. 
 
1.3 The Extracellular Matrix  
The ECM consists of many different protein types, including collagen for strength and 
elasticity, glycoproteins (e.g. fibronectin) and proteoglycans (e.g. hyaluronan) that together 
form the basement membrane (Mouw et al. 2014). As cells are anchorage dependent, the 
ECM is adherent and therefore necessary for cell survival, without which cells would die 
via anoikis (cell homelessness) (Chen et al. 1997).  Shown experimentally by Chen et al. 
who utilised microcontact printing to create ECM areas of various sizes, they found that 
the greater the area presented to the cell (>20 µm), the greater the chance of survival and 
further, an increase in DNA synthesis and cell spreading (Chen et al. 1997).  Areas below 
this critical threshold induced apoptosis due to limited cell spreading (Chen et al. 1997). 
 
Within the sequence of ECM proteins, there are certain amino acid cell-adhesion motifs 
that are particularly directive to cells for example IKLLI, IKVAV and PDSGR for laminin 
and DGEA and GFOGER for collagen (Weber et al. 2007). A particularly well studied 
amino acid adhesion sequence is the Arginine-Glycine-Aspartic Acid (RGD) motif found 
in for example, fibronectin.  These motifs are not always exposed in the secreted form of 
the protein, so are described as cryptic sites (Davis et al. 2000).   The motifs can be 
uncovered in relation to a conformational change via matricryptins for example, by ECM 
remodelling or cell attachment which alter the presentation of motifs (Davis et al. 2000). 
These sites can work in concert, e.g. the RGD and PHSRN (the synergy sequence) promote 
improved cell attachment and cell spreading (Benoit & Anseth 2005).  It is accepted that 
short peptide sequences, such as RGD, can be sufficient to direct cell behaviour making 
them useful for materials applications (Bellis 2011).  Another consideration of utilising 
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peptide motifs is the recognition by specific integrin combinations.  In vivo, distinct 
pairings of  and  subtypes recognise different ECM ligands e.g. 11 binds to collagen 
whereas v6 recognises fibronectin in osteoblast-like cells (Shekaran & García 2011). The 
combination of integrins expressed has an effect on cell behaviour.  For example, it is 
known that 51 is important for osteogenic differentiation and loss of the 51 interaction 
with fibronectin results in osteoblast apoptosis. In comparison, although v3 can support 
adhesion, it also inhibits differentiation of osteoprogenitors  (Shekaran & García 2011).  It 
has therefore been proposed that bioactive materials could target specific integrins (51) 
whilst preventing other combinations (v3), and thus enhance cellular behaviour and 
phenotype  (Shekaran & García 2011).  Care should be taken however, when replicating 
peptide motifs in vitro, as peptide conformation has an effect on receptor interactions.  It is 
known that cyclic RGD targets v3 integrins while linear RGD is less selective and can 
have an effect on multiple integrin receptors and therefore could alter cellular outcome 
(Mas-Moruno et al. 2016; Bellis 2011).   
 
As cell shape is defined by the ECM and shape infers function (Lutolf & Blau 2009),  
modification of the ECM is fundamental to differentiation, development and regeneration 
of cells and tissues (Mannello et al. 2006).  However, it is this same dynamic property that 
also renders the ECM subject to changes in age, disease and injury resulting in altered 
composition and changes in stiffness (Lutolf & Blau 2009).  It has been shown that cancer 
cells cultured on stiff matrices invade the basement membrane unlike those cultured on 
compliant surfaces.  Therefore tumour microenvironment is sufficient to support 
malignancy  (Wei et al. 2015; Paszek et al. 2005). 
 
In the context of TE, many materials have drawn on inspiration from the natural ECM.  
This is true for all cell types and not just that of the MSCs.  For example, Ott et al. has 
utilised bioreactors to engineer a heart (Ott et al. 2008).  In an animal study, they showed 
that seeding decellularised hearts with cardiac or endothelial cells and placing them in 
bioreactors that could simulate the pressure and flow of a beating heart, performed better in 
terms of viability, contractility and electrical signalling (Ott et al. 2008). Therefore, there 
are extracellular factors that play a role in cell fate.  
 
1.4 Cell Adhesion 
Cell adhesion is an important function for adherent cells, without which they would 
apoptose (Chen et al. 1997).  Furthermore, adhesion is essential for cellular behaviours 
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(e.g. migration), maintenance of cell shape and the communication of external stimuli to 
the nucleus. Adhesion is modulated by a group of cell adhesion molecules (CAMs) which 
include cadherins and integrins (Albelda & Buck 1990), for this section, the focus will be 
on integrins.  Integrins are transmembrane receptors that exist as dimers, with one alpha 
and one beta subunit (Albelda & Buck 1990).  There are multiple variations of each 
subunit and can be expressed in different combinations on the cell surface (Hersel et al. 
2003).  These combinations have different preferences for ligands presented by the ECM, 
for example 51 integrin binds to the RGD motif of fibronectin (Humphries et al. 2006).  
Adhesion to the ECM is not a passive process, it induces intracellular signalling cascades 
and overall change in cell behaviour.  Due to the multiple possible combinations of 
integrin subunits and the ever-changing presentation of ECM motifs, this results in a 
myriad of cell behaviours (Giancotti & Ruoslahti 1999). The extracellular part of the 
integrin ligates to adherent motifs in the ECM. The resultant adhesion can be classified by 
size, adhesions <2 µm long are known as focal complexes (or transient adhesions), these 
short-lived adhesions are involved in migration (Biggs et al. 2009).  Adhesions 2-5 µm 
long are known as focal adhesions (FA) and sizes >5 µm long are referred to as super 
mature adhesions (Biggs et al. 2009).  This classification system is a progression of the 
“dot” and “dash” system originally described by Bershadsky (Bershadsky et al. 1985).  
 
The binding of integrins occurs via a conformational change.  Prior to binding, the 
integrins are tightly folded however, in the presence of an ECM ligand, they unravel and 
extend exposing the binding site of the  chain to talin (Tadokoro 2003).  The unbending 
of the tail results in a high affinity adhesion to the ECM (Wehrle-Haller 2012).  Integrin 
binding and successful adhesion formation depends on ligand clustering which is limited to 
a certain threshold.  This was demonstrated by Arnold et al. who tethered RGD coated 
gold nanodots, measuring <8 nm across for the attachment of single integrins that were 
spaced at 28, 58, 73 and 85 nm.  Cell adhesion was most effective on substrates spaced at 
≤58 nm, with a greater number of cells adhering (Arnold et al. 2004).  Cavalcanti-Adam, 
continued this work also using RGD coated gold nanoparticles at 58 or 108 nm 
(Cavalcanti-adam et al. 2007).  At 58 nm as expected, cell adherence and spreading 
occurred after 3 hours.  In comparison, the 108 nm spacing did not facilitate integrin 
clustering (Cavalcanti-adam et al. 2007).  Cell motility on the 108 nm pattern was erratic 
and adhesions that did form underwent a rapid turnover (Cavalcanti-adam et al. 2007).   
Furthermore, Geiger et al. show that increasing ligand distance is inversely proportional to 
projected cell size, cell size being maximal when ligand spacing is minimal (Geiger et al. 
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2009).  In terms of cell morphology, increased spacing (58-70 nm) resulted in elongation 
of cells and increased migration (Geiger et al. 2009).  For persistent cell spreading, at least 
four ligand bound heterodimers are required to maintain the adhesion (Schvartzman et al. 
2011). 
 
The intracellular component of the integrin is involved in the recruitment of various 
secondary proteins to the integrin site (together known as focal contact), without which an 
adhesion cannot be sustained (Mitra et al. 2005).   These proteins are usually associated 
with adhesions between 1-5 µm in size.  These proteins include vinculin, FAK (focal 
adhesion kinase), talin and the cytoskeletal proteins (Figure 1.4). Each protein involved in 
the focal contact has an independent role in the formation and maintenance of the 
adhesion.  Talin wedges between the tails of each  and  subunit, the open conformation 
results in exposure of vinculin binding sites (del Rio et al. 2009).  This early interaction is 
critical, cells that do not express talin have unstable cell spreading and lack FAs  (Geiger et 
al. 2009).  Vinculin binding results in the stability of the adhesion and an increase in focal 
adhesion size (Humphries et al. 2007).  FAK is thought to act as a mechanosensor by 
revealing binding sites and promoting Src kinase signalling (Wehrle-Haller 2012).  
 
The focal contacts connect integrins to actinomyosin in a structure which has been 
described as the molecular clutch (coined by Mitchison and Kirschner, 1988) that is said to 
be engaged when the integrins bind to actinomyosin (Sun et al. 2016). The presence of 
talin also increases the rate of actin polymerisation (Medda et al. 2014).  Signalling events 
then occur including the phosphorylation of FAK and activation of guanosine 
triphosphatases (GTPases) through which kinase and phosphatase pathways are activated 
resulting in changes to cell behaviour downstream.  One such change is the regulation of 
cell morphology through GTPases: cdc42 (cell division control protein 42), Rho (Ras 
homologue gene family member A) and Rac create filopodia, stress fibres and lamellipodia 
respectively.  This process does not only involve different GTPases but also different  
subunits particularly, the 3 subunit must activate to begin clustering at the tip (Wehrle-
Haller 2012).  The change in morphology provides the cellular apparatus for either 
migration or adhesion.  
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Figure 1.4 - Downstream Effects of Integrin Binding.  Integrin binding to the ECM results in recruitment 
of other integrin dimers and a clustering of the integrins at the site.  On the intracellular side the integrins 
signal various protein molecules including FAK and vinculin. Through kinase and phosphatase pathways, 
downstream effects are organised leading to a diverse range of cell behaviours including differentiation and 
protein synthesis.  Figure Taken from (Berrier & Yamada 2007). 
 
After adhesion to the ECM is established, the downstream effects are achieved by 
activation of genes in the nucleus as the external information is relayed by the cytoskeletal 
apparatus.  “Tensegrity” was proposed by Ingber et al. to describe the method by which 
mechanical stimuli are transduced by cytoskeletal components to drive intracellular tension 
(Ingber 1993).  Tensegrity is also required to maintain cell shape and resist deformation 
(McGarry & Prendergast 2004).  Further, the mechanical stimulus can be related to the 
nucleus in the process of mechanotransduction where adhesion results in gene and protein 
level changes that alter cell behaviour (DuFort et al. 2011).  
 
Direct mechanotransduction refers to the effects of the cytoskeleton, the action of the ECM 
having a direct effect on nuclear deformation (i.e. the pulling of cells to a substrate) (Dalby 
2005).  Microtubules and intermediate filaments relay this mechanical stimulus through the 
plasma membrane to the nuclei via the LINC complex (linker of nucleoskeleton and 
cytoskeleton) proteins (Crisp et al. 2006).  The telomeres of the chromosomes are then 
lined to the nucleoskeletal lamins at matrix attachment regions (MARs) and mechanical 
changes at the adhesions sites can potentially have a direct impact on chromatin 
organisation (first identified in 1987 by Cockerill and Garrad (Cockerill & Garrard 1986).   
McNamara et al. utilised topography as a mechanical stimulus to demonstrate this and 
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found that providing tensile cues altered chromosome position and changes in gene 
expression (McNamara et al. 2012). 
 
Indirect mechanotransduction is undertaken by secondary signalling molecules in a 
biochemical cascade induced by the occupation of integrins for example, proteins such as 
expression FAK and mitogen-activated kinase (MAPK) (as shown in Figure 1.4) (Burridge 
& Chrzanowska-Wodnicka 1996).  The signalling cascade results in altered gene 
expression (Berrier & Yamada 2007).   
 
Tension relayed by integrins, is indicative of MSC differentiation to the osteogenic 
lineage.  In terms of MSC differentiation to the osteogenic phenotype, it is generally 
observed that adhesions are large and potentially stabilised by RACK1 (receptor of 
activated protein kinase C 1) causing high intracellular tension (Buensuceso et al. 2001; 
Balaban et al. 2001; Curtis et al. 2001). Tension, through activation of RhoA and ROCKII 
(Rho-associated protein kinase) stimulates osteogenesis.  Treatment with inhibitors that 
disrupt actin (e.g. blebbistatin or cytochlasin) reduces RUNX2 (runt-related transcription 
factor) activity  (Arnsdorf et al. 2009). This introduces the idea that cell tensegrity/strain 
has a role in differentiation.  Ward et al. have shown 3-5 % tensile strain on collagen I 
stimulates osteogenesis (Ward et al. 2007).  The mechanical strain caused an increase in 
mineralisation and downregulated adipogenesis and chondrogenesis (Ward et al. 2007). 
Understanding stem cell behaviour and the mechanisms that drive differentiation is critical 
for future use in therapeutics. The generation of bone cells from stem cells could be 
applied in future skeletal therapeutics, for which there is currently an unmet need. 
 
1.5 Bone Tissue Engineering 
Bone is the only tissue that after repair there is no scar and the bone regenerates itself to its 
original capacity (McKibbin 1978).  This system is only effective below a certain threshold 
known as the critical bone defect where beyond this size (2 mm), the bone will be unable 
to bridge the gap between the ends of the fragmented bone (Brydone et al. 2010). For 
fractures <2 mm, osteoblasts from the periosteum produce woven bone which forms a 
callus surrounding the dead tissue that is the fractured bone  (Brydone et al. 2010; 
McKibbin 1978).  Lamellar bone is produced via bone substitution and endochondral 
ossification (Brydone et al. 2010).  Osteoclasts move across the fracture site followed by 
osteoblasts which produce more bone (Brydone et al. 2010; McKibbin 1978).  For defects 
larger than this size caused by trauma, tumours, infections and prosthesis, there must be a 
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method of bridging the gap and promote of healing of bone by osseoinduction to restore 
functionality of the skeleton (Olivier et al. 2004).  Therefore, the differentiation of bone 
from stem cells could provide a method to bridge the gap if coupled with an appropriate 
material.   
 
This is particularly relevant to the current demographic of an ageing population where we 
expect an increase in the rate of age related skeletal issues in the next 20 years.  A 2016 
study for the office for national statistics (ONS) states that 17.8 % of the UK population is 
aged 65 and over, an increase of 21 % from 2005, and 2.3 % of the population is aged 85 
and over, an increase of 31 % since 2005 
3
.  The number of centenarians has also risen by 
65 % in the same period (Figure 1.5).  There has been a steady increase in ageing 
population (90 years and above) from 201,195 people in 1986 to 571,245 people in 2016 
(although this is representative of a small proportion of the population, Figure 1.5) 
4
.  The 
increase is accounted for by the decreasing mortality rates due to improvement in standard 
of living, nutrition and reduction in smoking.  The lag in 2008 is a result of the low birth 
rate prior to World War I, which recovered in the 1920s.  This is not just a UK trend, a 
recent study looked at 35 industrialised countries and analysed the projected life 
expectancy in the year 2030 (Kontis et al. 2017).  It was calculated that in 2030 life 
expectancy will increase for all 35 countries.  For example, they predict average life 
expectancy of women in South Korea would reach 90 years which was previously thought 
to be unobtainable (Kontis et al. 2017). The data was taken from statistics databases 
namely age-specific mortality rate, therefore this highlights that there is a world-wide 
aging population (Kontis et al. 2017).  This impacts all aspects of social care globally and 
there will need to be a change in policy to account for geriatric care and the consequences 
of the ageing population (Oreffo et al. 2005). 
 
                                                 
3
https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populati
onestimates/bulletins/annualmidyearpopulationestimates/mid2015 
   
4
 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/
bulletins/estimatesoftheveryoldincludingcentenarians/2002to2016#the-oldest-old-are-
getting-older 
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Figure 1.5 - Population Data for Persons Aged 90 Years and Over.  Graph replicated from the ONS and 
shows the number of people aged 90 and over.  There has been an increasing trend since 1986 and the 2016 
value stands at 571,245 people.  The value decreased slightly in 2008 and was attributed to the decreased 
birth rate prior to World War I.  Overall the trend is increasing and demonstrates an increasing ageing 
population. 
 
One such consequence of an ageing population is the incidence of skeletal diseases such as 
osteoporosis (incidence increases with age).  230,000 osteoporotic fractures occur per year 
and most joint replacement surgeries occur in patients over 65 years 
5
.  A group from The 
Netherlands state the cost of treatment for osteoporotic fractures to their country was € 200 
million (2010).  This accounts for 32 % of all fractures in The Netherlands where 55 % of 
fractures were of the hip (Lötters et al. 2016).  They estimated that the costs for 
osteoporosis related fractures would increase by 50 % from 2010 to 2030 due to increasing 
incidence (40 % from 2010-2030) (Lötters et al. 2016). 
 
Currently, bone grafts, ceramics or metal implants are utilised to repair critical defect 
fractures (Brydone et al. 2010). However, with allogeneic bone donations there is a risk of 
immune rejection (Brydone et al. 2010). Therefore, autologous bone replacements would 
be most effective but as each bone is specialised, rearrangement would need to ensure that 
the skeleton was not further compromised, which is impossible in the case of multiple 
fractures (Brydone et al. 2010). In addition, revision surgery is painful, costly, the sites that 
bone can be taken from are limited and there is a risk of comorbidity. 
 
                                                 
5
 www.ageuk.org.uk 
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Materials approaches have therefore been applied including the use of ceramics.  Calcium 
phosphate ceramics including hydroxyapatite (HAP), tricalcium phosphate (TCP), 
amorphous calcium phosphates (ACPs) and biphasic calcium phosphates (BCPs) have 
been widely used (Samavedi et al. 2013).  There is variation of cell response 
(osteoinductivity and osteoconductivity) for each ceramic due to differences in surface 
roughness, solubility, porosity and chemistry (Samavedi et al. 2013).  Moreover, ceramics 
can degrade over time, leading to loosening of the joint (Sumner 2015; Samavedi et al. 
2013). Furthermore, ions released from the ceramics can change local pH that affects cell 
viability (Sumner 2015; Samavedi et al. 2013).  
 
Metal implants are usually synthesised from titanium (McNamara et al. 2011).  For joint 
replacement surgeries particularly that of the hip, titanium implants are mechanically 
sound however, there are concerns with wear, corrosion and leaching of metal leading to 
osteolysis and resorption of remaining bone over time (Sansone et al. 2013).  Another 
concern of utilising metal implants is the stress shielding effect.  Stress shielding refers to 
reduction in bone density due to removal of typical stress from the bone to the implant 
because of the implants high elastic modulus (Yamako et al. 2017; Sumner 2015).  The 
loss of bone can have consequences for the long-term performance of the joint through 
loosening and instability, which can lead to fracture and subsequent revision surgery 
(Yamako et al. 2017; Sumner 2015).  Brydone et al. state that the revision rate stands at 
11.94  2.53 % for selected developed countries which means patients are undergoing 
multiple surgeries (Brydone et al. 2010).  This invasive surgery effects quality of life 
especially for older patients (Oreffo et al. 2005) and increases the risk of hospital inquired 
infections such as methicillin resistant staphylococcus aureus (MRSA) (Struelens 1998).   
 
The biocompatibility of current therapeutics is no longer sufficient to repair bone grafts, 
there is a need for bioactive materials i.e. one that encourages a response in vivo and can 
stimulate regeneration in tissues (Hench & Polak 2002).  One suggestion to overcome such 
limitations is the use of polymer scaffolds that can be used to bridge critical bone defects, 
that are resorbable and porous to encourage osseointegration (Hench & Polak 2002). 
Bioresorbable polymers such as polycaprolactone are ideal because of their resorbable 
properties, porosity that can be controlled during fabrication and the batch to batch 
reproducibility (Koh & Atala 2004). The polymers can be used in combination to allow for 
differing resorption rates and partial infiltration of the scaffold by osteoblasts.  Porosity is 
vital for the invasion (and attachment) of cells and vasculature to sustain the implant and 
removal of waste products (Hing 2005).  
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Whichever material is chosen, it will need to be seeded with a vast amount of high quality 
osteoprogenitor cells, a potential source of these cells would be MSCs.  Traditional tissue 
culture plastic although biocompatible, is sub optimal for stem cell culture due to the lack 
of directionality and the risk of spontaneous differentiation (Hench & Polak 2002).  In 
vivo, the niche is maintained by an ever-changing relay of regulatory signals (Watt & 
Hogan 2000).  On glass, there is no maintenance of phenotype and therefore spontaneous 
differentiation can occur.  This is where materials engineering could help by mimicking 
aspects of the niche and what this thesis aims to explore. 
 
1.6 Materials for MSC TE 
For TE to be successful, we need to have better control of cell behaviour in vitro to prevent 
off target effects.  One such method for controlling cell behaviour is the use of materials, 
where control is gained through the cell-material interface.  Manipulation of stem cell 
behaviour through materials allows us to direct cell behaviour in vitro. To be 
therapeutically useful, a pure population of stem cells must be available in large quantities, 
that can be differentiated in to the target cell (Koh & Atala 2004).  Material engineering 
gives us the opportunity to communicate to the cells the behaviour that we require, such as 
differentiation to bone cells.  This field is becoming increasingly collaborative and 
therefore increasingly novel technologies evolve.  The first consideration for any materials 
strategy is to be biocompatible and meet safety requirements, many available materials are 
FDA (Food and Drug Administration) approved (Koh & Atala 2004).  
 
The use of materials has evolved over time.  Biomaterials approaches in the 1970s aimed 
to mimic the mechanical properties of the tissue they were to replace and with minimal 
immune response (Hench & Polak 2002).  The second generation of materials aimed to be 
“bioactive” and included materials such as HAP that contained functional groups that 
elicited a cellular response (Hench & Polak 2002).  Another material advance was the 
creation of resorbable materials such as polylactic acid (PLA), which could be replaced 
over time by osseointegration.  These advances did not have lasting effects and a third 
generation of materials was implemented that aimed to manipulate the cells molecular and 
gene regulation in a known and reproducible manner (Hench & Polak 2002).  This was the 
beginning of the field of TE and with advancing technology and increasing collaboration, 
novel methods of synthesis and therefore “smart” materials were gained.  The soft 
lithography methods of George Whitesides' paved the way for many materials engineers.  
Soft lithography was an advantage to bioengineering owing to precise, scalable and cost 
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effective methods of cell culture (Qin et al. 2010; Kane et al. 1999). Other materials 
strategies include roughness, demixing, hydrogels, photolithography, microcontact printing 
and electrospinning to yield substrates with a variety of properties (Anselme & Bigerelle 
2005; Dalby et al. 2004; M P. Lutolf et al. 2003; Wilkinson et al. 2002; Rogers et al. 1997; 
Zhang et al. 2005).  They can be characterised depending on the material property; 
chemistry, topography or stiffness, in a system that can be visualised as a triangle of cell 
control (Anderson et al. 2016) (Figure 1.6).   The main commonality between these 
materials is the manipulation of cell adhesions which is not only necessary for cell survival 
(due to anchorage dependency) but also is responsible (in the case of stem cells) for 
driving changes in self-renewal or differentiation (Anderson et al. 2016).  There is now a 
new generation of materials in the field.   Stimuli responsive materials aim to be dynamic 
in nature to allow for the presentation of ligands to control cell behaviour in a similar way 
to the presentation of matricryptic sites in vivo (Davis et al. 2000).  The following section 
will explore materials engineering in terms of MSC cell culture and in particular, materials 
utilising the adhesive tripeptide Arg-Gly-Asp (RGD) for cell attachment.  
 
Figure 1.6 - The “Triangle” of Materials Engineering.  The “triangle” encompasses variations in 
chemistry, stiffness and topography (2D), all of which manipulate MSC adhesion.  The figure highlights the 
way in which the materials interface influences intracellular cell signalling through tension via integrins and 
focal adhesions (red). Reproduced from (Anderson et al. 2016). 
 
1.6.1 Topography 
Cellular response to substrate shape was firstly defined in 1911 by Harrison (Harrison 
1911) and in 1952 Weiss and Garber coined the term “contact guidance” to describe cell 
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alignment to topography (Weiss & Garber 1952).  However, it was not until the late 1980s 
that technology allowed more in-depth study of cell response to microscale.  This theory 
was first proposed by Curtis and Wilkinson and has since been the rationale for subsequent 
topographical studies (Clark et al. 1987; Clark et al. 1990).  The cellular response to the 
microscale was first tested by using baby hamster kidney (BHK) cells and a series of 
microchannels made from silica using photolithography (Clark et al. 1987).  It was then 
shown that cell morphology differs due to its’ contact guidance in response to changes in 
substrate properties; in this case, microchannel depth (Clark et al. 1987; Clark et al. 1990). 
Since this observation, many more publications have utilized microscale topography on a 
variety of cell types, all obtaining contact guidance (Britland et al. 1996; Chen et al. 1997; 
Engler et al. 2009; Lim et al. 2004; Teixeira et al. 2006).  Microchannels are thought to be 
particularly appealing to nerve tissue engineering, as these materials encourage elongation 
of cells and indeed, were utilised by Yim et al. for induction of MSC differentiation in a 
neural lineage (Yim et al. 2007). 
 
After the cell response to the microscale was established, nanoscale interactions were 
investigated.  Much like the microscale, novel technologies had to be developed.  Electron 
beam lithography (EBL) is one such technique that can produce areas of precise 
topographies in pre-defined geometries (Gadegaard et al. 2003).  The production of these 
can be up scaled by injection moulding, where a negative copy is created in a nickel shim 
(via electroplating), this method creates a high-throughput manufacturing system, ideal for 
replicates for cell culture (Gadegaard et al. 2003).  This technique was applied to MSC 
culture materials and it was found that a square geometry enabled MSCs to self-renew for 
up to 4 weeks, a period previously unachievable in culture (Dalby et al. 2007).  Slight 
disorder from this configuration (20 and 50 nm offset) facilitated osteogenic 
differentiation to a level comparable to traditional chemical induction (McMurray et al. 
2011). EBL has undoubtedly aided precision in the nanoscale and generated materials on a 
scale that is therapeutically relevant (mm
2
-cm
2
) however, it is time consuming (Anderson 
et al. 2016).   
 
Topography has been applied on the nanoscale using other materials such as titanium, by 
methods such as anodising through block copolymer templating with  Ps-b-P4VP to create 
a pillar formation rather than pits (Sjöström et al. 2009; Sjöström et al. 2013). As titanium 
is the current implant of choice for skeletal defects, patterning titanium with pillars could 
promote osseointegration (Sansone et al. 2013).  McNamara and colleagues have shown 
that titanium pillars of 15 nm are optimal for MSC differentiation to bone (McNamara et 
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al. 2011). Utilising patterns such as these on implants for hip replacements, could guide 
MSC differentiation toward bone formation preventing loss of bone that is usually 
observed in response to plain titanium implants (McNamara et al. 2011).   
 
1.6.2 Chemistry  
Soluble chemistries, while able to induce cell behaviour have the risk of off target effects 
and variability.  Materials engineering allows the same directive moieties to be tethered to 
a material and therefore creating a stable interface. The application of surface chemistry 
can be added using techniques like microcontact printing and dip pen nanolithography 
(DPN).   
 
DPN is the process by which functional groups are applied in a specified pattern to a 
substrate using an atomic force microscopy (AFM) tip (nanoscale) (Ginger et al. 2004).  
This allows several layers of control over the chemistry, firstly there is a wide choice of 
functional groups that can be chosen (e.g. peptides to  DNA) that can be deposited in 
defined patterns and tailored sizes (1-100 nm)  (Salaita et al. 2007; Ginger et al. 2004).  
Further, the fabrication method is mild enough to be used in a biological context and has 
the added advantage of precision, durability and is cost effective (Curran et al. 2010).   In 
the context of stem cell engineering, Curran et al. found that different functional molecules 
induced differential behaviours in MSCs (Curran et al. 2010).  By spacing chemistries 
measuring 70 nm in square or hexagonal array at differing distance of pitch, they found 
that –CH3 groups maintained stemness whereas –NH2 groups promoted osteogenesis via 
increased cell adhesion (Curran et al. 2010). 
 
Microcontact printing has provided a method to understand how cell shape regulates cell 
behaviour. McBeath et al. first correlated MSC spreading and tension as precursors to 
osteogenic fate (McBeath et al. 2004).  Using polydimethylsiloxane (PDMS) stamps to 
print large square areas (10,000 µm
2
) they found that spreading facilitated osteogenesis by 
activating RhoA and the downstream effector ROCK (McBeath et al. 2004).  In 
comparison, smaller stamps (1,024 µm), where cell size was restricted, lipid secretion and 
the upregulation of fat markers were observed (McBeath et al. 2004).  PDMS stamps can 
be used to pattern a wide array of geometries.  In an extension to this study, Kilian et al. 
utilised PDMS stamps to create star, pentagonal and flower shape patterns to correlate cell 
differentiation to morphology (Kilian et al. 2010).  These shapes, while comparable in 
area, differ in subcellular curvature creating changes in contractility of cytoskeletal 
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apparatus.  It was found that a specific shape (star) promoted contractility (Kilian et al. 
2010). This in turn resulted in differential signalling and activation of ERK1/2 
(extracellular related kinase 1/2) and JNK (c-Jun N-terminal kinase) via RhoA, Rac and 
cdc42, resulting in terminal differentiation to osteoblasts (Kilian et al. 2010). Thus, 
demonstrating that geometric cues, provided by the ECM, can regulate cell fate. 
 
Growth factors (GFs) are important molecules for cell physiology and homeostasis 
(Schultz & Wysocki 2009).  As such, researchers have utilised GFs as a stimulus to direct 
cell behaviour, albeit with limited success.  In some cases (clinical trials), the 
concentrations used for the effect have produced off target effects with dangerous 
consequences (Salmerón-Sánchez & Dalby 2016).  Llopis-Hernández et al. have used 
materials based methods to counteract these side effects (Llopis-Hernández et al. 2016).  
Fibronectin contains specific regions for GF binding fragments (FNIII12-14), coating  
poly(ethyl acrylate) (PEA) with fibronectin exposes these domains and allows the tethering 
of GF, in this example bone morphogenetic protein 2 (BMP-2) (Llopis-Hernández et al. 
2016).  Osteogenic differentiation of MSCs was achieved via enhanced Smad (small 
mothers against decapentaplegic) signalling and co-localisation of the integrin 1 subunit 
and the BMP receptor BMPR1a (Llopis-Hernández et al. 2016).  The benefit of this system 
is that the GF are used in small doses (25 ng mL
-1
) in a localised area without off-target 
effects and has potential as a method for GF engineering in future (Llopis-Hernández et al. 
2016). 
 
1.6.3 Stiffness 
Cell response to stiffness was popularised by Engler et al. in a seminal study in 2006 
(Engler et al. 2006).  Using hydrogels, they showed that the stiffness of a material can 
regulate MSC differentiation (Engler et al. 2006). By mimicking the stiffness of a certain 
tissue, MSCs will differentiate into the tissue native to that cell type i.e. by creating a 
hydrogel with elastic modulus that is like pre-mineralised bone, MSCs will differentiate 
down an osteogenic lineage (Engler et al. 2006). This study has caused a rippling effect 
seen on many levels.  Not only was it a novel idea for MSC growth but it also changed 
what was understood about MSC lineage specification.  Engler et al. created a hydrogel 
mimicking the elastic modulus of the brain and claimed that MSCs differentiate in a neural 
lineage (Engler et al. 2006). This was the first example of a neural link in potential MSC 
phenotypes. 
 
  24 
Khetan’s 2013 study uses hydrogels to confirm spreading and morphology is linked to cell 
fate decisions via traction in a 3D environment (Khetan et al. 2013).  They employed 
phototunable hydrogels that were degradable when exposed to light.  After irradiation, the 
cells were then able to remodel the matrix and when seeded with MSCs, encouraged cell 
spreading and osteogenesis.  Cells that were restricted by undegradable matrix differentiate 
to adipogenic lineage (Khetan et al. 2013).  
 
The stiffness engineering sector is controversial due to a debate on the mechanism of 
cellular response to material stiffness.  Trappmann et al. argue that it is the hydrogels pore 
size that is the defining factor in the cellular response to gels (Trappmann et al. 2012).  
They created two different polymer hydrogels (PDMS and polyacrylamide, PAAm) on the 
same range of stiffness’ as identified by Engler (Trappmann et al. 2012). The expected 
result was only produced when culturing on PAAm i.e. soft surfaces elicited adipogenesis 
whereas hard surfaces resulted in osteogenesis correlating to the results in Engler’s work 
from 2006 (Figure 1.7 A) (Trappmann et al. 2012; Engler et al. 2006).  Comparatively 
there was no trend with PDMS substrates (Figure 1.7 A) (Trappmann et al. 2012).  They 
argued that although the bulk stiffness properties were similar, the pore size was different, 
therefore providing differing anchoring points to the ECM.  The pore could be thought of 
as topography, and it was this feature that the cells are responding to, rather than the bulk 
stiffness (Trappmann et al. 2012). This theory was challenged by Wen et al. who created 
hydrogels of differing pore size but comparable bulk stiffness (Wen et al. 2014). On soft 
gels, adipogenesis was observed regardless of pore size, likewise for stiff gels that showed 
osteogenesis independent of pore size (Wen et al. 2014) (Figure 1.7 B). Based on current 
data showing that bulk stiffness effects phenotype in 2D surfaces and the additional 3D 
work by Engler et al, it is more likely that the conclusions drawn by Wen et al. are closer 
to the truth.  However, further work is required to robustly support the conclusions drawn 
by Wen et al. For instance, if they had repeated their experiments in hydrogels of different 
materials in addition to the polyacrylamide gels they could have effectively rule out 
porosity. 
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Figure 1.7 – The Debate on Porosity of Hydrogel Stiffness and Effects on MSC Differentiation.  A) 
Trappman et al. created hydrogels of stiffness defined by Engler et al. 2006 in two different polymers, 
PDMS and PAAm.  The PAAm polymer followed the same trend as described by Engler – osteogenesis on 
stiff and adipogenesis on soft surfaces.  The PDMS did not follow any trend and it was thought that pore size 
of the hydrogels effected tensegrity.  B) Wen et al. created soft and stiff hydrogels and various pore sizes for 
each.  They found that each stiffness acted as expected and that pore size was independent to phenotype. 
Adapted from (Anderson et al. 2016) 
 
1.7 Stimuli Responsive Materials  
These previous examples, while having been invaluable to understanding MSC behaviour, 
provide one biological cue.  Now there are materials to regulate stem cell behaviour on 
multiple levels using stimuli.  Stimuli responsive materials dynamically alter a material 
property in a bid to mimic the niche by regulating cell behaviour in situ.  Stimuli can come 
in many forms, the most notable are light, temperature and enzyme directive technologies. 
 
1.7.1 Light 
Due to the ease of control and reproducibility, light continues to be a well-used stimulus. 
In a two-dimensional system, a photoactive moiety is easily manipulated to change the 
material property.  In an early example, Wirkner et al. have used light to degrade 
photoliable benzylic hydrogen caging groups that block RGD (Wirkner, Alonso, et al. 
2011).  Once stimulated by light, the RGD is exposed and HUVECs (human umbilical vein 
endothelial cells) adhere to the material (Wirkner, Alonso, et al. 2011).  In a follow up 
study, they utilised the technology to pattern specific regions of a substrate and controlling 
HUVEC attachment (Wirkner, Weis, et al. 2011).  This system would be beneficial for co-
culture purposes to mimic tissues of specific architecture.  However, using this method, 
once photo-activated, the effect is one way.  Liu et al. developed a reversible system 
utilising azobenzene to switch from permissive to restrictive adhesion on demand, 
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depending on the conformation of azobenzene (trans-cis or cis-trans at 340-380 or 450-
490nm respectively) (Liu et al. 2009).   
Similar technology can also be applied in three dimensions.  Mosiewicz et al. have used 
light to uncage an enzyme responsive sequence within a hydrogel to create and on demand 
stimuli responsive system for cell invasion (Mosiewicz et al. 2013).  In this manner MSC 
adhesion can be spatiotemporally controlled in three dimensions. This could later be 
applied to developmental biology where spatiotemporal signalling could be tested e.g. 
morphogen effects on pluripotent stem cells (Mosiewicz et al. 2013).  Lee et al. took this 
idea a stage further and utilised caged RGD on poly (ethylene glycol) diacrylate (PEGDA) 
hydrogels in an in vivo system (Lee et al. 2015).  This was implanted in a mouse model 
and exposed to UV light at 350 – 365 nm (Figure 1.8A) (Lee et al. 2015). Increased cell 
number and cell spreading was observed with transdermal activation and subsequent 
availability of RGD.  However, cell attachment decreases by 50 % 500 µm from light 
exposure (Figure 1.8B) (Lee et al. 2015).  It would be difficult to scale this up or utilise in 
vivo as light does not penetrate skin.  
 
Figure 1.8 - Limitations of Light Responsive Hydrogels in vivo.  A) Transdermal activation of hydrogel 
via photomask. B) Adherent cell density versus distance of irradiation.  Adherent cells decrease dramatically 
with increasing distance from light source.  Images adapted from (Lee et al. 2015) 
 
Perhaps the best use of light is in conjunction with hydrogel stiffness and is used as a 
stimulus for either permissive or restrictive adhesion. It is thought that cells cultured at a 
defined stiffness prior to implantation, have a “mechanical memory” and therefore pre-
treatment maintains phenotype in vivo (Yang et al. 2014).  This was tested in situ by using 
light responsive hydrogels.  Irradiation at 365 nm for 360 s changes hydrogel properties 
from stiff (10 kPa) to soft (2 kPa) (Yang et al. 2014).  MSCs that had ten days’ pre-
treatment on the stiff hydrogel, retained the osteogenic phenotype, even when the hydrogel 
was photoinduced to have soft properties, unlike those that had been pre-treated for less 
time.   
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Perhaps the use of light as a stimulus is more useful to in vitro cell culture systems where 
cells could be removed from culture-ware without the need for trypsinisation or for coating 
materials used in healthcare to prevent bacterial colonisation before use, rather than a use 
for in vivo TE due to the limitations shown in Figure 1.8B. 
 
1.7.2 Temperature 
There have been many examples in the literature utilising temperature responsive 
materials.  Each have utilised various polymers and differing degrees of complexity to aid 
cell adherence.  Lutz et al. created copolymers of polyethylene glycol (PEG) and 
methacrylate that form temperature sensitive layers (Lutz 2008).  When heated (37 °C) the 
polymer acts as a medium for cellular adhesion (Lutz 2008).  In contrast, cooling the 
surfaces to room temperature (25 °C) cells were repelled (Lutz 2008).  This process 
changes conformation of the polymer but does not damage the surface and therefore 
generates a reversible platform for cell manipulation (Lutz 2008).  The optimal application 
for such a material would be a clinical setting where it could be used to coat an implant 
which would not support the growth of any bacteria or other cell types at room temperature 
prior to implantation, prohibiting infection post-surgery. This technique is not sufficient for 
future enabling technology as it does not direct cell behaviour.  An improvement on this 
method is presented by Yamato et al. who have patterned the temperature sensitive 
polymer poly (N-isopropolyacrylamide) (PIPAAm) onto a material using electron beam 
irradiation (Yamato, Kwon, et al. 2001).  This was employed to create a co-culture of 
hepatocytes and endothelial cells (Yamato, Kwon, et al. 2001).  Firstly, a monolayer of 
hepatocytes was established then the temperature was reduced preventing adhesion of 
hepatocytes on the areas patterned with PIPAAm.  The dish is then seeded with epithelial 
cells (Yamato, Kwon, et al. 2001).  Co-culturing was effective as it maintained albumin 
secretion of the hepatocytes (the standard functional assay for hepatocyte growth in 
culture) (Yamato, Kwon, et al. 2001).  Furthermore, by mimicking dynamic nature of cell 
interactions provides a better quality cell population over traditional culture particularly in 
the case of hepatocyte cell culture where it is difficult to maintain hepatocyte functionality 
in vitro (Schuetz et al. 1988).   Temperature has also been utilised in combination with 
topography to create vertical micropillars that were temperature-sensitive with regard to 
their permissiveness for adhesion. Notably, changes in temperature gave rise to alterations 
in micropillars angles, which subsequently resulted in a non-adhesive conformation 
(Reddy et al. 2007).  Using shape memory thermoplastic elastomers that altered 
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topography by adjusting transition temperature, adhesion could be controlled on demand 
(Reddy et al. 2007).   Although this application is intended as a sticky material, it would 
also be desirable to have a similar system for cell-surface interactions for the dynamic 
attachment and release of cells from a material. 
These techniques, while more dynamic than the 2D surfaces, do not fully encapsulate 
biomimicry.  Changes in light and temperature are rare in vivo, rather cells use enzymes to 
alter their environment.  Although temperature responsive materials in vitro are practical, 
they are unsuitable for in vivo use due to their limitations as a biological stimulus (de las 
Heras Alarcón et al. 2005). 
 
1.7.3 Enzyme Responsive  
Enzymes can be employed in a materials context in several ways.  They can be utilised as 
the stimuli for self-assembly (surface build up) or as a means of modifying the pre-existing 
surface.  This section will focus solely on the use of enzymes as a modifier.   As a 
stimulus, enzymes are beneficial because they are natural, specific and as they are a 
diverse group of proteins, there are many to select from depending on the desired 
application (Bugg 2001).  Therefore, for in vivo use, they could be a more appropriate as a 
stimulus, as they are more natural to a biological system.  It is accepted that enzymes are 
exquisitely selective and can discern not only between proteins but also between 
enantiomers of the same protein with proteolysis occurring at a specific site on a peptide 
chain
 
(Bugg 2001).  Before synthesis of the material can occur, there are certain design 
aspects to consider.  Firstly, a suitable enzyme must be identified for the application then 
selectivity and specificity of the peptide recognition sequence must be evaluated (this 
process can encompass both literary studies and bioinformatics).   Putting these elements 
together yields a material that is specifically cleaved to create a conformational change 
(Wang et al. 2010).  It is thought that this could be amenable to several different 
applications such as cell culture, therapeutics and diagnostics.   
 
The identified hallmarks of a cancer cell are increased neovascularisation and metastasis 
(Hanahan & Weinberg 2000).   The matrix metalloproteases (MMPs) are upregulated by 
cancer cells to promote this effect, for example glioblastoma cells show an increase in 
MMP-2 and MMP-9 expression.  Tauro and Gemeinhart in 2005 utilised a hydrogel loaded 
with the cancer inhibitor cisplatin, that was selectively released due to the presence of the 
target enzyme at the tumour site (Tauro & Gemeinhart 2005). Therefore, in terms of 
therapeutics, enzyme responsive peptides within hydrogels offer another advantage in that 
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they can be loaded with drugs.  In comparison, Lutolf et al. utilised MMP targetable 
hydrogels as a scaffold for cell invasion, to bridge a critical bone defect.  Here they loaded 
an MMP cleavable hydrogel with BMP-2 and implanted it into a critical bone defect in 
mouse models and showed that this system encourages osseointegration (M P. Lutolf et al. 
2003).  It is also possible to miniaturise hydrogels to create hydrogel beads.  Thornton et 
al. utilised this to incorporate an enzyme responsive sequence that releases a charged 
moiety that induces a reduction in bead swelling and pore size (Thornton et al. 2005).    
Prior to this cut off, the bead can absorb macromolecules from fluids and therefore could 
be used to remove harmful macromolecules from tissue fluids (Thornton et al. 2005).  
These examples offer an in vivo method for therapeutic benefit, but it is also possible to 
utilise them as in vitro reporters. In one application, amino acids were tethered to glass 
beads that were capped with a fluorescent reporter.  After incubation with different 
enzymes, the selectivity of that enzyme could be determined by identifying the presence or 
absence of the fluorescent marker.  This creates a high-throughput method for enzyme 
selectivity and could be applied to both healthcare and bioengineering (Doezé et al. 2004) 
 
There are some factors to be taken into consideration when designing an enzyme 
responsive technology particularly when designing a two-dimensional surface. Enzymes 
are active in hydrated environments such a biological systems but kinetically different in 
enzyme responsive materials (ERMs) (Ulijn 2006). 
 
1.8 Project Objectives 
It is our aim for this project to overcome limitations to traditional stem cell tissue culture 
by utilising an enzyme modifiable surface for MSC differentiation.  We aim to utilise the 
MMPs secreted by MSCs to modify a material that will result in control of MSC 
behaviour. This varies from other technologies available as it is under cellular control and 
there is potential for two behavioural cues to be delivered to the stem cells (stem cell self-
renewal and differentiation). 
 
As discussed above, effective materials engineering aims to mimic the cellular regulation 
that the ECM provides, this is particularly true for stimuli responsive materials where 
multiple roles are envisaged.   The surface that we propose to explore incorporates an 
ERM element but adds a level of complexity in that the stimuli comes from the enzymes 
that the cells themselves secrete (MMPs).  Figure 1.9 shows the schematic of the proposed 
surface.    By creating a surface chemistry (of peptide chains tethered to a glass coverslip) 
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that is amenable to these MMPs, we hope to control cell adhesion and ultimately cell fate. 
The RGD sequence is hidden beneath an enzyme recognition sequence and both are 
capped with a blocking group, PEG.  In response to MMPs, the recognition site is cleaved 
revealing the cell adhesive peptide RGD allowing cell binding via integrins.  This in turn 
will stimulate intracellular tension that is capable of initiating cell differentiation along the 
osteogenic lineage (RGD shown previously to be permissible to osteogenic differentiation, 
Section 1.6).  The blocking group was designed to be permissive to MSC self-renewal. In 
this manner, we hope to develop a system for mesenchymal cell culture that offers a non-
invasive method for both stem cell self-renewal and differentiation that is under cellular 
control.  
 
The surface is created by grafting peptides in a defined sequence onto a glass coverslip 
using solid phase peptide synthesis (SPPS).  SPPS is a versatile technique that allows 
addition of amino acids to a solid substrate in a configuration determined by the user.  We 
are therefore unrestricted in the length and composition of the desired sequence and we can 
tailor the chemistry to mimic the peptide sequence that is cleaved by MMPs.  MMPs are 
naturally secreted by cells primarily to remodel their ECM.  It has also been suggested that 
they have other functions within the body including development and wound healing 
(McQuibban et al. 2001). By providing a chemistry that is cleavable, we expect the ERM 
to be remodelled in situ by the cell population (this rationale has been previously employed 
in hydrogels (M P. Lutolf et al. 2003; Wade et al. 2015; Shekaran et al. 2014; Tauro & 
Gemeinhart 2005).  
 
 
Figure 1.9 – Schematic of Surface Remodelled by Cell Secreted MMPs.  MSC in situ secrete MMPs that 
will cleave the PEG blocking group (purple) and the recognition site (orange) to reveal RGD (green).  
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Binding to RGD is hypothesised to result in osteogenic lineage specialisation via increasing intracellular 
tension.  
 
There is a need for new materials for MSC growth as traditional culture ware cannot 
provide directional cues and other materials strategies contain static or inappropriate 
stimuli for mammalian cell culture (Hench & Polak 2002). Our system differs from other 
ERMs as it is designed to be controlled by a cell population, not in response to an enzyme 
added by the user.  Moreover, the surface is designed to provide two behavioural cues; 
stem cell self-renewal (in response to intermediate tension as the blocking group prevents 
direct binding to RGD) and differentiation (revealing of RGD).  In this manner, the system 
is reminiscent of the bone marrow niche as there is regulation of both growth, as stem cells 
repopulate and targeted differentiation. In addition, the presentation of motifs (created by 
SPPS peptides) is like that of the dynamic presentation of cryptic sites from ECM proteins. 
This is unlike other technologies that are static in nature (such as topography) and is more 
complex than other ERMs which have only demonstrated one cell phenotype.   
 
1.8.1 Solid Phase Peptide Synthesis (SPPS) 
SPSS was developed in the 1960’s as a method to synthesize long polypeptide chains in 
vitro that were unobtainable by other methods (Merrifield 1963).  Once completed, the 
chains were removed from the support allowing further experimentation. Merrifield’s 
technique was revolutionary, improving the field of peptide chemistry for which he was 
awarded the Nobel Prize in Chemistry in 1984.  
 
Figure 1.10 shows the SPPS methodology.  The technique works by grafting amino acids 
from an insoluble solid support via a linker, typically one that has a free amine group that 
the C-terminal of the first amino acid can bind to by a condensation reaction creating a 
covalent bond (Merrifield 1963; Mitchell et al. 1978). The amino acids used in the 
technique are protected on the N-terminal by a protecting group to prevent multiple amino 
acids binding to the chain and binding to each other.  Side chains are also protected to 
prevent amino acid addition from the side group (Palomo 2014). Coupling of amino acids 
is performed in the presence of a catalyst (Fields & Noble 1990).  Prior to chain 
elongation, the blocking group is removed to allow addition of the carboxyl group of the 
next amino acid to the free amino group of the amino acid added previously.  The coupling 
and deprotection stages are repeated in the required pre-determined sequence until the 
required chain length is achieved.  The sequence can then be maintained on the resin to 
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create a 2D surface chemistry or cleaved from the substrate to be used in other applications 
(Merrifield 1963).  
 
The  resin (material from which amino acids are grafted from) must have a free amino to 
allow coupling of the first amino acid (Merrifield 1963). If the resin does not have a free 
amine, a linker must be provided.  One requirement for the resin is that it must withstand 
the continual flow of solvents at low pressure (during washing steps for in situ SPPS) and 
must be insoluble in the solvents which are utilised in the washing steps (Fields & Noble 
1990).    Peptides that are maintained on the resin should have linkers that are also 
insoluble in the solvent that is used to remove side chain protecting groups (Fields & 
Noble 1990). 
 
 
Figure 1.10 – Schematic of SPPS Method.  Amino acids are coupled to an insoluble resin via a linker to 
provide a free amide group (in this case, PEG diamine).  Amino acids are protected on the N-terminal by a 
group such as Fmoc (purple).  Prior to the next amino acid addition, the Fmoc group must be removed 
(deprotected), in this example this is done by a base, piperidine.  Coupling and deprotecting are repeated until 
sequence is completed (chain elongation).  The chain is either maintained or cleaved from the resin.   
 
The amino acids that are employed in SPPS are capped on the N-terminal by a variety of 
different N-terminal protecting groups such as tert-butoxycarbonyl (Boc) and fluoren-9-
ylmethyloxycarbonyl (Fmoc). The choice of protecting group will depend on the 
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application however, the use of Fmoc is favourable as is it can be cleaved under mild 
conditions (Carpino & Han 1972). Fmoc chemistry was introduced in the 1970’s and while 
Fmoc chemistry is advantageous to SPPS, the utilisation of both allows efficiency for 
chemical synthesis of a range of different compounds (Fields & Noble 1990). This study 
was carried out exclusively using Fmoc protected amino acids and therefore this section 
will focus specifically on Fmoc SPPS.     As stated, the carboxyl terminus of the free 
amino acid is added to the amino linker of the resin via condensation reaction (removal of 
water).  Efficiency is paramount to ensure homogenous peptide products.  For efficiency, 
the reaction occurs in the presence of a catalyst, typically, a carbodiimide (Palomo 2014).  
Dicyclohexylcarbodiimide (DCC) was initially used however this was changed to 
diisopropylcarbodiimide (DIC) as it forms soluble urea by products that can be easily 
removed in washing solvents (Palomo 2014).  Coupling and deprotection are repeated until 
the full and final sequence is obtained.   
 
The removal of the protecting group is necessary to allow addition of the next amino acid. 
Fmoc is base labile and removal of the Fmoc group is therefore completed by the addition 
of a basic solvent for example piperidine.  Side group protection is also necessary for those 
amino acids that contain amine groups which prevents the addition of amino acids to side 
groups and allows chain elongation from the N-terminal in an expected manner. Further, as 
Fmoc deprotection is base labile, acid labile side chain protecting groups are favourable to 
withstand deprotection stages.  Asp side chains are typically protected by t-butyl (tBu) 
which meets requirements for Fmoc chemistry (Behrendt et al. 2016)  Arg side chains are 
of particular consideration due to the trifunctional guanidine side chain which can be easily 
acylated (facilitate binding by NH2) (Behrendt et al. 2016).  One or two of these chains 
have to be protected for Fmoc SPPS with for example, Pbf (Pentamethyl-2,3-
dihydrobenzofuran-5-sulfonyl) (Palomo 2014).  Side chain protecting groups are removed 
once the sequence is complete, if the chain is to be removed from the resin, the side groups 
and linker should be soluble in the same solvent.  There are many advantages to this 
technique for example, each addition and deprotection stage takes place in the same vessel.  
This is described as continuous SPPS where coupling, filtration and washing of by-
products can be performed easily (Merrifield 1963).  The reagents can be used in excess to 
force the reaction to completion and give high yields (Erickson & Merrifield 1976).  In 
addition, peptides can be synthesised with high purity making it attractive to use 
(Cherkupally et al. 2014).   
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1.8.2 SPPS for Cell-Surface Interactions 
The challenge for the application of this system in a biological context is the 
biocompatibility aspect for both cell survival and biological analysis.  Resin choice is 
important in this case as for microscopic techniques, transparent materials must be applied.  
The choice of glass as a resin is possible as it can be coated in silane which allows addition 
of a free amine group for amino acid addition (Piehler et al. 2000; Mosse et al. 2009). The 
surface was synthesised as described in Todd et al.; prior to amino acid addition, the 
coverslip is cleaned to remove organic material then silanised using (3-Glycidyloxypropyl) 
trimethoxysilane (GOPTS) creating a monolayer of epoxide groups for a PEG diamine to 
covalently bind to (Todd et al. 2009; Piehler et al. 2000). The PEG diamine provides a free 
amine group for the addition of the first amino acid while also preventing non-specific 
protein adsorption due to its anti-fouling property. 
 
The additional benefit for bioengineering is that peptides can be added in any sequence 
desired, this allows biomimicry of ECM peptide motifs.  As peptide motifs are 
instrumental for cell behaviour in vivo (Section 1.3) (Davis et al. 2000), this provides a 
method of communication with cells in a directive manner. This is achievable as it is 
known that short motifs are sufficient for directing behaviour without requiring the whole 
protein sequence (Bellis 2011).  SPPS was originally applied as a method to artificially 
create peptides in vitro.  Upon completion of SPPS, the peptide was cleaved from the resin 
and used for further analysis, independent of the resin it was grafted from (Merrifield 
1963).  However, resins can be biofunctionalised with peptides by maintaining the 
sequence on the resin after completion (Mosse et al. 2009).  This creates a 2D monolayer 
of peptide motif that allows directive behaviour of the cells cultured on the peptides as is 
the case in this thesis. 
 
SPPS has been used previously for cell culture. In 2012 Zelzer et al. applied it to create a 
ERM that changed chemical composition in response to cell secreted enzymes (Zelzer, 
McNamara, et al. 2012).  They created adhesive phosphorylated surface chemistries that 
were dephosphorylated in response to alkaline phosphatase (ALP) addition or secretion by 
cells seeded on the surface (Zelzer, McNamara, et al. 2012).  Although, the results showed 
that the material did not increase osteogenesis, it did provide an early indication that cell-
surface interactions could be dynamically manipulated by the cells themselves (Zelzer, 
McNamara, et al. 2012).  SPPS can also be used to present divalent peptides motifs.  This 
is based on the concept of synergistic motifs that exist in ECM proteins for example, the 
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RGD and PHSRN motifs of fibronectin, which have been shown to enhance cell adhesion 
(Gartner & Bennett 1985) .  Using SPPS, spacing between the motifs as found in 
fibronectin, could be mimicked and in addition, a branched chain could be created to allow 
accessibility to motifs by cells (Mas-Moruno et al. 2014). Saos-2 (osteosarcoma) cells 
were shown to attach and proliferate (Mas-Moruno et al. 2014).  In 2017, this concept was 
modified to substitute the PHSRN sequence for the lactoferrin derived antimicrobial 
sequence LFI-11.  The aim of this platform was to create an implant (for dentistry and 
orthopaedics) that can be adhesive to osteoblast like cells but prevent bacterial 
contamination that often results in failure of implants (Hoyos-Nogués et al. 2017).  The 
platform enhanced osteoblast spreading and increased mineralisation in comparison to 
other controls (Hoyos-Nogués et al. 2017). The presence of the LFI-11 peptide was also 
shown to inhibit bacterial adhesion for both S. sanguinis and S. aureus by 83 % and 91 % 
respectively (Hoyos-Nogués et al. 2017). 
 
Roberts et al. also incorporated SPPS to make an ERM (Roberts et al. 2016). Here they 
created a sequence that contained an enzyme modifiable component that can be targeted by 
the enzyme elastase (Roberts et al. 2016).  Cleavage of the sequence by elastase reveals the 
cell adhesive peptide RGD (Figure 1.11A). This was based on the chemistry presented by 
Todd et al. where the surface modification of glass by SPPS and response of cells 
(osteoblasts) were analysed (Todd et al. 2009).  Prior to this study, the enzyme efficiency 
of various enzymes (elastase, chymotrypsin and thermolysin) and recognition sequences 
were determined (Zourob et al. 2006). Elastase was selected, the peptide sequence was 
modified to reflect elastase preference (AA)  and then RGD was incorporated (Todd et al. 
2009).  A peptide responsive sequence was created (Fmoc-AARGD) which was not 
treated by piperidine after terminal amino acid was added so the N-terminal protecting 
group (Fmoc) therefore remained to conceal the sequence (Todd et al. 2009).  By masking 
RGD with the Fmoc group, cell adhesion could be triggered on demand.  Applying this to 
cell culture, they showed that seeding osteoblasts on an uncleaved surface (Fmoc-
AARGD) prevented cell adhesion resulting in rounded cells.  In comparison with the 
addition of elastase (-ARGD), the osteoblasts adhered to the surface and exhibited 
increased cell spreading comparable to that of the RGD control.  90 % of cells were spread 
by 5 days on cleaved surfaces compared to the capped (5 %) or the non-adhesive, RGE 
control (4 %) (Todd et al. 2009) (Figure 1.11B).   
 
  36 
This work was continued by Roberts et al. who applied the platform to MSC culture 
(Roberts et al. 2016).   They also demonstrated that cleavage of the blocking group 
promoted cell adhesion and increased cell spreading which promoted differentiation 
(Roberts et al. 2016).  The cells became osteoblastic in morphology and positively 
expressed osteocalcin by day 21 at a similar abundance to the positive control, RGD 
(Figure 1.11 C) (Roberts et al. 2016).  The maintenance of Fmoc on the RGD prevents 
adhesion and therefore differentiation, as minimal osteocalcin staining was observed 
(Roberts et al. 2016).  
 
Figure 1.11 - Cell Response to Fmoc/PEG-A↓ARGD Surface.  A) A platform for cell culture was 
synthesised by SPPS as in (Todd et al. 2009).  Maintaining a blocking group on peptides prevents cell 
adhesion to the RGD group prior to enzyme addition.  After the enzyme is added, the sequence is cleaved, 
allowing adhesion to RGD via integrin binding and stimulating MSC differentiation.  Replicated from 
Anderson et al. 2017 (Anderson et al. 2017). B) After cleavage, cell spreading is increased similar to the 
positive control (uncapped ARGD), approximately 100 % for both. Replicated from (Todd et al. 2009).  C) 
The experiment was repeated by Roberts et al. 2016 using MSCs and increasing the culture period to 21 
days.  After 21 days, osteocalcin expression increased on the cleaved surface and was significantly different 
to that of the untreated (Fmoc-D) and glass control.   Replicated from Roberts et al. 2016.  D) Roberts et al. 
also demonstrated a more biocompatible blocking group, PEG.  Immunofluorescent images show increased 
adhesions observed by day 5 on cleaved surface and an increase of Stro-1 on uncleaved surfaces by day 21. 
Therefore, maintenance of PEG increases stemness and removal induces differentiation by binding to RGD.  
Red = actin, blue = nucleus, green = Stro-1 or vinculin. E) Images quantified for D (Stro-1). C-E Replicated 
from (Roberts et al. 2016). *P<0.05, **P<0.01 ***P<0.001 as determined by ANOVA. 
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However, it was thought that the Fmoc was susceptible to fouling by cell secreted proteins 
and so the capping group was replaced by PEG chains that are anti-fouling and more 
biocompatible (PEG- AARGD) (MRes project published in (Roberts et al. 2016)). It is 
thought that the anti-fouling nature of PEG is due to the hydrophilicity, high mobility and 
steric hindrance (Dong et al. 2011).  This effect was increased with increasing chain length 
of PEG, as demonstrated by Dong et al. 2011 who tested a range of chain lengths on 
bacterial culture and found that adherence decreased with increasing chain length (Dong et 
al. 2011).  In this study, another advantage of the change in blocking group was that it was 
thought to promote MSC self-renewal in comparison to the switched surface (Figure 
1.11D) and when quantified, is significantly different to that of the plain glass control 
(Figure 1.11E) (Roberts et al. 2016).  Further, cleavage of PEG resulted in increased cell 
adhesion (Figure 1.11D), which suggests cell differentiation via mechanotransduction  
(Roberts et al. 2016).  These studies formed the rational for the MMP responsive surface 
where PEG was maintained to promote self-renewal.   In addition, focal adhesion 
formation was also expected in response to RGD and therefore osteogenic differentiation 
was anticipated. 
 
1.9 Conclusion 
MSCs are a worthwhile stem cell to invest research resources into for TE due to their 
immunogenic properties and ease of access from multiple sources.  Materials engineering 
therefore has the capacity to overcome traditional limitations for stem cell culture by 
creating the directionality needed for stem cell maintenance or differentiation without the 
need for soluble chemistries or animal feeder layers that will limit the progression of stem 
cell applications in the clinic.  Methods to do this include manipulation of surface 
characteristics such as of topography, surface chemistry or stiffness, which although have 
controlled MSC behaviour in vitro are static technologies.  The next generation of 
materials engineering includes a dynamic feature, by applying a stimulus to modify an 
aspect of the surface.  It is our belief that stimuli responsive strategies hold the most 
promise due to their versatility but also relevance to a biological context.  However, future 
materials strategies could combine methods that dynamically replicate the niche and 
improve stem cell culture. Here we propose to utilise meaningful biological motifs tethered 
to a glass coverslip using SPPS to control MSC behaviour to provide a cell expansion 
strategy by mimicking the in vivo bone marrow niche. 
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1.10 Project Aims 
a) Understand the MMP profile of MSCs 
b) Design a peptide surface to be targeted by the MMP secreted by MSCs 
c) Synthesise the surface utilising SPPS incorporating the sequence favourable for 
cleavage by MMPs and the cell adhesive peptide RGD. 
d) Understand the mechanism of action by enzymes on the surface 
e) Analyse the phenotype of MSCs on the surface over time
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2. General Methods 
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This chapter outlines all protocols used within this study.  Surface modification was 
carried out using solid phase peptide synthesis (SPPS).  Standard cell culture techniques 
are also described as well as techniques for biochemical analysis.  
 
2.1 Supplier Information  
 
Table 2.1 – Supplier Information.  Reagents used in Chapter 2. 
Technique Materials Supplier 
SPPS 
13mm Glass Coverslips  VWR, USA 
(3-Glycidyloxypropyl) Trimethoxysilane 
(GOPTS) 
Sigma Aldrich, UK 
PEG26-NH2 (Poly (ethylene glycol)) Diamine Polypure, Norway 
Fmoc-Protected Amino Acids Sigma Aldrich, UK 
N,N-Dimethylformamide (DMF) Sigma Aldrich, UK 
Ethyl (Hydroxyamino) Cyanoacetate (EHIC) Sigma Aldrich, UK 
N,N’-Diisopropylcarbodiimide  (DIC) Sigma Aldrich, UK 
Piperidine Sigma Aldrich, UK 
(O-Methyl-O’-Succinyl Polyethylene Glycol 
2’000) (PEG) 
Sigma Aldrich, UK 
Trifluoroacetic Acid (TFA) Sigma Aldrich, UK 
Cell Culture 
Dulbecco’s Modified Eagles Media 
(DMEM) 
Sigma Aldrich, UK 
Foetal Bovine Serum (FBS) Sigma Aldrich, UK 
Penicillin / Streptomycin Sigma Aldrich, UK 
Non-Essential Amino Acid Invitrogen, UK 
Sodium Pyruvate Sigma Aldrich, UK 
Trypsin Sigma Aldrich, UK 
Buffers 
Phosphate Buffered Saline (PBS)  Sigma Aldrich, UK 
Bovine Serum Albumin (BSA) Sigma Aldrich, UK 
Tween-20 Sigma Aldrich, UK 
2-Hydroxylethyl-1-Piperazine-
Ethanesulphonic Acid (HEPES) 
Sigma Aldrich, UK 
Zymography 
Gelatin / Casein Gels BioRad, USA 
Running Buffer BioRad, USA 
  41 
Zymogram Sample Buffer BioRad, USA 
Precision Plus Protein 
TM 
Dual Colour 
Standards 
BioRad, USA 
Renature Buffer BioRad, USA 
Development Buffer  BioRad, USA 
ELISA 
MMP-9 ELISA Invitrogen, UK 
MMP-2 ELISA Life Technologies, 
UK 
Array MMP Antibody Array Abcam, UK  
 
2.2 Surface Modification 
Surfaces were synthesised using SPPS as in (Todd et al. 2009). Glass coverslips were 
sonicated in acetone, ethanol, methanol, deionised water (dH2O) for 10 min each then 
allowed to dry.  The coverslips were acid cleaned in piranha solution: 3:7 solution of 
hydrogen peroxide (H2O2) and concentrated sulfuric acid (H2SO4) for 1 hour.  Coverslips 
were then rinsed in deionised water (dH2O) until the solution was neutralised, and 
coverslips were rinsed individually in 3x dH2O before drying with nitrogen (Figure 2.1i).   
As per Piehler et al. surfaces were silanized by immersing the coverslips in GOPTS at 37 
C for 1 hour followed by washing 3x in acetone and drying overnight at 75 C (Figure 
2.1ii) (Piehler et al. 2000). PEG26-NH2 was melted onto surface at 75 C for 48 hours to 
create an amine-functionalised monolayer, excess PEG26-NH2 was removed by washing 
the surfaces in 3x dH2O (Figure 2.1iii).  To build up the peptide chain, the first Fmoc 
protected amino acid (20 mM) was coupled to PEG26 diamine in a solution of EHICA (0.4 
mmol) and DIC (0.4 mmol) per 10 mL of anhydrous DMF.  Samples were treated for 2 
hours under agitation.  Samples were then rinsed in DMF, ethanol, methanol and DMF for 
10 min under agitation (Figure 2.1iv).  For the addition of subsequent amino acids, the 
Fmoc protecting group (of the bound amino acid) was removed using piperidine (20 % in 
DMF) for 2 hours under agitation then washed in DMF, ethanol, methanol and DMF for 10 
min (Figure 2.1v). The next Fmoc protected amino acid was added and last two steps were 
repeated until the sequence was complete (N-terminal and side chain protected amino acids 
shown in Table 2.2).  The sequences of controls synthesised are shown in Table 2.3.   
The Fmoc protecting group was removed from the final peptide then PEG (O-methyl-O′-
succinyl polyethylene glycol 2’000) was added to the terminal amino acid prior to removal 
of side chains.  The side chain protecting groups on the aspartic acid (O-tert. Butyl, OtBu) 
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and the arginine (pentamethyldihydrobenzofuran-5-sulfonyl, Pbf) were removed with a 90 
% solution of aqueous TFA for 4 hours. Samples were then washed and stored in a 
desiccator until ready for use.   
 
Figure 2.1 - Pre-treatment of a glass coverslip and first amino acid addition. i) Hydroxylation of glass 
via piranha solution. ii) Salinization of surface by GOPTS. iii) PEG26 diamine addition. iv) First amino acid 
addition in presence of EHIC and DIC.  v) Removal of Fmoc in solution of 20 % piperidine.  Re-drawn from 
(Zelzer, Scurr, et al. 2012)  black = surface chemistry prior to amino acid addition, orange = amino acid and 
side group (R1), purple = Fmoc protecting group. 
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Table 2.2 - Schematic of Fmoc Protected Amino Acids for SPPS. The chemical structure of each amino 
acid used in the formation of the oligopeptide sequence.  All amino acids are Fmoc protected and in the case 
of Arg side chains are protected with Pbf and Asp and Glu side chains are protected by OtBu respectively.  
Images taken from Sigma Aldrich website 
6
. 
 
                                                 
6
 http://www.sigmaaldrich.com/united-kingdom.html 
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Table 2.3 - Sequence of Controls.  Adhesive controls contain RGD, non-adhesive contain RGE.  For both 
adhesive and non-adhesive, uncleavable and pre-cleaved surfaces were synthesized.   
Adhesion Category Amino Acid Sequence Abbreviation 
- Glass - - 
Adhesive Uncleavable PEG-RGD - 
Pre-cleaved LRGD - 
Enzyme Responsive PEG-GPAGLRDG DIGE-D 
Non-adhesive Uncleavable PEG-RGE - 
Pre-cleaved LRGE - 
Enzyme Responsive PEG-GPAGLRGE DIGE-E 
 
2.3 Buffers 
2.3.1 Phosphate Buffered Saline (PBS)  
PBS solutions are made in house, one tablet is diluted in 250 mL distilled water then 
autoclaved at 200 °C for 20 min.   
 
2.3.2 Fixative 
Fixative constituted 10 % formaldehyde in PBS.  Generally, 10 mL formaldehyde was 
added to 90 mL PBS with 2 g of sucrose. Solution was stored at 4 °C prior to use. 
 
2.3.3 Permeability (Perm) Buffer 
Perm buffer consisted of 10.3 g sucrose, 0.292 g NaCl, 0.06 g MgCl2 and 0.476 g HEPES 
in 100 mL.  This solution was adjusted to 7.2 pH then 0.5 mL Triton X was added.  Perm 
buffer was stored at 4 °C prior to use. 
 
2.3.4 PBS/BSA 
2 g of BSA was dissolved in 100 mL PBS.  Solution was stored at 4 °C prior to immediate 
use or stored at -20 °C for long term storage. 
 
2.3.5 Tween  
Tween-20 was made to a solution of 0.1 % in PBS.  Generally, 100 µl of Tween-20 in 100 
mL PBS was stored at 4 °C prior to use.  
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2.4 Mesenchymal Stem Cell Culture 
2.4.1 Cell Culture 
MSCs were either donated from the University of Southampton with thanks to Professor 
Richard Oreffo (Stro-1 positive cells were selected from bone marrow by magnetic 
separation as in (Gronthos & Zannettino 2008)) or obtained from PromoCell (GmBH, 
Germany).  Cells were cultured in T75 flasks prior to use (passage between P1 and P4 as 
stated) using DMEM supplemented with 5 mL non-essential amino acid, 50 mL FBS, 10 
mL penicillin / streptomycin and 5 mL sodium pyruvate.  Flasks were incubated at 37 C 
in 5 % CO2.  Cells were cultured to approximately 80-90 % confluence prior to cell 
seeding (media changes performed twice weekly).  For seeding, cells were rinsed in 
HEPES saline, then incubated with 5 mL trypsin (37 C in 5 % CO2) for 5 min.  5 mL 
culture media was added to halt the action of the trypsin, the resulting cell suspension was 
transferred into 15 mL falcon tube and centrifuged for 4 min at 1400 g to sediment cells.  
The trypsin/media supernatant was decanted, and cells resuspend in media.  Cells were 
either seeded into another flask or used for experimental set up (Section 2.4.2). 
 
2.4.2 Experimental Set Up  
Prior to cell seeding, functionalised coverslips were incubated in 70 % ethanol for 10 
minutes.  Coverslips were then allowed to dry then were placed in a 24 well plate.  Cells 
were treated as in Section 2.4.1. After centrifuging, cells were counted using a 
haemocytometer then seeded at 1,000 cells / cm
2
 in 1 mL culture media.  Coverslips were 
incubated for the time stated with media changes performed twice weekly.  To maintain 
presence of cell secreted MMPs, 500 µl cell supernatant was removed from the well and 
topped up with a fresh 500 µl.  This was done to maintain the existing cell secreted 
proteins within the well. 
 
2.5 MMP Analysis 
2.5.1 Zymography   
Supernatant was collected from cell culture on functionalised coverslips stored at -80 C 
prior to zymogram analysis.  Supernatant was then mixed 1:1 with zymogram sample 
buffer (loading buffer) and 20 µl was loaded into each well of precast gelatin and casein 
gels.  Precision Plus Protein 
TM 
Dual Colour Standards were used as molecular standards 
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(10µl loaded per gel).  The gels were run at 200 V in running buffer (10 % 
Tris/Glycine/SDS running buffer diluted PBS) for 60 min in Criterion 
TM
 gel system until 
the bands reached the bottom.  Gels were soaked in zymogram renature buffer (10 % 
renature buffer in PBS) using gentle agitation for 45 min with buffer changes at 15 and 30 
min.  The gels were then incubated in zymogram development buffer (10 % development 
buffer in PBS) overnight at 37 C. Afterwards, gels were stained in 0.5 % (w/v) Coomassie 
Brilliant Blue R-250 in 4 % methanol, 10 % acetic acid at room temperature for 60 min 
with gentle agitation.  The Coomassie Blue solution was replaced with destain solution (4 
% methanol and 10 % acetic acid in PBS), which was replaced with 3 changes every 15 
min (at room temperature) until bands were visible.  Gels were imaged using a fusion Fx, 
Vilber Lourmat and bands were quantified using Fiji software (ImageJ derivative, free 
download from NIH)
7
.  
 
2.5.2 Enzyme-Linked Immunosorbent Assay (ELISA) 
MMP-2 and MMP-9 ELISAs were carried out as per the manufacturers instruction.  For 
each ELISA, samples of DMEM were included as controls and cell supernatant was 
diluted 1/10 with standard diluent.  For MMP-2 ELISA, an additional positive control was 
also included of 0.1 mg/ml MMP-2 spiked serum free media (components of serum free 
media include; 500 mL DMEM, 5 mL non-essential amino acid, 10 mL antibiotic, 5 mL 
sodium pyruvate).  ELISA plates were read at 450 nm using Clariostar microplate reader 
(BMG Labtech, Germany).   Standard curves were also performed with known 
concentrations of MMP and line of best fit applied.  Concentrations of samples were 
determined utilising the equation of the line (y = mx + c), where simultaneous equations 
were generated from two sets of coordinates from the line of best fit to solve the gradient 
(m) and the y intercept (c).  From this, the optical density (OD) value of the sample was 
substituted for y and the equation was rearranged and solved for x. 
 
2.5.3 Human MMP Antibody Array  
Cells were cultured on control surfaces in DMEM for three weeks after which the cell 
supernatant was pooled (n=3) and stored at -80 C until further use.  The experiment was 
carried out as outlined in the manufacturers instruction, where 1 mL of undiluted pooled 
sample was added to the membrane and incubated overnight.  The protein of interest is 
captured by antibody array chips (“spots”), biotin-conjugated antibodies and then labelled 
                                                 
7
 http://imagej.net/Fiji/Downloads 
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streptavidin which are then detected (Table 2.4).  The membranes were analysed with an 
Azure c500 Infrared Western Blot Imaging System and analysed using Fiji software 
(ImageJ derivative, free download from NIH) 
8
.  Pixel density was calculated for each spot 
then averaged.  
 
Table 2.4 – Position of Each Spot on Abcam Antibody Array.  Spots included both negative (neg) and 
positive (pos) controls along with 10 target MMPs and TIMPs (tissue inhibitors of matrix metalloproteases).  
All of which were spotted twice onto the array. 
 A B C D E F G H 
1 pos pos neg neg MMP-1 MMP-2 MMP-3 MMP-8 
2 pos pos neg neg MMP-1 MMP-2 MMP-3 MMP-8 
3 MMP-9 MMP-10 MMP-13 TIMP-1 TIMP-2 TIMP-4 Neg pos 
4 MMP-9 MMP-10 MMP-13 TIMP-1 TIMP-2 TIMP-4 Neg pos 
 
                                                 
8
 http://imagej.net/Fiji/Downloads 
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3. Design and Synthesis of Enzyme 
Responsive Dynamic Surfaces 
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We have discussed in Chapter 1 the limits of traditional cell culture and as stated, we aim 
to improve this by utilising an ERM.  In response to an enzyme, the material is altered to 
reveal the cell adhesive peptide RGD, designed to enhance cell binding via integrins.  The 
target enzymes for the alteration of this surface are the MMPs.   MMPs primarily remodel 
the ECM and are involved in processes such as migration (Birkedal-Hansen et al. 1993).  It 
is our aim that the material is controlled by these enzymes from the cell supernatant i.e. the 
MMPs required to remodel the ERM are secreted by the cells themselves. In this chapter, 
we will look at the MMP profile of MSCs and the design of the surface.  We will also 
describe in this section the synthesis of the surface using SPPS, the characterisation of the 
surface and the conditions in which the surface can be remodelled.  
 
3.1 Introduction 
Here we aim to create peptide motifs including the RGD sequence and an enzyme 
responsive sequence that are to be hidden beneath a low adhesion moiety (PEG) (Figure 
1.9).  This material aims to control MSC behaviour in response to MMP activity in vitro. 
This work differs from previous examples (where enzymes were added by the user to 
activate the system) as it aims to create a dynamic material that is not only enzyme 
responsive, but under cellular control in two dimensions.  There are earlier examples of 
peptides remodelling utilised in 3 dimensions and incorporated into hydrogels (Matthias P. 
Lutolf et al. 2003; Wade et al. 2015; Shekaran et al. 2014).  However, our system is 
designed to be a cell expansion system for multiple uses rather than a culture system for 
direct implementation.   
 
The surface is functionalised by SPPS to create a monolayer of peptides that can be 
cleaved by the cells.  SPPS has been applied to cell culture in the past by our group along 
with collaborators (Roberts et al., 2016; Todd et al., 2009; Zelzer et al., 2012) and through 
this means, we have demonstrated effective adhesion regulation to control MSC phenotype 
using peptides (Roberts et al. 2016).  In this chapter, we will analyse the MMP profile of 
MSCs, define the sequence that is likely to be targeted by the MMPs and discuss the 
synthesis and characterisation of the resulting material. 
 
3.1.1 MMPs  
The MMPs are a group of calcium dependant, zinc containing proteases that cleave the 
ECM.  There are 23 MMPs that are classed as a family due to structural homology and 
functional relation.  They can be subdivided by preferential action to certain ECM 
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substrates e.g. MMP-9 and MMP-2 are called gelatinases and act on gelatin, elastin and 
collagen (IV, V) (Snoek-van Beurden & Von den Hoff 2005).  Other families include 
collagenases and stromelysins (Nagase & Woessner  Jr. 1999).  These MMPs are secreted 
by the cell as zymogens then activated by external factors (Birkedal-Hansen et al. 1993). 
There is also a subset of MMPs that are membrane bound (Egeblad & Werb 2002) (Table 
3.1).   
 
The primary function of the MMPs is ECM remodelling, this allows cell migration and 
aids in processes such as wound healing (Vu 2000). In addition to this it is also thought 
that MMPs may have a regulatory role through action on signalling molecules (McQuibban 
et al. 2001).  It was thanks to the proteomic era that other substrates were identified, these 
substrates are collectively known as the “degradome” of MMPs (Morrison et al. 2009).   
This work led to novel substrates being identified that highlight the range of roles that 
MMPs could be involved in (receptors, mobility and angiogenesis Figure 3.1B).  
Surprisingly, what was thought to be their primary function (ECM regulation, Figure 3.1A) 
identified as 42 % prior to the degradomics testing, fell to 15 % with application of 
proteomic identification (Figure 3.1B) (Morrison et al. 2009).  It is necessary to look at the 
degradome as enzymes are often implicated in disease through dysregulation. For MMPs, 
dysregulation can contribute to inflammatory disorders and cancer (Egeblad & Werb 
2002). 
 
 
Figure 3.1 - Range of Substrates for MMP Activity.  A) non-proteomically identified substrates for 
MMPs, 42 % of consists of ECM related proteins.  B) Novel substrates identified by proteomics suggest that 
MMP have a wider range of function than initially understood (ECM regulation reduced to 15 %). Adapted 
from (Morrison et al. 2009) 
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Table 3.1 – Matrix Metalloprotease Families, Substrate Preference and Molecular Weights. Information 
was taken from (Nagase & Woessner  Jr. 1999; Egeblad & Werb 2002; Birkedal-Hansen et al. 1993; Visse & 
Nagase 2003). 
Family Name Substrates 
Molecular Weight 
(Mw) 
Inactive Active 
Membrane 
Bound 
MT-
MMP1 
collagen (I, II, III), aggrecan, gelatin, 
fibronectin, tenascin, vitronectin, 
laminin, entactin, perlecan 
- 66,000 
MT-
MMP2 
fibronectin, tenascin, entactin, 
laminin, aggrecan, perlecan 
- 72,000 
MT-
MMP3 
collagen I 
- 64,000 
MT-
MMP4 
gelatin 
- 58,000 
Stromelysins 
MMP-3 
collagens (III, IV, V, VII, IX, X, XI), 
gelatin, elastin, fibronectin, 
vitronectin, laminin, 
60,000 55,000 
MMP-10 
collagen (III, IV, V) gelatin, elastin, 
fibronectin, vitronectin, aggrecan 
60,000 55,000 
MMP-11 
gelatin, fibronectin, collagen IV, 
laminin 
55,000 45,000 
Collagenase 
MMP-1 
collagens (I, II, III, VI, VIII, X, XI), 
gelatin, fibronectin, vitronectin, 
laminin, entactin 
57,000 52,000 
MMP-8 collagen (I, II, III), aggrecan 75,000 65,000 
MMP-13 
collagens (I, II, III, IV, VI, XI, X), 
gelatin, fibronectin, perlecan, 
aggrecan 
65,000 55,000 
Gelatinase 
MMP-2 
collagens (I, II, III, IV, V, VII, X, XI), 
gelatin, fibronectin, elastin, 
vitronectin, laminin, myelin 
72,000 62,000 
MMP-9 
collagen (IV, V, XI, XIV), gelatin, 
elastin, vitronectin, laminin, aggrecan, 
92,000 82,000 
Matrilysin MMP-7 
collagen (I, IV), gelatin, elastin, 
fibronectin, vitronectin, laminin, 
entactin, aggrecan 
28,000 19,000 
 
Although there are several MMP families, redundancy does occur with multiple MMPs 
acting on overlapping substrates, this could be due to the catalytic cleft similarity 
(Sternlicht & Werb 2009; Kridel et al. 2001).  Turk et al. show experimentally that 
although redundancy is possible, it is not necessarily efficient (Turk et al. 2001).  The 
consensus sequence for each MMP was synthesised, then incubated with other MMPs to 
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determine efficiency of cleavage using Michaelis-Menten equation, Kcat/KM (M
-1
S
-1
) (Turk 
et al. 2001).  It was found that while cleavage of non-consensus sequences was possible by 
multiple MMPs, efficiency of cleavage increases with action of that MMP on its own 
consensus sequence (Turk et al. 2001). 
 
3.1.2 MMP Protein Structure 
The protein structure for the secreted MMPs demonstrates conserved structural homology 
(Birkedal-Hansen et al. 1993).  MMPs consist of specific domains; signal peptide, pro-
peptide, catalytic and hemopexin domain (Figure 3.2) (Kessenbrock et al. 2010). The 
signal peptide directs the enzyme to the secretion pathways namely, the endoplasmic 
reticulum (Egeblad & Werb 2002).  As they are secreted as zymogens, activation occurs 
due to a structural change by removal of the pro-peptide (Vandooren et al. 2013).  There 
are three helices joined together by loops between the pro-peptide and catalytic site 
(Morgunova et al. 1999).  Action on these loops is responsible for the activation of the 
zymogen (Morgunova et al. 1999). The catalytic domain contains a zinc ion which 
complexes with the pro-domain to maintain latency, specifically through action of cysteine 
group with zinc (Figure 3.2, Section 3.1.3) (Kessenbrock et al. 2015).  The catalytic and 
hemopexin domains are separated by a hinge region that varies in length per MMP.  The 
hemopexin region at the C-terminal domain is responsible for the specificity of substrate 
binding (Birkedal-Hansen et al. 1993; Sternlicht & Werb 2001) but also acts as site for 
inhibitors to bind to (Sternlicht & Werb 2001). The tertiary structure of the hemopexin 
domain consists of a 4-bladed -propeller fold that is stabilised by a disulphide bond 
between blades I and IV (Egeblad & Werb 2002). The overall structure for most MMPs is 
consistent with Figure 3.2, but there are some exceptions. The matrilysins lack the 
hemopexin domain and the gelatinases have an additional feature of a fibronectin domain 
which are thought to aid binding to collagen (Snoek-van Beurden & Von den Hoff 2005; 
Nagase & Fields 1996; Kridel et al. 2001). 
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Figure 3.2 - Conserved Structure for the Secreted MMPs.  The overall protein structure for the 
MMPs is conserved.  Prior to activation, the pro-peptide is cleaved, altering the interaction of the 
sulfhydryl group (-SH) from the “cysteine switch” of the pro-peptide and the zinc ion that is associated 
with the catalytic domain. Activation results in the removal of the pro-peptide.  The tail of the MMP 
contains a hemopexin region that is thought to be important for substrate specificity. The last repeats of 
the hemopexin domain are linked by a disulphide bond.  Image adapted from (Visse & Nagase 2003; 
Egeblad & Werb 2002; Vandooren et al. 2013). 
 
3.1.3 Activation 
Latency is maintained by specific interactions of conserved sequences in both the pro-
peptide and catalytic domain with the zinc ion (Visse & Nagase 2003).  Figure 3.3A shows 
the location of these sequences within the MMP-2 enzyme.  The pro-domain sequence 
PRCG(V/N)PD is conserved specifically, the cysteine residue is imperative for the 
interaction of the pro-peptide with the zinc ion, this interaction is described as the 
“cysteine switch” (Kessenbrock et al. 2010; Nelson et al. 2000; Nagase & Woessner  Jr. 
1999).  Disruption of the switch results in activation of the MMP via removal of the pro-
peptide (loss of around 10,000 Daltons) (Birkedal-Hansen et al. 1993; Woessner  Jr. 1991).  
The cysteine switch is located in the loop regions between the -helices of the pro-domain, 
specifically between helix 1 & 2 in a region that is described as the bait region (Visse & 
Nagase 2003).  In addition to this, the catalytic site also contains the conserved sequence 
HEXGHXXGXXH where the His centre around the zinc ion in the catalytic cleft (Visse & 
Nagase 2003) (Figure 3.3B). The catalytic site also contains a conserved Met which forms 
a structure known as the “Met-turn” which has been shown experimentally to be 
imperative to protein structure and therefore stability (Tallant et al. 2010; Nagase & 
Woessner  Jr. 1999).  Activation of the membrane bound MMPs (MT-MMP) is through a 
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different mechanism.  They contain a specific motif, the furin site, which allows activation 
by furin-like serine proteases (Egeblad & Werb 2002). 
 
 
 
Figure 3.3 – MMP-2 Active Site.  A) Mature MMP-2 peptide (blue) showing position of the conserved His 
in the catalytic site (pink) with cysteine switch (yellow) in conserved pro-domain (orange).  B) His 403, 407, 
413 complexes with the zinc ion (black) in the catalytic cleft.  Latency is maintained by the proximity of Cys 
102 of the cysteine switch with the zinc ion.  Images made on Pymol software.   
 
Regardless of the mechanism of activation, the cysteine switch must be disrupted and the 
pro-peptide removed for the enzyme to be activated (Nagase & Woessner  Jr. 1999).  
Activation can be induced by growth factors, cytokines, chaotropic agents, reactive 
oxygens, low pH and heat treatments (Visse & Nagase 2003).  The process is described as 
stepwise, the above factors contribute to the cleavage of the bait region in the pro-domain.  
However, the final step of activation is mediated by a mature MMP (Figure 3.4A) (Vartak 
& Gemeinhart 2007).  For MMP-2, this is particularly well studied as it takes place on the 
cell surface via MT-MMPs (Visse & Nagase 2003).  Another unique feature of this 
interaction is the involvement of the tissue inhibitor of matrix metalloprotease 2 (TIMP-2).  
MT1-MMP binds firstly to TIMP-2 then a free MT1-MMP is bound by proMMP-2 which 
complexes with TIMP-2 via the hemopexin domain (Worley et al. 2003).  After activation, 
MMP-2 dissociates from the complex as an active enzyme (Figure 3.4B).  This was 
demonstrated experimentally by Sato 1994, who engineered a membrane bound MT-MMP 
in lung carcinoma cells which was found to activate the MMP-2 and MMP-9 zymogens 
and result in invasion of cancer cells (Sato et al. 1994).  
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Figure 3.4 - Activation of MMPs.  A) Stepwise activation, inactive zymogens are activated by either 
proteolytic or non-proteolytic methods.  The catalytic site (white) contains the zinc ion.  The pro-peptide 
(black line) is cleaved at the bait region (black box).  Activation is by physical separation of the zinc ion from 
sulfhydryl group of the cysteine switch or chemical modification of the sulfhydryl group B) proMMP-2 is 
activated by MT1-MMP and TIMP2.  MT-MMP1 and TIMP-2 bind on cell surface and proMMP-2 binds to 
TIMP-2 via hemopexin domain. MMP-2 dissociates from cell surface after activation.  Both images from 
(Visse & Nagase 2003). 
 
3.1.4 Regulation  
MMPs are regulated by TIMPs of which 4 have been identified and display homologous 
structures (TIMP-1, -2, -3, -4) (Bigg et al. 2001; Troeberg et al. 2002). The TIMP N-
terminal domain is responsible for the inhibition of the MMPs, specifically at Cys1-Pro5 
sequence (Visse & Nagase 2003; Bode et al. 1999).  The TIMP wedges into the active site 
of the MMP reversibly and with high affinity like a substrate/product interaction 
(Woessner  Jr. 1991; Bode et al. 1999).  Loss of balance of this response contributes to 
diseases such as rheumatoid and osteoarthritis and cardiovascular disease.  TIMPs are 
tissue specific and act locally (Mannello 2006).  Activation of MMP does not correlate 
with activity of MMP as they can be bound by the TIMP molecules.  However, as 
described above (Figure 3.4) the activation of MMP-2 via MT1-MMP is mediated by 
TIMP-2 and occurs in a concentration dependent manner.  Insufficient concentrations of 
TIMP means the pro-enzyme is not brought to the cell surface and high concentrations are 
inhibitory (Bigg et al. 2001).  
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3.1.5 MSCs and MMPs  
MMP-2 and MMP-9 are found in the connective tissue cells and cells of the bone marrow 
(Morgunova et al. 1999). The type II fibronectin domains that are unique to the gelatinases 
allow them to bind gelatin, collagen and lamin (Lozito & Tuan 2011). MMP-2 is the 
consistently cited MMP secreted by MSCs (Morgunova et al. 1999). 
 
3.1.5.1 Migration 
It is accepted that MMPs are required for ECM degradation.  But in the case of MSCs (also 
true for cancer cells) it is required for migration (and invasion) through basement 
membranes (Steingen et al. 2008).  MMP-2 is important for MSC homing through bone 
marrow (Steingen et al. 2008; Becker & Hummelen 2007). Cell surface adhesion 
molecules are thought to play a role in anchoring MMPs to the site of matrix destruction 
(Yu & Stamenkovic 1999).   For example, CD44 complexes with MMP-9 in TA3 
mammary carcinoma cells and increases the invasiveness of the tumour (Yu & 
Stamenkovic 1999).  It is also thought that the SIBLING proteins (Small Integrin-Binding 
Ligand N-linked Glycoproteins) such as bone sialoprotein (BSP), osteopontin (OPN) and 
dentin matrix protein 1 (DMP1) have a MMP binding partner of MMP-2, MMP-3 and 
MMP-9 respectively (Karadag & Fisher 2006). Karadag et al. have shown that there is a 
localisation of MMP-2 to v3 integrin via BSP that in turn enhances the migration of bone 
marrow stromal cells (Karadag et al. 2004).  As BSP contains RGD domains, it is thought 
that the binding to the integrin is mediated through the RGD (effect not seen when RGD 
deleted from BSP) (Karadag et al. 2004).  This in turn has a downstream effect resulting in 
activation of MT-MMP-1 (known to be an activator of MMP-2, as in Figure 3.4) (Karadag 
et al. 2004).  
 
3.1.5.2 Differentiation 
There is overlapping expression of secreted MMPs by stem cells however, this is due to 
differential protein secretion rather than indicators of lineage specification (Almalki & 
Agrawal 2016).  In a review of MMP secretion by MSCs, Almalki et al. show that there 
are a range of MMP responses associated with MSC differentiation (but also with 
processes such as angiogenesis and proliferation) (Almalki & Agrawal 2016).  Almalki et 
al. discuss that increases in MMP-2 & -13 and decreases in MMP-11 and TIMP-1 are a 
signature of adipogenic differentiation (Almalki & Agrawal 2016).  Further, increases in 
MMP-2, -9, -13 & -14 indicate chondrogenic differentiation.  In comparison, osteogenic 
  57 
differentiation is thought to be as a result of increasing MMP-3, -13, -14 and TIMP-2 
(Almalki & Agrawal 2016).   
 
MMP-13 has a role in both adipogenesis and osteogenesis.  MMP-13 expression is high in 
adipose tissue (Shih & Ajuwon 2015).  In a mouse model of obesity, it was shown that 
inhibition of MMP-13 in this tissue suppressed adipose mass and adipocyte differentiation 
(Shih & Ajuwon 2015).  Comparatively, Ozeki et al. have demonstrated that in response to 
inorganic phosphates, MMP-13 secretion increases over time and further siRNA against 
MMP-13 abolishes expression of osteogenic proteins in adipose derived MSCs (Ozeki et 
al. 2016). Taken together, the increasing expression of MMP-13 is a characteristic of both 
adipogenesis and osteogenesis.  From this example, it is obvious that expression of MMPs 
in MSCs does not infer phenotype – the presence of MMP-13 in supernatant is not 
indicative of a specific phenotype and therefore cannot be a marker of lineage 
specification. 
 
In this chapter, we confirm that MMP-2 is preferentially secreted by MSCs.  From this 
data, we designed a peptide sequence that mimics the consensus sequence (preferential 
sequence cleaved by an enzyme).  The synthesis of the sequence by SPPS was completed 
effectively and is responsive to MMP concentrations in the cell supernatant.   
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3.2 Methods 
3.2.1 Supplier Information 
Table 3.2 – Supplier Information.  List of reagents used in Chapter 3. 
Technique Materials Supplier 
Supernatant 
Treatment 
Recombinant MMP-2 Sigma-Aldrich, USA 
Recombinant MMP-9 Sigma-Aldrich, USA 
 
3.2.2 SPPS 
Materials were synthesised as described in Chapter 2, Section 2.2.  For this chapter, 
DIGE-D surfaces were specifically synthesised and compared to glass controls as 
stated. Samples were then washed and stored in a desiccator until use.  Prior to use, 
surfaces were washed in 70 % ethanol for 10 minutes then air dried. 
 
3.2.3 Zymography 
Supernatant from Stro-1 MSCs grown on glass coverslips was saved at day 7 in 
triplicate and stored at -80 C prior to use.  Casein and gelatin were run as in Section 
2.5.1, Chapter 2. Zymograms were imaged on a Syngene PXI gel doc system and bands 
were quantified using Fiji software.   
 
3.2.4 6-Week Supernatant Analysis 
Cells were cultured on glass coverslips for 6 weeks in triplicate.  Media was saved at a 
weekly time points and stored at -80 C.  Supernatant was diluted 1/10 in diluting 
buffer and ELISA performed as stated in Chapter 2, Section 2.5.2.   
 
3.2.5 MMP Antibody Array 
Supernatant from Stro-1 cells grown on glass coverslips were saved at 3 weeks in 
triplicate.  Supernatant was added to a Human MMP Antibody Array (Abcam) and 
carried out in as described in Section 2.5.3, Chapter 2. 
 
3.2.6  Fluorescent Spectroscopy 
Coverslips were saved after Fmoc protected amino acid addition and after deprotection 
by piperidine to indicate all stages of SPPS.  Coverslips were dried and mounted onto a 
microscope slide and fluorescence spectra recorded using a JASCO FP-6500 
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spectrophotometer. This technique was specifically developed for SPPS coverslips by 
Zelzer et al. 2012 and uses a custom-made sample holder (Figure 3.5 A) (Zelzer et al., 
2012).  Coverslips were angled 30 from the incident light to minimize the amount of 
reflected excitation light on the detector (schematic Figure 3.5B).  Samples were 
exposed to an emission spectra = 270 nm and excitation spectra = 320 nm with a slit 
width of 20 nm (light source and detector).   The position of a coverslip in the holder is 
shown in Figure 3.5C.  Analysis was performed on 3 datasets with 2 images per dataset 
(n=6 per set). A spectrum was generated where Fmoc peak can be observed at 320nm 
(Figure 3.5D). 
 
Figure 3.5 – Schematic of Equipment for Fluorescent Spectroscopy Analysis of Glass Coverslips.  
Images A and B were adapted from (Zelzer et al., 2012).  A) Top and bottom of the coverslip holder for 
the fluorescence spectroscopy, values = dimensions in mm.  B) Schematic of light path from source to 
detector. C) Position of coverslip in the holder. D) Spectra showing peak at 350 nm in the presence of 
Fmoc (blue) and after the Fmoc is removed by piperidine (red).   
 
3.2.7  Water Contact Angle (WCA) 
Coverslips were saved after Fmoc protected amino acid addition and after deprotection 
by piperidine to indicate all stages of SPPS.  WCA measurements were carried out 
using the sessile drop technique (3 µl droplets, spotted 5 times per coverslip and angle 
calculated per droplet, Figure 3.6).  Standard error was calculated using 50 images per 
dataset with 15 datasets taken across 3 substrates (n=450 images per set).  The angle 
was calculated using a Theta optical tensiometer (Biolin Scientific, Stockholm 
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Sweden). 
 
 
Figure 3.6 –WCA Measurement Parameters. A) WCA to drop. B) software measuring angles of the 
droplet on the surface.  
 
3.2.8 ToF-SIMS for Sequence Analysis  
Time of flight secondary ion mass spectrometry (ToF-SIMS) was carried out in 
collaboration with Dr Mischa Zelzer at the University of Nottingham.  DIGE-D 
samples were synthesised and sent for analysis.  ToF-SIMS was carried out using an 
ION-TOF ToF-SIMS IV instrument (Münster, Germany), equipped with a bi liquid 
metal ion gun (LMIG). The primary ion beam was directed at the sample under an 
angle of 45 ° in relation to the normal (beam spot of 1-2 µm in the high-current 
bunched mode); 25 keV Bi
3+
 primary ions were used in all measurements. Charging of 
the sample is compensated with the low-energetic electrons of the flood gun. Ion 
images were recorded in the high current bunched mode, which allows for higher mass 
resolution. Large scale (3 mm x 3 mm; 304 x 304 pixels) and small scale (380 µm x 
380 µm, 256 x 256 pixels) images were obtained in positive polarity for each sample (1 
shot per pixel). Positive ion mass spectra were calibrated with m/z 15 (CH3
+
), 29 
(C2H5
+
), 41 (C3H5
+
) 67 (C5H7
+
) and 91 (C7H7
+
). A peak search was performed to 
identify ions indicative for amino acids according to data previously reported in the 
literature (Table 3.3) (Wagner & Castner 2001). Contamination was determined by 
identifying PDMS particles, at m/z ratios 73, 147 and 221. For semi-quantitative 
comparison of ion intensities, the large-scale images were divided into four regions of 
interest (ROIs) of 1.5 mm x 1.5 mm from which intensities of ions of interest were 
generated. Spectra used for peak shape comparison were extracted from the small-scale 
images.
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Table 3.3 – Expected m/z Ratio of Each Amino Acid used in SPPS. Table shows each amino acid and 
the associated mass to charge ration (m/z) as determined by (Wagner & Castner 2001).  
Amino Acid Fragment 
Name Code m/z Molecular 
Structure 
Alanine A 44 C2H6N
+
 
Arginine R 43 CH3N2
+
 
Aspartic acid D 88 C3H6NO2
+
 
Glycine G 30 CH4N
+
 
Leucine L 86 C5H12N
+
 
Proline P 68 C4H6N
+
 
 
3.2.9 MMP treatment of DIGE-D coverslips 
MMP-2 and MMP-9 (20 ng/ml and 0.25 ng/ml respectively) were spiked into serum 
free media at defined concentrations.  Coverslips were incubated for 3 weeks (5 % CO2 
and 37 C) then analysed by ToF-SIMS. 
 
3.2.10 Supernatant Treatment for ToF-SIMS 
Supernatant was saved at week 2 from cells cultured on glass surfaces.  Supernatant 
was added to fresh DIGE-D surface and incubated for 24 hours (5 % CO2 and 37 C).  
Surfaces were washed in dH2O x3 then sent for ToF-SIMS analysis.   
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3.3 Results 
3.3.1 MSC secretion of MMP 
To utilise MMP as a cell secreted enzyme for materials engineering, we firstly analysed 
the MMP profile of MSCs in culture on glass coverslips. Using zymography we 
determined the presence of MMPs in cell supernatant at 7 days.  Zymography is a gel-
based assay that allows visualisation of MMPs from cell supernatant based on the 
enzymes substrate preference.  Gelatin gels for example, are amenable to digestion by 
the gelatinases (MMP-2 and MMP-9) whereas casein gels are applied for the detection 
of MMP-1, -7, -12, -13. If MMPs are present, they will digest proteins the gel is 
synthesised from.  Bands can be identified after staining with Coomassie Blue, where 
the background gels are stained blue and white bands highlight where digestion has 
occurred (Leber & Balkwill 1997).  The presence of different MMP species can be 
implied from molecular weight.    
 
At 7 days, no bands were observed on the casein gels and therefore we could discount 
the presence of those MMPs (Figure 3.7A).  However, bands were identified at 
approximately 80 kDa and 60 kDa indicating the presence of active MMP-9 and MMP-
2 respectively (Figure 3.7B).  The gelatin gel also revealed presence of MMP in the 
media control, that may be a result of the presence of serum proteins (however, only 1 
media sample was tested).  The bands were quantified using Fiji software which 
showed that supernatant concentrations of MMP-9 were significantly less than the 
supernatant concentration of MMP-2, suggesting that although both MMPs were 
secreted the cells were actively secreting more MMP-2 after 1 week (Figure 3.7C). 
 
We then looked at the long-term expression of the gelatinases in MSC supernatant (6-
weeks).  The concentration of cell secreted MMP (from cells seeded on glass 
coverslips) was analysed by ELISA.  Figure 3.8A shows that there was a consistent 
concentration of MMP-2 for the period tested (10 ng/ml), it was also double that of the 
media control (5 ng/ml). However, this was not a significant increase.  MMP-9 
secretion was also analysed, it was found that MMP-9 concentration for the supernatant 
was reduced in comparison to MMP-2 (0.4 ng/ml compared to 10 ng/ml week 1) and 
comparable to that of the media control. However, MMP-9 expression did increase 
from week 4 onward and was significantly different to that of weeks 1-3 (Figure 3.8A). 
Collectively, this provides the concentration of the gelatinases in the supernatant 
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(Figure 3.8) and the relative activity of secreted MMP-2 in comparison to MMP-9 
(Figure 3.7C).
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Figure 3.7 – Zymography, 1 Week. Supernatant from cells grown on glass in comparison to cell media 
at 7 days on A) Casein and B) Gelatin.  Ladder shown on LHS of gel, numbers in kDa. A) MMPs were 
not observed on casein gels. B) Bands clearly visible on gelatin gel at 60 and 80 kDa indicating presence 
of MMP-2 and MMP-9 respectively.  There is some MMP found in the media.   C) Quantification of 
gelatin gel from B) indicating presence of active MMP-2 in the cell supernatant was significantly 
different than that found in the media.  Graph shows mean  SD, n=4 for supernatant, n=1 for media, 
statistics calculated by ANOVA (** p< 0.01).   
 
 
Figure 3.8 - Gelatinase Expression Over Six Weeks as Determined by ELISA. A) MMP-2 B) MMP-
9 concentration of cell supernatant collected over 6-week culture on glass coverslips in comparison to 
plain DMEM media. A) MMP-2 concentration remained consistent over the period tested, approximately 
11 ng/ml.  B) MMP-9 concentration increased after week 3 to approximately 0.5 ng/ml (note difference 
in scale between both y axis).  Graph shows mean  SD, n=3 for all controls,  * p < 0.05, ** p < 0.01, 
**** p < 0.0001 by ANOVA. 
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 These results were confirmed using an antibody array against multiple MMPs to 
determine the full MMP profile of MSCs at 3 weeks. This technique works by spotting 
antibodies against specific MMPs onto an array and depending on the density, is an 
indicator of the relative amount of MMP.  Figure 3.9 shows that MMP-2 is the most 
abundant MMP in the cell supernatant and is expressed at statistically significantly 
higher levels than the other MMPs (p<0.0001).  MMP-9 expression was not detected 
which was unexpected due to the observed bands in the zymogram (Figure 3.7B) and 
from the ELISA data (Figure 3.8).  However, concentration of MMP-9 was evaluated 
to be 0.4 ng/ml at 3 weeks (Figure 3.8) and is perhaps too low for detection by array.  
MMP-1 and MMP-3 were also detected, which suggests there is an increase in these 
MMPs over time as this was not observed on the casein gel at day 7 (Figure 3.7A).   
 
These results confirm that MMP-2 is the prominent MMP that MSCs secrete.  As a 
stimulus to activate the ERMs, it is more likely for MMP-2 to be effective due to the 
increased concentration of that MMP in the cell supernatant.  This suggests that there is 
an increased likelihood of action by MMP-2 on any experimental surface design over 
other MMP family members.  In addition, these results are consistent with the 
literature, where it is stated that MMP-2 is the prominent MMP expressed by MSCs 
(Morgunova et al. 1999). 
 
Figure 3.9 – MMP Profile of MSC Supernatant.  Media was collected after 3 weeks of culture and 
MMP concentration determined using membrane analysis.  Data shows that MMP-2 concentration is 
greater than that of the other MMPs. MMP-1 and MMP-3 were also detected albeit at a lower level. 
MMP-8, -9, -10 & -13 were not detected in the supernatant.  Graph shows mean  SD, n=3, where **** 
p<0.0001 by ANOVA.   
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3.3.2 MMP Substrate Preference  
The results of the previous section demonstrate that there was a greater concentration 
of MSC-derived MMP-2 in comparison to MMP-9. Thus, MMP-2 was considered the 
best candidate for surface cleavage.  From this data, we progressed to define MMP-2 
substrate preferences prior to synthesis of the surface.  For this section, it is important 
to note that peptide sequences are labelled according to Schechter and Berger 
nomenclature.  This refers to N-terminal residues which are labelled as P1, P2, P3 
(non-prime) and residues that are located on C-terminal are labelled P1’, P2’, P3’ 
(prime) (Schechter & Berger 1967).  N-terminal and C-terminal residues are separated 
by the point of cleavage known as the scissile bond (Schechter & Berger 1967).  
 
Discovery and accumulation of data from cleavage sites is becoming more high-
throughput thanks to the –omics and bioinformatics era.  Subsequently there is an 
omics field devoted to the cleavage products of proteases known as degradomics.  This 
field aims not only to profile the individual proteases to determine substrate preference 
but also to identify the activity of these proteases in vivo (López-Otín & Overall 2002).  
One such example of this is the use of peptide libraries. Peptide libraries allow high-
throughput analysis of peptide sequences and from this, patterns in preference can be 
highlighted (Turk et al. 2001; Vartak & Gemeinhart 2007; Seltzer et al. 1990) 
  
Peptide libraries have been instrumental to determining MMP sequence preference.  
Each MMP has slight variations in preference for each position, for example, where 
MMP-1, MMP-2 and MMP-9 prefer Ala, Gly or Ser at P3’, MMP-3 and MMP-7 prefer 
Met at the same position (Turk et al. 2001). For most MMPs it is thought that there is 
consensus for Pro at position P3, P2 is generally hydrophobic (Turk et al. 2001) and P1 
is generally a small residue (Vartak & Gemeinhart 2007). Pro at position P3 is 
significant because of the interactions of the substrate with the enzyme, particularly the 
hydrophobic pocket of the enzyme active site and therefore Pro is the most kinetically 
favourable amino acid at P3 (Kridel et al. 2001).  Recognition of sequence also depends 
on the complementarity of active site to the sequence in the substrate (Turk et al. 2001). 
Further, use of peptide libraries suggested that peptide length was important to 
sequence recognition.  Huang et al. showed that increasing lengths of peptides lead to 
more specific cleavage at a faster rate (Huang et al. 2013).  Similarly, Schilling et al. 
suggested that for MMP-2 selectivity, the subsite interactions are as important as the 
consensus motif (Schilling & Overall 2008). Therefore, residues surrounding the 
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scissile bond are equally as important in terms of enzyme kinetics. Degradation 
encompasses the characteristics of adjacent residues to the cleavage site and not 
P1P1’ alone.  
 
Collating the information from enzyme/peptide interactions into databases allows ease 
of access and wealth of knowledge for researchers in multiple fields (Rawlings 2009). 
For example, for healthcare, databases could include the degradome of diseased tissue 
to be compared to normal tissues with the view of finding drug targets based on 
degradomic profile (López-Otín & Overall 2002). In a bioengineering context, 
biomimicry of significant peptide sequences can be accessed easily to be included in 
materials applications.   
 
One such protease database is the MEROPS
9
 database that collates data from 
publications on various protease families to give an overview of all aspects of the 
protease of interest (Rawlings 2009).  One advantage of this website is that it also 
collates data from in vitro studies as well as in vivo studies, whereas other databases for 
example CutDB only provides information from those peptides that are physiologically 
relevant
 
(Rawlings 2009).  MEROPS has gathered data from PubMed and accumulated 
the number of times an amino acid has been cited at each position along the scissile 
bond (although from this number, the context in which the MMP has been cited (i.e., 
active or inactive) is not known).  From this, a heat map can be generated to provide a 
visual representation of this information. We looked specifically at the gelatinase 
sequence preference as shown in Figure 3.10.  As noted in Section 3.3.1, MMP-2 is the 
predominant MMP that MSCs secrete. However, we designed the peptide motif with 
the aim of it being targetable to both gelatinases as it is known that there is overlap in 
substrate preference.  This is also advantageous as while MMP-2 is mostly found in 
self-renewing cells and MMP-9 is involved in osteogenesis (Morgunova et al. 1999; Vu 
2000). 
 
The amino acids in Figure 3.10 have been arranged in order of properties starting with 
non-polar then polar, acidic and basic (Rawlings 2009).  Those positions that are highly 
cited are more likely to be acted on by that MMP (and are coloured red in Figure 3.10). 
The bottom of the heat map shows the most cited peptide for each position P4-P4’.   
Comparing both MMP-2 and MMP-9 it is shown that there are slight differences 
                                                 
9
 https://www.ebi.ac.uk/merops/ 
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between the gelatinase’s sequence preference which could account for gelatinase 
redundancy. There is a similar trend for both gelatinases in that there is a favourability 
for non-polar amino acids at most positions along the scissile bond and in particular 
P2’ position (Turk et al. 2001).  There is also a consensus for Pro at P3 as consistent 
with Kridel’s work (Kridel et al. 2001).  What is also clear is that there is a greater 
number of citations for MMP-2 than MMP-9.   
 
The citations for amino acids involved in the cleavage site are the dominant amino 
acids cited.  There is a preference for small amino acids at position P1 and Leu at P1’ 
for both MMP-2 and -9.  It has been shown previously that MMPs cleave before a 
hydrophobic side chain particularly Leu, Ile, Met, Phe or Tyr (Visse & Nagase 2003).  
For MMP-2 this is apparent as hydrophilic amino acids are avoided, fewer than 150 
citations for polar amino acids at P1’ in comparison to Leu which is cited 1387 times.  
 
To make the sequence amenable to osteogenic differentiation, RGD was substituted 
into P2’-P4’ (as RGD has shown to help drive regulation of the osteogenic phenotype 
as described in Chapter 1).  As shown in the Figure 3.10, Gly is maintained at position 
P3’ for both consensus sequences.  However, Asp and Arg are acidic and basic amino 
acids respectively.  For MMP-2 a P4’ AD substitution could be tolerated (331 vs 278 
citations respectively) however, P2’ VR may be less well tolerated (444 vs 99 
citations respectively). It is similar for MMP-9 with P2’ AR (41 vs 34 citations 
respectively) and P4’AD (49 vs 24 citations respectively). There is obviously a 
preference for certain amino acids at defined positions, however non-consensus 
sequences can also be cleaved although this would not be expected to be as efficient 
(Turk et al. 2001).  Maintaining Pro at P3, small amino acids at P1 and Leu at P1’ 
should be sufficient to drive cleavage.  It might have been more accurate to use the full 
consensus sequence rather than substituting RGD at the prime side.  However, due to 
the time taken to add one amino acid (24 hours) the RGD peptide was substituted in 
rather than adding to the prime side (8 amino acids rather than 11 for the consensus and 
RGD).  Had the synthesis been automated, these sequences could have been compared 
to analyse the most efficient sequence for MMP cleavage. 
 
As cleavage occurs between position P1P1’, effective mimicry of enzyme consensus 
sequences is imperative for efficient kinetics.  We compared the number of citations 
exclusively for every amino acid at position P1 and P1’ to determine the most likely to 
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be acted on (Figure 3.11).  Non-polar amino acids were favoured for both enzymes at 
P1’ with Leu as the most cited (1387 and 102 citations for MMP-2 and MMP-9 
respectively).   P1 for MMP-2 was more ambiguous, with approximately 500 citations 
for each Gly and Ala (481 and 506 respectively).  However, these amino acids are 
small non-polar and therefore have similar properties.  In the case of MMP-9 there is a 
clearer distinction for P1 (120 for Gly and 44 for Ala, Figure 3.11).  We are confident 
therefore that gelatinase cleavage of a sequence occurs with a small amino acid at P1 
and Leu at P1’. P1’ has direct effects on enzyme kinetics as determined by Seltzer et al.  
Using synthetic peptides substituted various amino acids at P1’ in the sequence Pro-
Leu-Gly-X-Leu-Glu, they found that substitution of Leu for X (P1’) enhanced 
cleavage efficiency by increasing the cleavage rate (80 µmol/mg/h in comparison to 
Ala at 22 µmol/mg/h) (Seltzer et al. 1990).  Maintaining Leu at this position for our 
sequence, gives confidence not only for peptide recognition, but also in terms of 
efficiency (Seltzer et al. 1990).  To be amenable to both gelatinases, and substituting 
cell adhesive motif (RGD), we selected the sequence Gly-Pro-Ala-Gly-Leu-Arg-Gly-
Asp. 
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Figure 3.10 – Gelatinase Consensus Sequence.  MEROPS database collates the publication information available per MMP which has been replicated in this table.  The number in each 
box refers to the number of citations for amino acids at each position along the scissile bond.  For those amino acids that have a greater number of citations (red), there can be confidence 
that the MMP will act on that sequence when arranged at that site.  For both gelatinases, there is a consensus on the non-prime side and at the cleavage site, P2’ is the only position where 
there is variation in the consensus sequence between MMP-2 and MMP-9 (Val and Ala respectively). The cell adhesive peptide (RGD) is substituted in the prime side of the scissile bond.  
Number of citations were coloured on a scale from red (many citations) to green (few or no citations).
  71 
 
Figure 3.11 - Scissile Bond Preference.  For all amino acids for position P1 and P1’ for both MMP-2 
and MMP-9, it is apparent there is a preference for Leu at the prime side.  The P1 position for both 
MMP-2 and MMP-9 is occupied by small amino acids. For MMP-9 it is clearly defined (Gly) in 
comparison, MMP-2 has similar preference for small amino acids at P1 (Ala or Gly). 
 
We also analysed the consensus sequence for other MMPs (Figure 3.12).  Plotting the 
preference (number of citations) for each of the amino acids in the sequence, we 
compared the number of citations at each position for the MMPs identified.  Figure 
3.12 reveals that MMP-2 has the most citations as expected.  MMP-9 has the next 
highest citations, particularly on the non-prime side of the sequence and P1’, this 
should be expected due to the redundancy of the gelatinase family.  However, the data 
available for the other MMPs shows that there are less than 100 citations per amino 
acid at each position.  It is apparent from position P2’ that there are less citations for 
Arg at this position for MMP-2 and is cited equivalent number of times with that of 
other MMPs. However, from Figure 3.8, only MMP-1 & -3 were identified and not 
expressed at the same concentration as MMP-2 in MSC supernatant and therefore it is 
more likely that MMP-2 is responsible for cleavage.   
  72 
 
Figure 3.12 -Preference of Other MMPs for the Sequence GPAGLRGD (P4-P4’).  Several MMPs 
were identified from the supernatant of MSCs.  Looking at the number of citations for each amino acid 
for the selected sequence GPAGLRGD we see that MMP-2 is favorable for all positions.  Therefore, 
we have confidence that MMP-2 will act on the selected sequence alone.  
 
Table 3.4 shows the most highly cited amino acids along the scissile bond for selected 
MMPs.  The data was collected from the MEROPS database and analysed as in Figure 
3.10.  From this data, it is obvious that there are similar preferences for certain 
positions regardless of MMP family.  These include Gly at P4, Pro at P3, small 
hydrophobic at P1 and Leu at P1’. There is a use of polar amino acids in MMP-8 and 
MMP-10 consensus sequence which may prevent cleavage of the selected sequence by 
these MMPs.  There is also a preference for Arg at the P2’ position, however, these 
MMPs are not expressed by MSCs and therefore will not contribute to surface 
cleavage. 
 
 Table 3.4 – Consensus Sequences for Selected MMPs.  Preferred amino acids at P4-P4’ for MMPs-
1,3,8,10 & 13, taken from MEROPS database.  
MMP Scissile Bond 
 P4 P3 P2 P1 P1’ P2’ P3’ P4’ 
MMP-1 G P L/Q/E A L K/R G A 
MMP-3 G P A G L R G P 
MMP-8 G P S G L R G L 
MMP-10 G P A/G G L S T A/G 
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MMP-13 G P P/L G L R G P 
3.3.3 Design and Synthesis of the Surface 
With identification of a consensus sequence for the gelatinases, synthesis was then 
carried out. Figure 3.13 shows the successive coupling of each amino acids from Fmoc-
D to full PEG-GPAGLRGD sequence which we have shortened to DIGE-D for 
digestible adhesive peptide, –D indicating RGD.  Deprotection and coupling are 
repeated for all amino acids in the sequence which are then capped with a PEG group 
after deprotection of the last amino acid (Fmoc-Gly).  The sequence is synthesised 
bottom up from P4’-P4 which is then capped with PEG.  Cleavage is hypothesised to 
occur between prime (green) and non-prime (orange) amino acids. 
 
Figure 3.13 - Progression of SPPS for Sequence PEG-GPAGLRGD. Amino acids are added to the 
pre-treated surface (silane and PEGylation, black) from non-prime side, bottom up starting with Fmoc-
Asp (P4’). Green = prime amino acids, orange = non-prime amino acid, purple = protecting (Fmoc) or 
blocking (PEG) group.  Side chains for Asp, Arg and Leu are shown in the box. 
 
3.3.4 Surface Characterisation 
3.3.4.1 Pre-treatment 
Prior to amino acid addition, there are certain pre-treatment stages required to provide a 
free amine for the first amino acid to bind to (as described in Chapter 1, Section 1.8.1).  
  74 
This includes cleaning (piranha solution), silanization (to create a flexible linker) and 
PEGylation (to provide a free amine), each of which can be tracked using WCA 
measurement (Figure 3.14) (Zelzer et al., 2012).  Cleaning the surface by both solvent 
cleaning and acid cleaning increases the hydrophilicity of the surface. Coating with 
silane also increases the hydrophobicity due to the covalent attachment of epoxide 
groups (from 40.4  4.4 to 39.7  3.3, Table 3.5). PEG is known to be hydrophilic, with 
an WCA of 39.7  3.3 (Table 3.5) being recorded suggesting that the PEG diamine has 
efficiently bound to the surface and the pre-treatment stages have primed the surface 
ready for amino acid addition.   
 
Figure 3.14 - Water Contact Angle of Pre-Treated Glass Coverslip Prior to Amino Acid Addition.  
There are various pre-treatment stages to create a free amine for a condensation reaction with carboxylic 
tail of the first amino acid.  After washing, contact angle increases with silane addition then decreases 
with PEG monolayer. Pre-treatment is complete as PEG is in place for amino acid addition.  Graph 
shows mean  SD, 50 images per dataset with 15 datasets taken across 3 substrates (n=450 images per 
set). 
 
Table 3.5 - Quantification of WCA for Pre-Treatments. WCA measurements of untreated glass, 
cleaned glass, silane and PEG diamine treatment.  Values correspond with Figure 3.14; standard error 
was calculated using 50 images per dataset with 15 datasets taken across 3 substrates (n=450 images per 
set). 
Sample Average 
Untreated Glass 72.0   3.8 
Solvent Clean 53.7  1.7 
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Acid Clean 40.4  4.4 
GOPTS 59.8  1.1 
PEG26 diamine 39.7  3.3 
Due to the robustness of the technique, no further characterisation was carried out.  The 
coating of coverslips with silane was originally published by Piehler et al. who 
demonstrated homogeneous coating utilising GOPTS that could be functionalised with 
PEG (Piehler et al. 2000).  This resultant PEG layers was found to be of a higher 
density that was better ordered than using other amino-functionalised silanes (Piehler et 
al. 2000).   
 
3.3.4.2 Amino Acid Addition 
Amino acid addition was analysed firstly using ToF-SIMS. ToF-SIMS is used to 
analyse material surface properties by scanning the surface with a primary ion beam 
which causes the emissions of secondary ions that are then analysed (Hagenhoff 2000).  
A time of flight ioniser is used to measure the mass to charge ratio (m/z) of the emitted 
ions.  This is more advantageous than techniques such as WCA (which only monitors a 
change in surface properties) as it can distinguish between different proteins based on 
molecular structure (Wagner & Castner 2001).  
 
Measurements can also generate images of the surface from the ion spectrum (Figure 
3.15). We can use the emitted secondary ions to determine the abundance of specific 
compounds on the surface, the lighter the image the more abundant that compound is. 
Silicone is an indicator of untreated glass which was abundant as expected on the glass 
control, indicating little or no contamination of the substrate. The abundance of silicone 
decreased with the completion of the full-length sequence (DIGE-D).  This suggests 
that the glass coverslip had been treated effectively by the SPPS procedure. PEG was 
not identified on the glass control but increases after treatment, suggesting SPPS had 
been carried out as expected and capped with PEG.  The total ion column is the sum of 
all ion intensities and was used to demonstrate uniform signal intensity over the whole 
sample.  This was slightly heterogeneous for the glass control, indicating some 
scratching on the surface. However, after modification the surface is a more 
homogeneous layer.  Normalised ion intensity was quantified for both PEG and silane 
(m/z = 45, m/z = 28, Figures 3.15B & C respectively).  This shows that the surface had 
been modified and that PEG blocking group is in place.  
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Figure 3.15 - ToF-SIMS Images for SPPS Build-Up. A) ToF-SIMS images and average ion intensities 
of surface B) before and C) after modification.  The ion images were normalised to the total ion intensity.  
Images show a reduction in silane and increase in PEG after SPPS indicating completion of sequence.  
PEG was measured at m/z = 45 and glass (Si
+
) measured at m/z = 28. B & C were quantified as 
normalised ion intensity and confirmed the abundance of silane for untreated and PEG for treated 
surface, ****p<0.0001 as determined by t-test, graphs show ±SD, n=4.  
 
We can also look for individual mass to charge ratios of the expected amino acids 
(Table 3.4). Unfortunately, there was some contamination observed on untreated glass 
sample, specifically, Pro and Ala fragments.  We would expect an increase of signal 
intensities on the peptide surface in comparison to glass.   Indeed, peaks were observed 
at all expected m/z ratios for the DIGE-D samples (Figure 3.16A).  Figure 3.16 B 
shows the same information but as an image where the last frame in Figure 3.16B 
compares the ion intensity of the complete peptide.  There was an increase of full 
peptide surface for DIGE-D in comparison to glass demonstrating that although there 
was some contamination of the glass sample, peptides characterised on DIGE-D were 
more abundant (Figure 3.16B). The results are consistent with Figure 3.15, as the 
presence of PEG could also be viewed (m/z = 45) for DIGE-D sample alone, 
confirming no PEG was observed on the untreated sample. 
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Figure 3.16 – ToF-SIMS Analysis of Amino Acid Addition.  A) The spectra were normalised to the 
total ion intensity and plotted on the same scale.  Signal intensities show expected amino acids on the 
DIGE-D surface, reduction of silane and presence of PEG. B) ToF-SIMS images of surface showing 
abundance of complete peptide sequence for DIGE-D samples.   
 
The intensities of each amino acid were plotted for both glass and DIGE-D samples 
(Figure 3.17A). It is important to note that some amino acids in this sequence have 
weak ion intensities specifically, Pro and Leu (Figure 3.17A).  Stronger intensities 
appear as a result of some amino acids producing a higher amount of stable secondary 
ions than others.  These generate higher signals and are better indicators of the presence 
of the sequence (Hagenhoff 2000).  The remaining amino acids, Arg, Gly, Ala and Asp 
were present on the surface at a higher intensity than that of glass (p<0.0001, p<0.0001, 
p<0.01 and p<0.01 respectively).  The lack of PDMS signal on the treated surface 
suggests that there was no contamination of the substrate during synthesis (Figure 
3.17B).  If contamination had been observed, then signal may be compromised for the 
expected amino acids.  As this is not the case, we can determine that we are indeed 
witnessing a true weakness of signal.   
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Figure 3.17 – Quantified Normalised Ion Intensity per Substrate and Potential Contamination by 
Other Factors.  A) Ion intensity was calculated per amino acid at defined m/z ratios and normalised to 
total ion intensity then plotted on the same scale.  Results show signal intensities for Gly, Arg, Asp and 
Ala but highlight weakness in signal for Pro and Leu.  Statistics calculated by ANOVA, statistics shown 
for differences in normalised ion intensity for that amino acid on glass in comparison to the DIGE-D 
sample. ****p<0.0001 and **p<0.01.  B) Contamination by PDMS was not observed on DIGE-D 
surface, indicating efficient synthesis *p<0.05, determined by t-test, graphs show ±SD, n=4.  
 
Due to the weakness in signal as a result of the poor ionisation of some amino acids in 
the sequence, the technique was complemented with fluorescence spectroscopy (Figure 
3.18) and WCA measurements (Figure 3.19).  An advantage of Fmoc protection is that 
Fmoc itself is fluorescent (Behrendt et al. 2016).  Using flourescence spectroscopy 
specifically designed by Zelzer et al. for analysis of 2D coverslips, we can track 
progression of coupling and deprotection via the presence or absence of the Fmoc on 
the coverslip at each stage of SPPS process (Zelzer et al., 2012).   A specific holder for 
coverslips had been previously produced enabling the light path (excitation at 270 nm) 
to hit the coverslip at an angle, allowing detection of reflected light (emission 320 nm) 
(Figure 3.5) (Zelzer et al., 2012).   The resulting peak on the spectra at 320 nm 
indicates the presence of Fmoc, which is removed after the deprotection stage. To 
evaluate the progression of SPPS, coverslips were removed from the batch 24 hours 
after amino acid addition and immediately after treatment with piperidine to 
demonstrate both Fmoc protection and deprotection stages (Figure 3.18). It was found 
that surfaces containing Fmoc emitted a spectrum at 320 nm suggesting that the Fmoc 
protected amino acids were coupled to the surface as expected.  In comparison to those 
that had been treated with piperidine (to remove Fmoc), no peak was observed at 320 
nm nor was any fluorescence signal detected suggesting effective removal of Fmoc in 
the deprotecting stage.  This was tracked during the whole SPPS process for every 
amino acid in the sequence and implies that Fmoc amino acids were added.  Although 
the data is not quantitative, the technique was reproducible between coverslips (n=3) 
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and provides an indication that effective SPPS build up has occurred.  As for the final 
blocking group, PEG is not fluorescent and therefore the cap could not be confirmed 
using this technique.  
 
 
Figure 3.18 - Fluorescent Spectroscopy of Amino Acid Addition.  Stepwise construction of peptide 
chain from Fmoc-D to -GPAGLRGD.  Figures show emission spectra at 320 nm when excited at 270 
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nm.  No peak was observed after each deprotection step suggesting effective deprotection of the amino 
acid. 
WCA measurement was also used as Fmoc protected amino acids have slightly higher 
hydrophobic signature than their deprotected counterparts (Rawsterne et al. 2006). 
Coverslips were analysed before and after piperidine treatment to observe amino acid 
protection and deprotection stages.  For all Fmoc protected amino acids, a more 
hydrophobic angle was observed (>50 ) (Figure 3.19).  When the piperidine is applied, 
we observed a significant reduction of WCA for unprotected amino acids in 
comparison to their protected counterpart (p<0.0001, Table 3.6). This suggests that 
Fmoc protection and deprotection occurred and SPPS progressed as expected.  The 
protecting side chains may also affect the WCA result.  After addition of Arg (where 
the side chain is protected by Pbf to prevent acylation), angle measurement increases 
for subsequent coupling and deprotection stages (50.9  ± 2.6 to 65.0  ± 3.7 with Arg 
addition). PEG is hydrophilic and therefore has a characteristically low contact angle 
value. Using this method, we can also observe the presence of the PEG capping group 
at a lower WCA in comparison to uncapped sequence (51.5  ± 1.6 vs 42   1.5). 
 
 
Figure 3.19 - Water Contact Analysis of Amino Acid Addition.  Increase of WCA occurs after Fmoc 
coupling (red) this is reduced with removal of Fmoc in deprotection stages (blue).  As PEG is a 
hydrophilic molecule we would expect a low angle, and the final sequence PEG-GPAGLRGD (green) 
exhibits such a value (42∘ 1.5).  This data suggests SPPS was completed as expected. 
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Table 3.6 - Quantification of WCA for Amino Acids. WCA measurements of each stage of SPPS 
(addition and deprotection).  Values correspond with Figure 3.19; standard error was calculated using 50 
images per dataset with 15 datasets taken across 3 substrates (n=450 images per set). Statistics calculated 
by ANOVA and stated for comparison of Fmoc protected and unprotected amino acids only, 
****p<0.0001. 
Fmoc Protection Fmoc Deprotection P 
value Sequence Angle Sequence Angle 
Fmoc-D 51.3 ± 4.1 D 43.1 ±2.8 **** 
Fmoc-GD 50.9 ± 2.6 GD 46.8 ± 1.9 **** 
Fmoc-RGD 65.0 ± 3.7 RGD 49.9 ± 1.3 **** 
Fmoc-LRGD 57.0 ± 1.6 LRGD 52.3 ± 3.0 **** 
Fmoc-GLRGD 57.6 ± 2.2 GLRGD 51.9 ± 2.1 **** 
Fmoc-AGLRGD 63.6 ± 0.9 AGLRGD 54.0 ± 0.8 **** 
Fmoc-PAGLRGD 55.6 ± 1.3 PAGLRGD 53.8 ± 5.8 **** 
Fmoc-GPAGLRGD 58.7 ± 2.7 GPAGLRGD 51.5± 1.6 **** 
  PEG-GPAGLRGD 42.0 ± 1.5 - 
 
3.3.4.3 DIGE-D Cleavage  
Based on results from fluorescence, ToF-SIMS and WCA, we were satisfied that the 
surface had been made to completion with amino acid addition occurring as expected.  
With the surface complete, we performed in vitro experiments to determine surface 
cleavage. DIGE-D coverslips were incubated with defined concentrations of MMP in 
serum free media.  The concentrations were chosen to reflect MSC gelatinase 
supernatant concentration in response to DIGE surface (as determined by ELISA in 
Figure 4.14).  From the MEROPS data, we designed the sequence with the hypothesis 
that cleavage occurs between G and L in the sequence GPAGLRGD (Figure 3.20A).  
Using ToF-SIMS we evaluated the ion intensities for the full-length peptide (sum of 
ion intensity of all amino acids in the sequence GPAGLRGD).  As expected, the 
untreated DIGE-D has an abundance of the full-length peptide which is reduced upon 
treatment by the gelatinases (p<0.0001, Figure 3.20B).  This indicates that the MMPs 
are reducing the presence of the full-length fragment, indicating cleavage.  There was a 
further reduction in the abundance of full length peptide when treated by MMP-9 in 
comparison to MMP-2 (p<0.01, Figure 3.20B).  This was unexpected due to the small 
concentration and activity of MMP-9 observed in Figure 3.7 & 3.8 in comparison to 
MMP-2, this indicates MMP-9 is more potent that MMP-2, which was unexpected.  We 
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were unable to accurately determine cleavage at GL due to the weak ionisation of the 
amino acids of the remaining fragment.  
 
 
Figure 3.20 – Cleavage by MMP-2 on Sequence PEG-GPAGLRGD. A) It is hypothesised that 
cleavage of the sequence will occur between GL as determined by MEROPS.  The sequence LRGD is 
thought to remain on the glass coverslip after PEG-GPAG removal.  The schematic indicates the 
chemical composition of the surface before and after MMP cleavage. Purple = PEG cap, orange = GPAG 
fragment removed after cleavage, green = LRGD remaining fragment, black = pre-treated surface. B) 
Normalised total ion intensity of GPAGLRGD amino acids before and after treatment with gelatinases. 
DIGE-D coverslips were treated with 20 ng/ml MMP-2 and 0.25 ng/ml MMP-9 as in cell supernatant 
concentration for three weeks. Statistics calculated by ANOVA where ****p<0.0001 and **p<0.001, 
graphs show ±SD, n=4.  
 
Cleavage was also analysed by observing the abundance of the PEG cap.  The image in 
Figure 3.21A shows that there is an abundance of PEG for the untreated sample.  This 
is reduced after treatment with the gelatinases.  The image of total ion intensity is also 
displayed (Figure 3.21A).  This indicates that surface is uniform before and after 
treatment by MMPs. This was then displayed graphically, showing peaks for PEG 
which was reduced when treated with gelatinases. PEG was quantified (from the ion 
intensity of PEG per sample) in comparison to the untreated surface to determine % 
removal of PEG.  Figure 3.21B indicates that the PEG blocking group was reduced by 
both gelatinases at approximately 80 % removal for MMP-2 and 85 % removal for 
MMP-9.  This figure again highlights a difference in MMP-2 efficiency in comparison 
to MMP-9 (p<0.01).  To evaluate the effects of unspecific loss of peptides, this data 
was also expressed as a ratio which was calculated from total ion intensity of both PEG 
and the full peptide sequence (Figure 3.21C).  This highlights that as PEG is removed, 
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the presence of peptide sequence material increases, indicating that removal of PEG by 
enzyme or unspecific loss of peptide chain still results in increased expression of 
peptides on the surface (p<0.0001).   The data presented in Figures 3.15 – 3.21 suggests 
that the cell secreted concentration of MMP was sufficient to cleave the surface 
although MMP-9 is potentially a better candidate for cleavage of the sequence than 
MMP-2. 
 
 
Figure 3.21 - PEG Remaining After Gelatinase Treatment.  All samples refer to cleavage by 20 ng/ml 
MMP-2 and 0.25 ng/ml MMP-9. A) Images of DIGE-D surface before and after treatment with 
gelatinases. PEG column indicates there is an abundance of PEG on the untreated sample which is 
reduced in response to MMP treatment. B) Quantification of PEG total ion intensity expressed as a 
percentage of total ion intensity present on untreated surface.  Graph indicates reduction by 80% for 
both gelatinases.   C) Ratio of PEG vs peptide intensity increases after treatment suggesting there is less 
PEG and more peptide on the surface. Reduction in PEG expression suggests cleavage occurs.  Statistics 
calculated by ANOVA for both graphs, ****p<0.0001 and **p<0.01, graphs show ±SD, n=4. 
 
3.3.4.4 Surface Response to Supernatant  
We also used ToF-SIMS to determine the effects of cell supernatant deposition on the 
surface (Figure 3.22). The total ion column indicates the generation of uniform 
sequence for Glass, PEG26 diamine and untreated coverslips.  Supernatant from glass 
coverslips was saved at week 2 then added to fresh DIGE-D surface.  When treated 
with supernatant, it is clear that there was a heterogeneous surface with deposition of 
surface proteins that have accumulated on the surface.  PEG26 diamine was not found 
on untreated glass coverslips (in line with previous experiments) but increases with 
PEGylation and addition of PEG blocking group.    With the addition of cell 
supernatant, we can see a reduction in PEG, this suggests cleavage of the surface by 
enzymes in the media.  However more experiments would need to be conducted to 
confirm which MMP found in the supernatant is acting on the sequence.  
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Figure 3.22 – Supernatant Treatment of DIGE-D.  Prior to supernatant addition, a homogenous 
surface is observed for all stages of SPPS; untreated glass, PEGylation and untreated DIGE-D.  Presence 
of PEG is observed in abundance for PEGylated and untreated samples as expected.  Supernatant was 
saved from MSCs cultured on glass coverslips for 2 weeks, then added to fresh DIGE-D coverslip and 
incubated for 24 hours. PEG is reduced in response to cell supernatant suggesting supernatant is 
sufficient to reduce surface bound PEG. 
 
3.4 Discussion 
We have previously shown, along with our collaborators, that peptide motifs as 
presented to cells by SPPS have been sufficient to control and direct cell behaviour 
(Roberts et al., 2016; Todd et al., 2009; Zelzer et al., 2012). As described in Chapter 1, 
Figure 1.9 we aimed to create a surface that was amenable to cell secreted MMPs.   
 
We have confirmed that MMP-2 is the MMP preferentially secreted by MSCs.  Using 
zymography, ELISA and antibody arrays, MMP-2 is the most consistently expressed 
MMP at the highest concentration (Figure 3.7-3.9).  MMP-1 & -2 were also identified 
at three weeks using antibody arrays (Figure 3.9) and MMP-9 concentration increased 
at week 4 (Figure 3.8).  However, the expression of these MMPs was significantly 
lower than the expression of MMP-2 (p<0.0001 and p<0.001 respectively).  This data 
led us to believe that MMP-2 would be the enzyme responsible for cleavage of the 
sequence.  However, due to the redundancy of the gelatinases and the increase in MMP 
production at week 4 (Figure 3.8), we designed the sequence to be amenable to both 
MMP-2 and MMP-9. Therefore, the sequence that was selected was PEG-
GPAGLRGD, which mimics the position of Pro at P3, scissile bond to be between 
GL and use of small hydrophobic amino acids (Figure 3.10-3.11).  RGD was 
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substituted into the prime side of the sequence.  The sequence was abbreviated to 
DIGE-D to denote digestible peptide.  Due to the time taken to synthesise the 
sequences, we were unable to test sequences that did and did not substitute RGD to the 
prime side (GPAGLRGD in comparison to GPAGLV/AGARGD) to better 
understand efficiency of cleavage by the gelatinases (Section 3.3.2).  This was a 
limitation and if synthesis had been of higher throughput, multiple sequences could 
have been compared to find the most efficient and specific sequence. 
 
As stated above, manual synthesis was time consuming.  Synthesis of materials 
manually took 1 month.  This was a limitation and it would have been better to 
automate synthesis however; this technique was not available to us.  In addition, there 
may have been areas where synthesis could have been improved, for example, when 
coating coverslips in PEG diamine.  This procedure was again done by manually 
spreading molten PEG over the surface of the coverslip.  This does not guarantee a 
homogeneous surface and due to human error, there could be areas in PEG distribution.  
This could have created local areas where there was no coating by peptides which will 
have an effect on cell behaviour and potentially create an unsynchronised population of 
cells.  In hindsight it would have been better to confirm coating efficiency utilising the 
ninhydrin test (Pires et al. 2014).  The test is a simple colour change that indicates the 
presence of free amines (solution is blue in presence of free amine).  This could also 
have been utilised at the coupling stage to confirm that all free amines were bound and 
that the correct combination of peptides were added.  Based on the result of the test, 
coupling could have been repeated until there was no free amine available.  By not 
ensuring efficiency, there is a risk that deletion peptides, peptides with the wrong 
sequences or areas with no peptide could be found on the surface, which may have an 
affect the biological result.   
 
We utilised several techniques to confirm the presence of peptides. Using WCA and 
fluorescent spectroscopy we can track the presence of the Fmoc moiety in terms of its 
hydrophobicity and fluorescent properties.  The addition of Fmoc protected amino 
acids results in the presence of a peak of 320 nm when excited by 270 nm as shown in 
Figure 3.19.  Presence of Fmoc is also categorised by a larger WCA and is therefore 
hydrophobic (Figure 3.19).  Analysing successive rounds of SPPS using WCA and 
fluorescent spectroscopy allows tracking of coupling and deprotection stages in real 
time. There is a limitation to using fluorescent spectroscopy and WCA measurement.  
Fluorescence only shows the presence or absence of Fmoc and although is an indicator 
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of SPPS, it is not quantitative.  Similarly, WCA is only a measurement of the 
hydrophobicity of the surface and can be caused by other properties such as 
topography.  Both techniques comment on the change of surface but not the chemical 
modification.   
 
Utilising ToF-SIMS has the advantage of looking at surface properties including 
chemical composition.  The chemical signature of all reagents was identifiable by m/z 
ratios.  We observe the reduction of silane signal (Si
+
) indicating the presence of 
peptides and the increase of PEG suggesting the blocking group is in place (Figure 
3.15-3.17).  Figure 3.16 shows the presence of all expected amino acids are observed 
on the surface indicating successful synthesis. Taken together, (with knowledge of the 
limitations of each strategy) this data strongly suggests that SPPS has been completed 
and synthesised as expected and all amino acids are in place. ToF-SIMS is qualitative 
and can be used to comment on the chemical composition, but in this case, is a 
challenge due to the weakness in ion intensities of selected amino acids. We also tried 
to confirm the presence of peptides by high-performance liquid chromatography 
(HPLC), but it was thought that the concentration of peptide was too low.  We also 
utilised Raman spectroscopy to identify the presence of peptides on 2D surface as 
described by Sahoo et al. however, we could not replicate the results (Sahoo et al. 
2016).  
 
Using recombinant MMP, we can conclude that cleavage of the surface is occurring as 
monitored by ToF-SIMS where we see approximately an 80 % reduction of PEG with 
the addition of each gelatinase (Figure 3.21).   It was observed there was further 
cleavage when treated by MMP-9 than MMP-2 suggesting MMP-9 may be more 
efficient (Figure 3.20-3.21).  This was an unexpected observation, which has several 
potential interpretations. Namely, MMP-9 (0.25 ng/ml) is more potent than MMP-2 (20 
ng/ml) or MMP-2 was added in excess and its activity compared to MMP-9 cannot be 
inferred. The amino acid sequence selected was permissive for both gelatinases and 
therefore action by both MMPs is not unexpected. Thus, potency of the respective 
enzymes requires further investigation. To achieve this would require an exhaustive 
dose response curve which was unachievable during this PhD, as it would have 
comprised more months of synthesis and expense in utilising TOF for analysis. 
 
Finally, this experiment was also carried out using cell supernatant showing a 
decreasing abundance of PEG in response to cell secreted enzymes (Figure 3.22).  It 
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would have been prudent to block expression of MMP-2 and MMP-9 in culture either 
utilising small molecule inhibitors or siRNA to confirm these enzymes were 
responsible for cleavage alone.  
 
3.5 Conclusions 
Based on initial results of increasing concentrations of MMP-2, a gelatinase responsive 
surface was designed using bioinformatics data and synthesised using SPPS.  Although 
we have shown there is more abundance of MMP-2 expressed by MSCs, cleavage data 
suggests it is not necessarily more efficient than cleavage by MMP-9.  More 
experiments will have to be conducted to understand MMP potency in response to 
DIGE-D surfaces.
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4. Biocompatibility 
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This chapter aims to determine the initial cell response to the surface chemistry in terms of 
biocompatibility. We also created other surface chemistries including those with the non-
adhesive peptide (RGE) incorporated as controls.  We utilised live/dead staining, alamar 
blue and methylthiazolyldiphenyl tetrazolium (MTT) assay to determine cell viability in 
response to the peptides.  The surface chemistry (particularly RGE controls) did seem to 
affect cell behaviour initially however, this became less apparent with increasing time in 
culture. Further, we analysed cell adhesion and the presence of ‘super-mature’ adhesions, 
which were increased on RGD controls comparison to RGE; confirming that RGE is non-
adhesive to cells and RGD is manipulating cell adhesion.  MMP secretion was also 
determined and MMP-2 was found to increase on DIGE surfaces after 3 weeks in culture.  
These factors provide initial data that suggests the cells are responding favourably to the 
surface chemistry in that they are surviving, adhering and responding to the enzyme 
sequence with an increase in MMP-2 secretion. 
 
4.1 Introduction 
As discussed in Chapter 1, the presence of peptide motifs incorporated into a material are 
sufficient to direct cell behaviour.  The use of RGD has shown great successes in directing 
behaviour of MSC differentiation (Kilian & Mrksich 2012).  The method of SPPS to graft 
RGD to the surface has also been proven to be effective (Todd et al. 2009; Zelzer, 
McNamara, et al. 2012; Roberts et al. 2016).  
 
The previously designed enzyme responsive peptide surface (as described in Chapter 1, 
Figure 1.11) was user controlled and contained an Fmoc cap group (Fmoc-AARGD).  
Biocompatibility of MSCs cultured on Fmoc-AARGD was demonstrated by Roberts et 
al. using both live/dead staining and MTT assay (Roberts et al. 2016).  In addition to the 
enzyme remodelled surface (Fmoc-AARGD) a non-adhesive capped surface was also 
synthesized (Fmoc-AARGE) and pre-cleaved ARGD and ARGE controls.  It was shown 
that the surface chemistry did not negatively affect the survival of cells on the surface 
(Roberts et al. 2016).  With exception of PEG18 diamine and RGE controls, survival was 
observed on all other controls (Roberts et al. 2016).  PEG is known to be anti-fouling and 
non-adhesive therefore cell adhesion to PEG is not expected (Dong et al. 2011).  The 
results of the live/dead stain carried out in the Roberts paper is shown below (Figure 4.1) 
(Roberts et al. 2016).  Figure 4.1A shows the non-adhesive properties of RGE which 
resulted in fewer cells binding as would be expected on this surface; those that did attach 
however, survived. The results also highlighted that Fmoc did not negatively affect cell 
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survival and therefore the blocking group was biocompatible (Figure 4.1A).   The trigger 
for cell adhesion in this example is via elastase addition which acts on the dialanine 
sequence (AA).  As determined by MTT, the addition of elastase did not affect cell 
viability and there is no difference in cell metabolism with the addition of elastase (Figure 
4.1B) (Roberts et al. 2016).   
 
 
Figure 4.1 – Viability of Fmoc-AARGD Surface.  A) Live/dead staining on cells grown on different 
control surface chemistries.  RGE control and PEG18 diamine limit cell adhesion and therefore fewer cells are 
observed on these surfaces.  The RGD controls promote adhesion and viability.  There is little difference 
between Fmoc-RGD and Fmoc-RGE suggesting that Fmoc itself is biocompatible however, the presence of 
RGD enhances the effect.  Green = live cells, red = dead cells. B) MTT assay of cells on switched surfaces 
(treated with elastase) in comparison to unswitched surfaces (no elastase added). There is no detrimental 
effect of elastase on the cell culture. Both images replicated from (Roberts et al. 2016). 
 
At longer time points (>4 weeks) it was thought that Fmoc became coated with ECM 
proteins therefore reducing the efficacy of the surface (Roberts et al. 2016).   The blocking 
group was substituted from Fmoc to PEG to reduce this effect allowing the peptides to 
direct behaviour rather than ECM proteins (Roberts et al. 2016).   We have thus maintained 
the use of PEG as the blocking group for the MMP modifiable surface (PEG-
GPAGLRGD).  We hypothesise that this surface is both biocompatible and adhesive in a 
similar manner to that shown in Figure 4.1.  In addition to this, we have synthesised an 
uncleavable and pre-cleaved control (PEG-RGD and LRGD respectively). These 
sequences were repeated substituting Asp for Glu creating the non-adhesive RGE control 
(full list of sequences in Table 2.3, Chapter 2).  RGE is low adhesion as determined by 
Chen et al. who demonstrated that by mutating Asp for Glu in vitronectin, the mutant 
protein was found to be non-adhesive due to reduced interaction of integrin binding to the 
protein (Chen et al. 2009).  The  3 integrin is central in the recognition of the YGRGDSP 
sequence of vitronectin with specific interactions between the integrin and the receptor 
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(Chen et al. 2009).  This is lost in the mutant protein and integrin binding is not achieved 
(Chen et al. 2009). 
 
The uncleavable sequence was synthesized by removing the enzyme target sequence and 
the RGD/E peptide was capped with the PEG blocking group (PEG-RGD/E).  This was 
synthesised to evaluate the cell interaction with PEG and determine changes in MSC self-
renewal as originally observed in Roberts et al. Figure 1.11 (Roberts et al. 2016). A pre-
cleaved positive control was also synthesised (LRGD/E) to mimic the action of MMP and 
removal of the PEG and prime side of the sequence.   
 
In this section, we tested the viability of the controls used in this study using a variety of 
techniques; alamar blue, MTT and live/dead assays. In addition, proliferation analysis and 
adhesion studies were also performed to confirm the adhesiveness of RGD and RGE 
peptides. And finally, the MMP profile of the MSCs in response to the manipulation of 
surface chemistries.
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4.2 Methods 
4.2.1 Suppliers Information  
Table 4.1 – Supplier Information.  List of reagents used in Chapter 4. 
Technique Reagent Supplier 
Viability 
Live/dead kit Invitrogen, Molecular 
Probes, UK 
Calcein Invitrogen, Molecular 
Probes, UK 
Ethidium homodimer-1 Invitrogen, Molecular 
Probes, UK 
MTT powder Sigma Aldrich, UK 
Dimethyl Sulfoxide (DMSO) Sigma Aldrich, UK  
Alamar Blue BioRad, UK 
Immunohistochemistry 
Primary antibodies Sigma –Aldrich, USA 
Biotinylated secondary antibodies Vector Laboratories, USA 
Tween-20 Invitrogen, USA 
Phalloidin conjugated rhodamine Invitrogen, USA 
Fluorescein streptavidin Vector Laboratories, USA 
DAPI Vector Laboratories, USA 
Proliferation BrdU Kit GE Healthcare, USA 
 
4.2.1 Cell Seeding 
Prior to seeding with MSCs, surfaces were ethanol sterilised for 10 minutes then air dried 
in the fume hood.  Coverslips were then seeded at a density of 1,000 cells/cm
2 
in DMEM 
and incubated at 37 C, 5 % CO2 for times as stated. 
 
4.2.2 Viability  
Live/dead - P2 MSCs (PromoCell GmBH, Germany) were seeded on all controls and 
incubated for 24 hours under standard conditions (37 C, 5 % CO2).  Cells were stained 
using 1 µl of calcein and 1 µl ethidium homodimer-1, which was added to 1 mL of cell 
culture media (DMEM).  100 µl of solution was added to controls for 30 min (37 C, 5 % 
CO2).  The coverslips were then inverted and placed on microscope slide.  Slides were then 
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imaged using Zeiss Axiophot fluorescence microscope with an Evolution QEi digital 
monochromatic CCD camera and Q-capture imaging software.   
 
MTT - P3 MSCs (Stro-1 selected, University of Southampton) were cultured for 1 week. 
Samples were rinsed in 1x PBS.  A 5 mg/mL solution of MTT powder in 1 x PBS was 
added to the samples 1:10 in DMEM.  The well plate was placed on shaking plate for 5 
min then incubated under standard conditions (37 °C, 5 % CO2) for 5 hours.  The media 
was removed, and the cells were washed twice in cold PBS.  200 µl of DMSO was added, 
then the cells were shaken for 5 min.  The solution was transferred to a new 96 well plate 
and analysed using a Clariostar microplate reader (BMG Labtech, Germany). % viability 
was calculated using the following equation; 
% 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = ( 
𝑠𝑎𝑚𝑝𝑙𝑒
𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 ) x 100 
 
Alamar Blue – P3 MSCs (Stro-1 selected, University of Southampton) were cultured for 1 
week under standard conditions. Alamar blue solution was mixed 1:10 in DMEM then 600 
µl was added to each coverslip then incubated for 6 hours (30 C, 5 % CO2).  3 x 200µl of 
solution (supernatant) was transferred to a 96 well plate and analysed using a Thermo-
Scientific, Multiskan FC.   Absorbance was analysed at 1= 570 nm and 2 = 600 nm.  % 
reduction was calculated using the following equation; 
 
% 𝑅𝑒𝑑𝑢𝑐𝑒𝑑 =
(𝜀𝑂𝑋)2 𝐴1− (𝜀𝑂𝑋)1 𝐴2
(𝜀𝑅𝐸𝐷)1 𝐴’2−(𝜀𝑅𝐸𝐷)2 𝐴’1
 x 100 
 
Where; 
(OX) 2 = 11,7216 A1 = absorbance, test well 
(OX) 1 = 80,586 A2 = absorbance, test well 
(RED) 1 = 155,677 A’1 = absorbance, control 
(RED) 2 = 14, 652 A’2 = absorbance, control 
 
4.2.3 Immunohistochemistry 
P2 MSCs (PromoCell GmBH, Germany) were seeded on controls for 24 hours then fixed.  
The cell culture media was removed from the wells and coverslips were rinsed in 1x PBS. 
Cells were then fixed with fixative for 15 min at 37 °C followed by perm buffer at 4 °C for 
5 min.   Cells were then blocked in a solution of PBS/BSA for 5 min at 37 C.  Primary 
antibodies were added at 1/150 in PBS/BSA (see Table 4.2) at 37 °C for 1 hour then 
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washed 3x in Tween-20.  The biotinylated secondary antibodies and phalloidin conjugated 
rhodamine (F-actin staining) were added at a 1/150 dilution at 37 °C for 1 hour then 
washed 3x in Tween-20.  Fluorescein streptavidin was added (1/100) at 4 °C for 30 min 
followed by a final washing step 1x in Tween-20. Coverslips were mounted on microscope 
slides using Vectashield-DAPI mounting medium. Images taken using a Zeiss Axiophot 
fluorescence microscope with an Evolution QEi digital monochromatic CCD camera and 
Q-capture imaging software.   
 
Table 4.2 – Immunohistochemistry Antibodies. Samples were stained using tertiary staining method.   
Primary antibodies 
Secondary Antibody 
Tertiary 
Antibodies Marker Raised in 
-tubulin 
 
Mouse monoclonal IgG 
Biotinylated anti-mouse, 
 Fluorescein 
Streptavidin 
Vinculin 
 
Vimentin Goat monoclonal IgG 
Biotinylated anti-goat, 
 
 
4.2.4 Proliferation 
P3 MSCs (Stro-1 selected, University of Southampton) were cultured for 1 week under 
standard conditions. A solution of 1mM 5-bromo-2-deoxyuridine (BrdU) in DMEM was 
made then 600 µl was added to each coverslip and incubated for 6 hours. Cells were 
washed in 1x PBS then fixed at 37 C for 15 min.  Cells were permeabilised for 5 min at 4 
C then washed in 1% PBS/BSA for 10 min at 37 C.  Mouse monoclonal anti-BrdU 
(1/100 in nuclease solution, prepared as per manufacturer’s instruction at 37 C for 2.5 
hours.  Samples were rinsed in Tween-20 then 1 x 5 min wash in Tween-20.  A dilution of 
1/100 biotinylated anti-mouse IgG in PBS/BSA was added at 37 C for 1 hour after which 
the coverslips were washed 3x Tween-20 for 5 min. A dilution of 1/100 fluorescein 
streptavidin and 1/150 rhodamine-phalloidin was added to coverslips in PBS/BSA for 37 
C for 1 hour.  Then 1/100 fluorescein streptavidin was added in PBS/BSA to coverslips 
which were incubated at 4 C for 30 min then washed using Tween-20 1 x 5min.  
Coverslips were mounted onto slides with DAPI mounting media and imaged using a Zeiss 
Axiophot fluorescence microscope with an Evolution QEi digital monochromatic CCD 
camera and Q-capture imaging software.   
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4.2.5 MMP Profile  
Zymography – Supernatant was collected at 3 weeks from DIGE-D, DIGE-E and glass 
surfaces (n=3).  Zymogram was carried out as described in Section 2.5.1, Chapter 2. 
 
ELISA –  Supernatant was collected at 3 weeks from DIGE-D, DIGE-E and glass surfaces 
(n=3) and compared to DMEM control.  Array was carried out as described in Section 
2.5.2, Chapter 2. 
 
MMP Antibody Array – Supernatant was collected at 3 weeks from DIGE-D, DIGE-E and 
glass surface (n=3) in comparison to DMEM control.  Array was carried out as described 
in Section 2.5.3, Chapter 2. 
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4.3 Results 
4.3.1  Cell Viability  
After several publications using SPPS to create substrates for cell growth (Todd et al. 
2007; Roberts et al. 2016; Zelzer, McNamara, et al. 2012), we are confident that cell 
survival is maintained on these surfaces.   To demonstrate this for the MMP responsive 
sequences, viability was tested using live/dead staining, tubulin staining, MTT and alamar 
blue between 24 hours and 7 days. 
 
We initially analysed cell survival using live/dead staining after 24-hour exposure to the 
surface chemistries.  Cells survived on all surfaces however, the most striking result of this 
experiment was the difference in the number of cells observed on the RGD surface in 
comparison to RGE controls, indicating a direct correlation between cell adhesion and cell 
survival.  Figure 4.2A shows cells seeded on glass controls that exhibit minimal cell death 
(no red staining observed) and further, numerous cells that were observed that had adhered, 
but were small and fibroblastic in morphology.  The presence of the PEG blocking group 
did not affect cell survival (Figure 4.2B and 4.2C) or cell number (Figure 4.2H), as 
determined via both image analysis and quantification.  In comparison to glass however, 
PRG-RGE was significantly different (p<0.05) whereas PEG-RGD was not.  This could be 
due to proximity of the cells to the peptides; an observation previous documented in 
(Roberts et al. 2016).  RGD and RGE had observable differential effects on cell adhesion, 
as is apparent when comparing Figure 4.2D (LRGD) and Figure 4.2E (LRGE), where less 
cells are on the LRGE surface.  Those cells that did adhere survived but were poorly 
spread.  Figure 4.2H confirms this, and also provides support that there was a significant 
difference between LRGD and LRGE controls (p<0.0001), suggesting that the peptides 
were directing cellular behaviour.  The images appear to suggest that there were fewer 
cells on DIGE-E in comparison to DIGE-D (Figure 4.2F-G).  However, when quantified, 
there was no difference in cell number between controls, although DIGE-E may be 
behaving similarly to LRGE and was statistically significant in comparison to glass (Figure 
4.2H). Furthermore, from the images there may be a difference in cell morphology (cells 
have an elongated phenotype on DIGE-E, Figure 4.2G in comparison to DIGE-D, Figure 
4.2F).  Suggesting that PEG cap is not affecting cell number between controls, although 
there may be a response to the peptide underneath the cap.   Collectively, the RGE controls 
were different to that of the glass control in terms of cell number (p<0.05, p<0.0001 and 
p<0.001 respectively for PEG-RGE, LRGE and DIGE-E, Figure 4.2H).  It was expected 
that PEG-RGE and DIGE-E would behave more similarly and although they are not 
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statistically different from each other, DIGE-E has more of a negative effect on cell 
survival in comparison to glass (p<0.05 and p<0.01 respectively).  This could be due to 
increasing chain length of peptide and limited adhesion from RGE. This is consistent with 
prior expectations, as it was hypothesised that that there would be limited cell attachment.  
The presence of RGD was comparable to glass suggesting that at this time point, survival 
is not enhanced by the presence of RGD.  Furthermore, the presence of PEG does not seem 
to affect cell survival for RGD controls, as they are comparable with glass and each other. 
Taken together, there is a cellular awareness of peptides beneath the PEG cap. 
 
 
Figure 4.2 – Live/dead Staining of Control Surfaces. Cell survival was analysed using live/dead staining 
after 24 hours.  Cell survival differed per surface.  A) Glass B) PEG-RGD C) PEG-RGE D) LRGD E) LRGE 
F) DIGE-D G) DIGE-E.  The glass coverslip supports adherence of cells in higher quantities than the other 
controls.  The RGD coverslips are more adhesive and cells were subject to increased spreading in 
comparison to RGE controls, and although cells stained positive for survival, there is fewer present to 
analyse.  This suggests there is a difference in adherence of cells on the RGE coverslips. Scale bar = 100µm 
green = live, red = dead. H) Cell number from images A-G were quantified.  RGE controls have significantly 
less cells per surface in comparison to glass confirming RGE is non-adhesive to cells. Graph shows mean  
SD, n=15, statistics determined by ANOVA *p<0.05 ***p<0.001 ****p<0.0001.  
 
To assess the metabolic activity of the cells, we looked at tubulin staining after 24 hours on 
all controls.  Tubulin gives an indirect measure of cell metabolism as microtubules are 
associated with vesicles and motor proteins as a means of transport of metabolites 
(Caviston & Holzbaur 2006).  The increased expression of tubulin would indicate a more 
metabolically active cell, one that is utilising energy and transporting metabolites 
intracellularly.  
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We observed increased tubulin expression on the glass control indicating metabolically 
active cells (Figure 4.3A). There is a similar expression of tubulin for cells grown on RGD 
controls (PEG-RGD, LRGD and DIGE-D, Figures 4.3 B – D).  Filopodial formation was 
also observed on RGD controls although this was most prominent on LRGD (Figure 4.3C) 
suggesting that when PEG is removed, adhesion is enhanced. Tubulin was expressed 
throughout these cells in dense bundles, and even expressed to the ends of the filopodia 
(Figure 4.3C).  In comparison, for the RGE controls (PEG-RGE, LRGE and DIGE-E, 
Figure 4.3 E - G), we noticed limited tubulin organisation and reduced cell spreading 
particularly for PEG-RGE and LRGE (Figure 4.3 E & G). No filopodia were observed on 
RGE controls, although the representative pictures allude to more cells present on DIGE-E 
(Figure 4.3G) in comparison to PEG-RGE (Figure 4.3E), which was not expected due to 
the results from Figure 4.2H.  Future quantification studies are required to follow up this 
observation.  Taken together these results suggest that cells on the RGD controls were 
more metabolically active at this time point and further, promote filopodial formation.  
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Figure 4.3 – Tubulin Expression After 24 Hours.  A) Glass B) PEG-RGD C) LRGD D) DIGE-D E) PEG-
RGE F) LRGE G) DIGE-E.  Cells were stained for tubulin 24 hours after seeding.  There are clear 
differences in morphology after 24 hours in response to surface chemistry.  Those cells cultured on RGD 
surfaces show noticeable tubulin expression and increased spreading with filopodia formation (white arrow).  
Cells cultured on RGE are less spread and show less tubulin expression.  Green = tubulin, red = actin, scale 
bar = 100µm. 
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Vimentin staining was also used as a marker of cell integrity.  Vimentin is an intermediate 
filament (IF) and a component of the cytoskeleton, IFs also included desmin, keratin and 
glial fibrillary acidic protein (GFAP). IFs are so named due to their intermediary diameter 
size in comparison to other cytoskeletal components (10 nm) and along with the myosin 
and actin filaments are responsible for the cell cytoskeletal function (Fuchs & Weber 
1994).   Of the IF proteins, vimentin is widely expressed in mesenchymal cell types.  IFs in 
general associate with membranes including that of the nucleus via interactions with 
laminin (Fuchs & Weber 1994).  In addition, vimentin organises cell organelles and 
membrane associated proteins by acting as a scaffold.  Through this mechanism, vimentin 
also has a role in adhesion through regulation of integrins that associate with IFs (Ivaska et 
al. 2007).    It is thought that the phosphorylation of vimentin is dynamically regulated 
depending on cell functions including differentiation (Ivaska et al. 2007).  
 
Vimentin was well organised in the control cells (glass) as expected, cell spreading was 
also observed (Figure 4.4A).   The result was similar for the adhesive PEG-RGD and 
LRGD controls particularly around the nucleus of the cells where dense vimentin staining 
was observed (Figure 4.4B&C).  This indicates cell integrity on these surfaces in response 
to the RGD motif.  The staining on DIGE-D surface was more pronounced with uniform 
expression of vimentin throughout the cell.  The results from the adhesive controls show 
adequate cell binding and in turn, increased cell spreading (Figure 4.4D).  PEG-RGE also 
showed well defined staining, in comparison, limited vimentin was observed for LRGE 
surfaces and there were differences in cell morphology (Figure 4.4E&F).  This result 
indicates that the PEG is providing better adhesion for the cells on the RGE surfaces 
compared to LRGE alone (Figure 4.4G).  However, vimentin was observed on all surfaces 
suggesting that the presence of peptides do not negatively affect cell structure and IFs are 
expressed uniformly throughout the cell. 
 
Cell area was quantified in Figure 4.5 which confirms lack of cell spreading for LRGE, 
which had significantly lower cell area in comparison to all other controls.  The capped 
controls behaved similarly (5000 µm
2
 each) and there was a slight increase in cell area for 
both LRGD and DIGE-D surfaces although this is not significant.  The PEG group on the 
pre-cleaved and full length RGE controls seems to enhance spreading when compared to 
the LRGE. 
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Figure 4.4 – Vimentin Staining at 24 hours. A) Glass B) PEG-RGD C) LRGD D) DIGE-D E) PEG-RGE 
F) LRGE G) DIGE-E. Image shows uniform vimentin staining across most controls.  Vimentin is less well 
defined on the LRGE surface and this correlate to limitation in cell spreading. Scale bar = 100µm, green = 
vimentin, red = actin. 
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Figure 4.5 – Quantification of Vimentin Staining. Cell area was quantified from images above.  There is a 
trend for increasing cell area on the DIGE-D surface.  All surfaces were significantly different to that of the 
LRGE control which had a minimal cell area.  Graph shows mean ± SD, n=15 (frames), statistics calculated 
using ANOVA where *p<0.05, **p<0.01 and ***p<0.001. 
 
We increased the duration of the culture to 1 week and determined cell viability at this 
point using both MTT and Alamar Blue assays. MTT is used to assess cell metabolic 
activity by determining the activity of enzymes to reduce MTT to formazan dyes (Riss et 
al. 2004).  The quantity of formazan is directly proportional to the number of viable cells 
and therefore is a quantitative assay (Mosmann 1983).  Viable cells actively convert MTT 
to formazan creating a purple product that can be analysed using a spectrophotometer at 
570 nm (Mosmann 1983).  Apoptotic cells lose the ability to convert MTT and therefore 
no colour change is observed. The conversion of MTT is via the enzymes of the 
mitochondria (Riss et al. 2004).   A complementary technique to this is the use of Alamar 
Blue.  Alamar Blue is a commercial product used to test viability of cells using redox 
indicator; the reduction of resazurin to the resorufin product (Riss et al. 2004).  Again, this 
results in a colour change from blue to pink analysed by a fluorometer at 560 nm excitation 
(Riss et al. 2004).  Both techniques are high throughput techniques as they are carried out 
in 96 well plate format and read with plate reader (Riss et al. 2004). 
 
We expected that cells were viable on each surface with increased time as shown in 
previous publications (Figure 4.1) and due to the results in Figures 4.2-4.5.  The results 
from the MTT assay (Figure 4.6A) and the Alamar Blue assay (Figure 4.6B) are consistent 
with this.  The data suggests that after one week in culture, the cells are surviving on all 
control surfaces. The results show comparable levels of cell metabolism for all surfaces 
(Figure 4.6), which was unexpected due to the lack of adherence on the LRGE surfaces for 
Figures 4.2 – 4.5, although the live/dead staining did indicate that there was survival of a 
  103 
few cells on this surface (Figure 4.2).  Those that did adhere, had the ability to survive, 
probably aided by the culture medium.  The cells are cultured in 10 % serum and therefore 
the presence of serum proteins could influence the long-term survival of the cells on the 
non-adhesive surfaces. The exposure of RGD on the pre-cleaved surface did not have a 
synergistic effect on survival in that the results were comparable to the RGE pre-cleaved 
control. We can therefore conclude that after 1 week, cell survival is comparable across 
multiple controls as determined by two different assays.  
 
Figure 4.6 -  Viability at 1 Week. A) MTT assay expressed as % viability in comparison to glass control B) 
Alamar blue expressed as the % reduction of resazurin product in comparison to glass control. Data is 
consistent for both methods suggesting viability of MSCs across all controls. Graph shows mean ±SD, n=3 
for both. 
 
4.3.2 Cell Adhesion 
Based on the morphology observed from the 24-hour experiments (filopodial expression 
on RGD surfaces and lack of adhesion on LRGE and DIGE-E Figure 4.1, 4.2 & 4.3), it 
would suggest that there are early changes in cell adhesion in response to the surface 
chemistries.  We looked at vinculin expression after 24 hours to observe focal adhesion 
(FA) expression for each surface (Figure 4.7).  Vinculin is a key component of FAs and is 
recruited by integrins to bridge to the actin cytoskeleton (Geiger et al. 2001).  The length 
and density of vinculin adhesions serves to determine the adhesiveness of the surface and 
in addition is proportional to the cellular tension that results from the clustering of 
integrins (Wozniak et al. 2004) (Section 1.4, Chapter 1).  
 
On the glass control, there were defined adhesions at the periphery of the cell (Figure 
4.7A).  Spreading on the PEG-RGD control was enhanced as there was prominent 
adhesions at the edge of the cell (Figure 4.7B). The PEG-RGE control (Figure 4.7C), 
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although much less spread than the adhesive counterpart does also express vinculin.  This 
suggests that the surface chemistry under the PEG blocking group had an effect on cell 
adhesion, similar to the data presented in Figure 4.2H.  The number of adhesions per cell 
was quantified (Figure 4.8A) where this difference was confirmed (p<0.001).  PEG-RGD 
(Figure 4.7B) appears to have a larger cell area than LRGD (Figure 4.7C), although when 
quantified there is no difference between controls (Figure 4.8). It was thought the 
uncapping of peptides would enhance cell spreading however, it could be too early to see 
differences or there could be a risk in that the process of capping with PEG during SPPS 
has not been efficient and therefore has affected cell behaviour.  LRGD controls are much 
more spread than LRGE controls (Figure 4.7D and 4.7E), with cells cultured on LRGD 
expressing many more adhesions than the LRGE (Figure 4.8A, p<0.001).  The enzyme 
cleavable surfaces also differed in the expression of vinculin depending on the presence of 
adhesive RGD.  The cells cultured on DIGE-D appeared to show more pronounced 
adhesions than the DIGE-E control (Figure 4.7F and 4.6G), however, the average number 
of adhesions per cell is not different between these controls nor is cell area (Figure 
4.8A&B).  Overall, this suggests that there are changes in adhesion in response to the 
surface chemistry and further, it is the presence of RGD that is driving large scale 
adhesions.  The effects shown in Figure 4.7 are quantified in Figure 4.8. 
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Figure 4.7 - Vinculin Expression at 24 Hours. A) Glass B) Peg-RGD C) Peg-RGE D) LRGD E) LRGE F) 
DIGE-D G) DIGE-E. Cells positively express vinculin on all surfaces.  There are differences in the number 
of adhesions and cell spreading.  Cells on RGD surfaces express many, substantial adhesions at the periphery 
of the cell.  Those on RGE controls have a limited number of adhesions.  Green = vinculin, scale bar = 
100µm. 
 
Overall, the PEG-RGE and LRGE controls have significantly less adhesions per cell in 
comparison to the glass controls (Figure 4.8A).  The LRGE chemistries are less adhesive 
to cells than RGD, which was significantly different to the uncapped, pre-cleaved and full 
length RGD (p<0.0001, p<0.01 and p<0.01 respectively). It was unexpected that the 
DIGE-E control did not behave like LRGE and PEG-RGE, this could potentially be due to 
chain length and the increasing distance from the RGE peptide. 
 
We quantified cell spreading (µm
2
) to determine if there was correlation between 
increasing cell spreading and increasing number of adhesions.  Figure 4.8 shows that there 
was a similar trend for both, with PEG-RGD showing the greatest number of adhesions 
and the largest cell area (65 adhesions, ~8000 µm
2
) comparatively, LRGE controls 
contained least number of adhesions and the smallest cell area (23 adhesions, ~3000 µm
2
, 
Figure 4.8A & B).  The smallest cell area was observed on the LRGE, which is consistent 
with previous observations (Figure 4.5).  
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Figure 4.8 – Vinculin Quantification, 24-Hour Culture.  Quantification from Figure 4.7 A) The average 
number of adhesions per cell, per control. B) Average cell area (µm
2
).  Graph show mean ± SD, n=15, 
statistics calculated by ANOVA, *P<0.05, **P<0.01, ***P<0.001 ****P<0.0001. 
 
Adhesions can be classified depending on length.  Differential adhesion length was 
originally defined by Bershadsky in 1985 and defined as “dot” and “dash” adhesions 
(Bershadsky et al. 1985).  Since this observation, adhesions have been reclassified 
depending on their size with each size responsible for a different role. Focal complexes 
(FCs) are short transient adhesions that measure <2 µm in length and are usually involved 
in cell mobility and migration (Sun et al. 2016). FAs are greater than 2 µm long and are 
stable adhesions involved in cell maturation and ECM production (Wozniak et al. 2004). 
Super mature adhesions (SMAdh) are very large adhesions that indicate high intracellular 
tension and in case of skeletal cells, encourage osteoblastic differentiation (Biggs et al. 
2009). 
 
From the results of Figure 4.7, we separated the adhesions into FCs, FAs and SMAdhs and 
totalled the number of adhesions across all images (Figure 4.9). For all controls, there was 
generally fewer FCs than FAs or SMAdhs.  The number of FAs and SMAdhs for the RGD 
controls were comparable (approximately 400 in total for both).  There was a larger 
difference in the number of FA and SMAdh for the glass control in comparison to RGD 
controls which suggests that the presence of the RGD increases the number of SMAdhs.  
There was a decrease in the number of SMAdhs for the non-adhesive controls.  The LRGE 
samples had fewer adhesions for all subtypes as expected in comparison to RGD controls.  
This result confirms that the RGE controls are non-adhesive and for the pre-cleaved 
control (LRGE) this is due to the direct exposure of the cells to the peptide motif.     
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Figure 4.9 – Total Number of Adhesions. Distribution of adhesion length for all controls.  Total number of 
adhesions quantified by length from all cells imaged, n=15.  FA = focal adhesion (<2 µm), FC = focal 
complexes (2-5µm), SMAdh = super mature adhesion (>5µm).  There are a greater number of SMAdh on 
RGD controls.  
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Figure 4.10 – Percentage Adhesions Per Cell. A) FC B) FA C) SMAdh.  A) FCs are prominent on glass 
and RGE controls except for PEG-RGE. LRGE and DIGE-E controls have limited number of adhesions with 
increasing number of FCs in comparison to other controls. B) FAs are the main adhesion type of the PEG-
RGE control however, FAs are the major adhesive component for all controls accounting for approximately 
50 % of total cell adhesions.  C) SMAdh are most prevalent on the RGD controls, specifically for the LRGD 
(40 % of adhesions are SMAdh). Graph shows mean ± SD, n=15 (cells), statistics calculated by ANOVA 
*P<0.05, **P<0.01, ***P<0.001 ****P<0.0001. 
 
This data (Figure 4.9) was then expressed as the % adhesions per cell for each adhesion 
length (Figure 4.10A-C).  FCs account for approximately <10 % of adhesions per cell, this 
is slightly higher for the glass, LRGE and DIGE-E surfaces and could indicate cell motility 
for these controls (Sun et al. 2016) (Figure 4.10A).    The percentage of FAs per cell was 
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greater than that of the FCs (approximately 50 % for all controls).  This would be expected 
as the FAs are expressed in response to adherent surfaces (whether that is ECM production 
or peptides).  The results in Figure 4.10B suggests that the cells on all surfaces are 
adhering, which is consistent with the previous data presented in this chapter.  However, as 
the density and length of FAs increase as the density of adhesive moieties increase (Chen 
et al. 1997; Cavalcanti-adam et al. 2007).  There was a decrease in FAs expressed on 
LRGE surfaces (approximately 30 %), consistent with the previous data in that there were 
a few cells that had adhered to the LRGE control.  This must reflect a minimal level of 
adhesion as the percentage of these adhesions that have been measured as SMAdhs 
equalled <20 % (statistically different from the rest of the controls, Figure 4.10C) 
reinforcing that LRGE is not supporting increased cellular adhesion.  Figure 4.10C also 
shows that there is a greater proportion of SMAdh per cell for the RGD control 
specifically, LRGD enhances this effect (approximately 50 % are SMAdhs) due to the 
proximity of cell to the RGD element. However, there was no difference between the RGD 
controls in terms of the number of SMAdhs, suggesting that the blocking group was having 
no effect on adhesion.  This should be repeated at later time point to fully understand if this 
phenotype is maintained. 
 
4.3.3 Proliferation 
We determined cell proliferation utilising BrdU (brominated analogue of thymidine) 
uptake.  This assay was utilised to provide insight to the ability of surface chemistry to 
induce cell growth and population expansion. BrdU is incorporated into cell DNA at the S 
phase of the cell cycle (Taupin 2008). Upon addition to the media, BrdU can replace 
thymidine in the cell’s DNA and be stained for with an anti BrdU antibody.  
 
After one week, proliferation was observed on all surfaces (Figure 4.11).  No difference 
was observed between controls (Figure 4.12) and proliferating nuclei were calculated to 
account for between 10-20 % of the total cell number (Table 4.3).  From the image in 
Figure 4.11D, there appeared to be more proliferating nuclei in DIGE-D than those 
observed in the other control samples.  However, when quantified, there was found to be 
no difference between controls (Figure 4.12). Proliferation was also observed on RGE 
controls (Figure 4.11 E-F), this gives an indication that cell survival is occurring on the 
RGE controls over time resulting in viable cells as consistent with Figure 4.6. This study 
only reveals a 6-hour window in a 1-week culture. It would have perhaps been better to 
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conduct this experiment at 24 hours, to understand the initial response to peptides and 
correlate the lack of cells observed in Figure 4.1 to proliferation.  
 
Figure 4.11 – BrdU Staining.  Cells were cultured for 1 week then treated with BrdU for 6 hours.  A) Glass 
B) PEG-RGD C) LRGD D) DIGE-D E) PEG-RGE F) LRGE G) DIGE-E. Proliferating nuclei (green) in 
comparison to total nuclei (blue).  Merge, actin = red.  Actin = red scale bar = 100µm.   
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Figure 4.12 – Quantification of BrdU Positive Cells.  Average % positive BrdU cells per frame calculated 
from Figure 4.11.  There is no difference in % proliferation between controls.  Graph shows mean ± SD, 
n=15 (frames). 
 
Table 4.3 - % BrdU Nuclei of Total Cells. Images from Figure 4.11 were quantified and expressed as % of 
the total cell population ± SD (n=15 frames). 
Surface % positive BrdU 
nuclei ± SD 
Surface % positive BrdU 
nuclei ± SD 
Glass 16.1 ± 8.3 - - 
Adhesive Controls Non-Adhesive Controls 
PEG-RGD 17.8 ± 7.0 PEG-RGE 10.4 ± 10.8  
LRGD 9.7 ± 9.3 LRGE 10.4 ± 10 
DIGE-D 16.3 ± 8.3 DIGE-E 10.8 ± 10.8 
 
We then quantified cell area and cell number from the images in Figure 4.11.  Figure 
4.13A shows that after 1 week, LRGD surfaces have larger cell size than that of PEG-RGD 
and LRGE (p<0.05 for both).  There was a large standard deviation observed for cells 
cultured on LRGD.  Perhaps this was due to poor homogenisation of the surface and there 
may be some areas where the coverslip has not been totally covered by peptide and 
therefore there was not coordinated cell behaviour.  It was unexpected that LRGD was 
significantly different to PEG-RGD (p<0.005), which suggests the cells may not be 
responding to peptides under the blocking group as originally thought from previous work 
(Figure 4.7).  The controls containing PEG blocking group were not different from each 
other, which could suggest that the PEG group itself is controlling behaviour in some way.  
Cell number was also quantified for Figure 4.11 and it was found that there is no difference 
in cell number between controls at 1-week culture (Figure 4.13).  This was unexpected due 
  112 
to the results seen in Figure 4.2 but suggests the cells on the LRGE and DIGE-E controls 
have recovered.  This further supports the data presented in Figure 4.6, which highlighted 
cell metabolism was similar per control as cell survival is not negatively affected by 1 
week. 
 
Figure 4.13 – Quantification of Cell Area and Number, 1 week.  Images from Figure 4.11 were quantified 
for A) cell area and B) cell number.  A) cells cultured on LRGD were significantly larger than cells cultured 
on PEG-RGD and LRGE.  B) there was a similar number cells per frame for all controls tested.  Graphs show 
± SD, n=15, statistics calculated by ANOVA where *p<0.05. 
 
4.3.4 MMP response to the surface  
4.3.4.1 Gelatinases 
We then looked at the MMP profile in response to the surfaces. Using an ELISA, we 
analysed cell supernatant concentration of both gelatinases over three weeks (Figure 4.14).  
At week 3, there is no trend for MMP-9 expression and supernatant concentration is 
maintained at approximately 0.2 ng/ml.  There was a slight increase for LRGE at week 2 
(p< 0.05) however, this effect was not sustained to week 3.   
 
There was a significant difference in concentration of MMP-2 for DIGE-D, LRGE and 
DIGE-E at week 3 in comparison to week 1 from approximately 9 ng/ml to approximately 
14 ng/ml (p<0.01, p<0.01 and p<0.05 respectively).  For the DIGE surfaces, this could 
suggest that the cells are accumulating their MMP expression in the presence of the 
enzyme responsive sequence.  Comparing expression of both MMPs, the results show that 
for MMP-9, there was a 10-fold reduction of expression in comparison to MMP-2. This is 
consistent with Figure 3.8 (gelatinase in response to glass) suggesting that the presence of 
surface chemistry has maintained the relative abundance of each gelatinase.   MMP-2 
concentration increases at week 3 for DIGE and LRGE controls in comparison to the 
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concentrations observed at weeks 1 and 2 for each. Furthermore, MMP-2 concentration on 
DIGE controls at week 3 were significantly different to that of glass (p<0.05), suggesting 
the increase is due to the presence of peptides.  This data formed the basis of the 
hypothesis that at this time point due to the increasing abundance of MMP-2, the 
concentration in culture would be sufficient for cells to cleave the surface.  However, 
Chapter 3 demonstrated that relatively small concentrations of MMP-9 were sufficient to 
cleave DIGE-D surfaces.  From the data presented in Figure 4.14 alone, we cannot rule out 
that MMP-9 is not having an effect on the surface and that abundance does not guarantee 
potency.  It would have also been useful to have a media control to understand relative 
amounts of MMP from serum and if it could be contributing to cleavage. 
 
Figure 4.14 – Gelatinase Response per Surface Over 3 Weeks.  Using ELISA, the concentration of the 
Gelatinases was determined over three weeks for both A) MMP-9 and B) MMP-2.  A) There was consistent 
expression of MMP-9 for 3 weeks.  There was a slight increase in MMP-9 on LRGE at week 2.  B) There 
was a significant increase in MMP-2 expression by week 3 for cells cultured on full length surfaces and 
LRGE.   MMP-9 concentration is 10-fold lower of that of MMP-2.  Therefore MMP-2 expression is altered 
in response to the surface over time.  Graph shows mean ± SD, n=3, statistics calculated by ANOVA where 
*p < 0.05 and **p < 0.01. 
 
This was repeated for the DIGE-D and DIGE-E controls at 3 weeks using gelatin 
zymography (Figure 4.15).  Due to the weight of the band (62 kDa for MMP-2 and 82 kDa 
for MMP-9) we were observing the active form of the enzyme.  Again, it was apparent that 
for all surfaces, MMP-2 expression was greater than that of MMP-9.  There was no 
difference in activity of MMP-2 between controls, which taken together with the results of 
Figure 4.14 highlights that concentration does not correlate to potency. 
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Figure 4.15 – Gelatin Zymography at Week 3. Supernatant was collected from Glass, DIGE-D and DIGE-
E surfaces and ran on gelatin gels.  MMP-9 is still expressed at very low levels in comparison to MMP-2.  
There was a slight increase of MMP-2 for DIGE-D controls. Graph shows mean ± SD, n=3, statistics 
calculated by ANOVA where *p < 0.05, **p < 0.01 and ***p < 0.001. 
 
This was again repeated by antibody array. Here, we specifically looked at the gelatinase 
expression of MSCs cultured on DIGE surfaces in comparison to plain DMEM (with 
serum) and cell supernatant from cells seeded on glass (Figure 4.16).  The results showed 
that there was minimal level of MMP-9 in all supernatant tested apart from that of the glass 
supernatant from which MMP-9 was absent.  MMP-2 appeared to be expressed in all 
samples at a higher level than that of MMP-9 as would be expected from the previous data 
(Figures 4.14 and 4.15).  However, it was not found to be statistically different.   
 
 
Figure 4.16 - Gelatinase Expression as Determined by Membrane Analysis.  MMP-9 expression is at a 
similar level for most surfaces although there is an absence of MMP-9 detected on glass. MMP-2 was found 
in all samples tested.  Graph ±SD, n=2, ns as determined by ANOVA. 
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4.3.4.2 MMP Family Members 
The antibody array also provided information on other MMP families in addition to the 
gelatinases; stromelysins (MMP-3, -10), the collagenases (MMP-1, -8, -13) and the 
regulatory TIMP (TIMP-1, -2, -4) families.  Firstly, for the MMP families, in comparison 
to the gelatinases, these were expressed at a much lower level (Figure 4.16 compared to 
Figure 4.17A&B).   Figure 4.17A shows the results for the collagenases.  No difference in 
MMP-1 expression was found between controls whereas MMP-8 was absent from all 
samples (Figure 4.17A).  However, MMP-13 is specifically secreted by cells that are 
cultured on DIGE controls (p<0.01 and p<0.05 for DIGE-D and DIGE-E respectively), 
suggesting cells are actively secreting MMP-13 in these control conditions (Figure 4.17A). 
There was no expression of MMP-10 of the stromelysin family in either DMEM nor 
secreted by the cells (Figure 4.17B).    For MMP-3 it was apparent that expression was 
inhibited by culture on DIGE-D and that it was expressed at similar concentrations for all 
other controls (DIGE-D statistically different from other controls, Figure 4.17B). TIMP 
expression was specifically observed in response to the culture of cells on substrates (there 
may be a slight concentration observed in DMEM for TIMP-2 and TIMP-4, Figure 4.16C).  
However, TIMP-1 expression is the most abundant of all TIMPs tested, TIMP-1 
expression is further increased in supernatant taken from DIGE controls (p<0.001 and 
p<0.05 for DIGE-D and DIGE-E in comparison to glass).  Wilhelm et al. show that in 
response to secretion of significant levels of TIMP-1, TIMP-1 complexes and inhibits 
MMP-9 (Wilhelm et al. 1989).  This could account for the limit in MMP-9 expression 
observed in this and previous sections.  It has been observed that for MSCs, expression of 
TIMP-2 in conjunction with MT1-MMP and MMP-2 are required from MSC mobilisation 
and invasion (Ries et al. 2007).  If TIMP-2 is acting as an activator of MMP-2 then this 
could account for the increased expression of MMP-2 observed on the DIGE sequences. 
TIMP-2 expression was lower than that of TIMP-1 for glass, DIGE-D and DIGE-E 
surfaces (p<0.05, p<0.0001, p<0.01 respectively).  TIMP-4 was absent from glass and 
expressed at a much lower concentration than TIMP-1 (p<0.001 in comparison to other 
control surfaces).  Data published by Bigg et al show that TIMP-4 specifically inactivates 
MMP-2 (Bigg et al. 2001). As shown in Figure 4.14, MMP-2 increases at week 3, this 
could be due to increasing TIMP-2 and decreasing TIMP-4.  This experiment could be 
repeated with supernatant collected at weeks 1-3 to determine the interplay of TIMPs and 
their regulation of MMPs in MSCs in response to the surface chemistries.  
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Figure 4.17 -  Presence of Other MMPs and TIMP Families.  There is differential expression of selected 
MMPs per surface. A) MMP-13 expression is specifically expressed on both peptide surfaces whereas MMP-
8 is absent. B) MMP-10 was not found on any controls and further MMP-3 is not secreted in response to 
DIGE-D.  C) TIMP expression is specific to cell culture.  TIMP-1 may be an increasing on DIGE controls.  
In comparison to other controls.  Graphs show ± SD, n=2 (spots per membrane), ****p<0.0001, ***p<0.001, 
**p<0.05.  For # and §, statistics calculated in relation to TIMP-1 for that control.  #
1
p<0.05, #
2
p<0.01, # and 
§ p<0.0001.  
 
All data obtained from the 3-week antibody array (Figures 4.16 & 4.17) was plotted on the 
same scale (Figure 4.18).  TIMP-1 was expressed at the greatest level in comparison to 
other TIMPs and MMPs.  This suggests that there is a regulation of MMPs by TIMPs as 
secreted by the cell population. TIMP-1 expression was specifically expressed in the cell 
supernatant demonstrating that these regulators are specifically secreted by the cells, 
regardless of surface chemistry. DMEM (media) contains less MMP-2 than the supernatant 
analysed from the controls suggesting the media itself is not contributing to cleavage.  
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Figure 4.18 – MMP and TIMP Expression. The results show all MMPs and TIMPs identified by the 
antibody array per control.  There was differential expression of MMPs depending on the surface 
chemistries. It was apparent that the cell supernatant contains TIMPs which are expressed at a much higher 
concentration than that of the MMPs.  This is only a feature of the supernatant which highlights that the cells 
are regulating the secretion of MMPs. 
 
4.4  Discussion  
After the design and synthesis of the surface was deemed to be sufficient (Chapter 3), cell 
survival in response to surface chemistries was evaluated.  Due to the previous studies of 
cells on similar chemistries employed by our collaborators, we expected good cell growth 
(Figure 4.1) (Roberts et al. 2016; Todd et al. 2009; Zelzer, McNamara, et al. 2012). The 
results from live/dead staining show that cells were found on all surfaces however, cell 
number was greatly decreased for DIGE-E and LRGE controls (Figure 4.2).  This shows 
that the cells can react to the presence of the surface chemistries.   When quantified, the 
data confirms that there were less cells observed on RGE controls (in comparison to glass) 
which indicates reduced cell attachment (Figure 4.2H).   
 
Tubulin is a marker of cell metabolism and is actively involved with the transport of 
metabolites in the cell (Caviston & Holzbaur 2006). Tubulin expression was prominent on 
RGD controls and in particular, LRGD (Figure 4.3).  The results of this also highlighted 
differences in cell morphology as filopodia were observed on LRGD controls which is 
consistent with the literature as adhesion to RGD peptides allow for increasing spreading 
and a well organised cell cytoskeleton (Kilian and Mrksich, 2012). This appeared to be 
enhanced for LRGD in comparison to PEG capped RGD controls.  Importantly, this 
experiment set-up should be repeated over multiple time points to track if there are any 
further changes to cell morphology in response to uncapped peptide. Changes in 
morphology are also apparent on RGE controls, with round or slightly elongated cells 
indicating that RGE is not supporting adhesion or spreading (Figure 4.3). However, it must 
be acknowledged that for the early cell studies (24-hour; Figure 4.2-4.4 & 4.7) the PEG 
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blocking group did seem to support cell survival even for RGE controls. There was a 
similar trend for vimentin staining which can also be used as a marker for cell integrity 
(Figure 4.4).   
 
Cell culture time was increased to 1 week and cell survival analysed by MTT and Alamar 
Blue assays. The results in Figure 4.6 show consistency for both assays for all controls.  
After 1 week, it is apparent that all cells that had attached are metabolising on all controls.  
This was surprising due to the results of the 24-hour studies where it was indicated that 
RGE is limited in cell adhesion and survival (Figure 4.2-4.5).  Figure 4.13B shows that 
there is a comparable number of cells on all surfaces by 1 week suggesting recovery of 
cells from 24 hours to 1 week.  This effect could be due to the presence of serum proteins 
deposited on the surface which may affect the surface properties and therefore support 
survival of cells on RGE controls (Bellis 2011).   Figure 3.22 does allude to coating by 
supernatant proteins and perhaps this had an impact on cell behaviour.  However, the 
presence of the PEG should minimise this due to the anti-fouling properties of this chain 
length (PEG diamine Mw = 2,000) for capped controls (Dong et al. 2011) and therefore this 
effect was unexpected. Perhaps different blocking groups or longer PEG chains should 
have been used or the percentage of serum used to culture cells should have been reduced. 
 
Vinculin staining confirmed there is a difference in adhesion at 24 hours across each 
surface.  Figure 4.7 suggested an increase in vinculin expression for RGD controls and 
increase in cell spreading specifically for PEG-RGD control.  This result was quantified in 
Figure 4.8A which confirmed an increasing number of adhesions for the RGD controls per 
cell in comparison to the PEG-RGE and LRGE controls. The increase in the number of 
adhesions resulted in a similar trend in cell spreading as quantified in Figure 4.8B and was 
most pronounced for the PEG-RGD control.  
 
Vinculin expression was then calculated as a unit of length (µm), then distributed into 
specific size brackets to represent FCs (<2 µm), FAs (2-5 µm) and SMAdhs (>5 µm).  
Results from Figure 4.9 show a limited expression of FCs, most adhesions were classed as 
FAs and the presence of SMAdhs was directly correlated to the presence of RGD (Figure 
4.9).  When separated into adhesion type and expressed as a percentage of total cell 
adhesions, FCs were prominent for glass controls and LRGE and DIGE-E surfaces (Figure 
4.10). FAs composed the majority of cell adhesions but was slightly upregulated for the 
uncleavable controls. SMAdh were most prominent on RGD controls specifically in 
comparison to LRGE and DIGE-E.  This suggests that presence of RGD is promoting 
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mature adhesion formation which in turn is expected increase cellular tension downstream 
(as explored in Chapter 5).  This adhesion morphology has been observed in the past to be 
responsible for MSC differentiation to osteogenic phenotype (Biggs et al. 2009).  Taken 
together, the results from Figures 4.3-4.5 & 4.7-4.8 suggest that cell adhesion correlates 
with cell spreading. Further, cell adhesion is differentially regulated depending on surface 
chemistry which, in turn, alters cell morphology in response.   This could suggest that the 
cells are experiencing increased tension in response to the surface chemistry.  And indeed, 
at week 1 the uncapped LRGD surface had a larger cell area (than PEG-RGE and LRGE, 
Figure 4.13A). 
 
The result of the BrdU assay when quantified and analysed showed no significance 
between controls (Figure 4.12).  This was only a 6-hour snapshot in a 1-week culture. 
More specifically, it would have been better to observe the first 24 hours to determine if 
there are changes in proliferation and the changes observed in Figure 4.2H are just the 
result of changes in adhesion. This experiment could be repeated at various time points to 
determine proliferative changes in response to surface chemistry over time (Chong et al. 
2009).   
 
We then looked at the cell secreted MMP-2 concentration over a range of weeks.  Using an 
ELISA for MMP-2, it was determined that there was an increase at week 3 for LRGE, 
DIGE-D and DIGE-E sequences (Figure 4.14).  This suggests that MMP-2 is actively 
secreted by cells at this time. The concentration of MMP-2 was much higher than MMP-9 
consistent with Figure 3.8.  However, we know from Chapter 3 that abundance does not 
necessarily mean potency and even though MMP-9 is not expressed at the same level as 
MMP-2, it could still be acting on the peptide.  However, it was this data that contributed 
to the hypothesis that switching of the surface occurs at the 3-week time point. 
 
We also found differential expression of TIMPs, stromelysins and collagenases (Figure 
4.17). However, the differential regulation of MMPs is not an indicator of cell phenotype.  
Amalki et al. highlight in their review that differentiating MSCs secrete multiple MMPs 
and that no one MMP drives differentiation to a specific lineage (Almalki & Agrawal 
2016).  From the results presented in Figure 4.17, we cannot say definitively if the trends 
in MMP expression correlate to phenotype.  It may have also been better to explore the 
media concentrations of MMPs to determine their effects.  If it was found to have an 
effect, we could have lowered the concentration of serum for cell culture.  Moreover, 
Figure 3.20 and 3.21 indicate that potency does not correlate to concentration, therefore the 
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action of the identified MMPs from Figure 4.17 should have been tested on DIGE-D 
surfaces to rule out the effects of these MMPs on the surface. 
Expression of TIMP-2 was exclusively observed in the cell supernatant which could 
suggest a migratory function of the seeded MSCs.   However, as shown in Figure 3.4, 
TIMP-2 is a mode of activation for proMMP-2 in conjunction with MT1-MMP (Worley et 
al. 2003).  Therefore, the increased secretion of this TIMP could relate to the activation of 
proMMP-2 via MT1-MMP although this is dependent on concentration (activation was 
determined to be 0.3 to 5 nM concentrations of TIMP-2 (Bigg et al. 2001)).  The increased 
expression of TIMP-1 hints that this is a factor in the inactivation of MMP-9.  These 
observations could explain the increase in MMP-2 and decrease in MMP-9 expression 
shown in Figure 4.14-4.16. 
 
Finally, due to lack of characterisation of efficiency in the build-up of peptides by SPPS, 
the presence of deletion peptides or peptides with differing sequences may be present on 
the surface.  This could affect the cell behaviour as a result.  Further the MMP secretion by 
the cell was assumed to be a trigger for the whole coverslip.   This may not be the case and 
the MMPs could be acting locally and therefore there may be an heterogenous display of 
peptides. The action of MT-MMPs was also not explored, however the action of these 
MMPs on the peptides could also contribute to any local effects.  
 
4.5 Conclusion  
The early cell studies did hint at differential behaviour in response to peptides however, 
cell number did recover by week 1 which was unexpected. The increase in MMP-2 was 
thought to be driver of cleavage due to the increase in expression at week 3 but the 
question of potency remains. Increasing TIMP expression may also be having a regulatory 
effect on the MMPs, which may affect efficiency of cleavage and also may be acting 
locally. 
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5. Phenotype 
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Having established effective synthesis of the surface (Chapter 3) and demonstrated cell 
viability in response to the chemistry (Chapter 4), we then determined the phenotypic 
changes of the MSCs. This is twofold due to the aim of this technology; to provide two 
behavioural cues to MSCs on one dynamic surface.  In this chapter, we looked for self-
renewal markers in response to the PEG cap and osteogenic markers in response to RGD.  
Osteogenesis was expected on RGD controls rather than RGE controls due to enhanced 
adhesion as demonstrated in Chapter 4.  The results of Chapter 5 show a reduction of self-
renewal over time on all surfaces tested.  Osteogenesis was specifically observed in 
response to DIGE-D surface whereas cells cultured on DIGE-E surface also exhibited 
upregulation of other phenotypic markers, suggesting an unsynchronised cell population.  
  
5.1 Introduction 
This chapter aims to determine cell phenotype in response to the surface chemistries.  It 
has been shown that the presence of similar engineered surface chemistry was not 
detrimental to MSCs (Roberts et al. 2016) which we have also observed for the MMP 
responsive surfaces.  Further, there was differential adhesion and cell spreading in 
response to the surface chemistries (Chapter 4) which has been shown previously to be a 
prerequisite to osteoblastogenesis (McBeath et al. 2004).  Therefore, it is our intention for 
this chapter to determine if the differential regulation of adhesions observed in the previous 
chapter, results in changes in phenotype over time. 
 
Figure 5.1 shows the hypothesised MSC response to the surfaces.  It was hypothesised that 
the PEG cap increases stem cell self-renewal of MSCs.  This was previously demonstrated 
by Roberts et al. for the PEG-AARGD surface (Figure 1.11) (Roberts et al. 2016).  This 
response was thought to be due to an intermediate tension generated by MSCs; the 
proximity to the RGD coupled with the blocking group prevents full attachment and high 
intracellular tension negating osteoblastic differentiation and encouraging self-renewal 
(Roberts et al. 2016). Continued self-renewal of MSCs would therefore be expected until 
the PEG group is removed by cell secreted MMPs.  From previous chapters, we observe an 
increase in cell secreted MMP-2 at week 3 (Chapter 4, Section 4.3.4). This was originally 
thought to be the enzyme responsible for cleavage and experiments were conducted prior 
to ToF-SIMS analysis where cell supernatant concentration of MMPs was applied to 
DIGE-D surfaces.  Chapter 3 revealed that cell supernatant concentration of MMP-2 at 
week 3 was determined to be sufficient as this effect was mimicked in vitro and the PEG 
signal was reduced (Figure 3.20 – 3.22, Chapter 3).  The original hypothesis was, that if in 
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response to increasing cell supernatant concentration of MMP-2 at week 3, the PEG cap is 
completely removed, then this time point is the starting point for osteogenesis due to MSC 
exposure to RGD and subsequent integrin binding (Figure 5.1). Generation of osteoblasts 
from MSCs with calcification and mineralisation was estimated to take 28 days (Stein & 
Lian 1993).  We would therefore expect osteogenesis to occur 28 days after the 3-week 
time point due to the removal of PEG (Figure 5.1).   However, 0.25 ng/ml MMP-9 also 
seemed to reduce the PEG signal (Figure 3.20 and 3.21) and therefore may also be having 
an effect on cell behaviour.  Unfortunately, this was not fully explored, and phenotypic 
experiments were generated based on the original hypothesis (MMP-2 responsible and 
sufficient at week 3). 
 
Increased adhesion that precedes osteogenesis is communicated to the nucleus via integrins 
as described Chapter 1 (mechanotransduction, Section 1.3).  Based on the presence of 
SMAdhs observed on RGD controls (Chapter 4, Figure 4.8 & 4.9), we therefore expected 
that the increased adhesion would result in osteogenesis over time on this control.  
 
 
Figure 5.1 – Hypothetical Model of Cell Response to Surface. The presence of the PEG blocking group is 
proposed to stimulate self-renewal until a critical point where MMP concentration is sufficient to cleave the 
surface (week 3). With a sufficient concentration of MMP-2, the blocking group is removed, and 
differentiation can occur via cell binding to RGD.   Therefore week 3 is hypothesised as the start point for 
osteogenesis.   
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5.1.1 Osteogenesis as a result of adhesion  
As stated above, MSCs adhesions influences phenotype.  Low adhesive states correlate to 
adipogenic phenotypes, whereas osteogenic phenotypes are as a result of increased focal 
adhesion formation (Engler et al. 2006; McBeath et al. 2004). With increased adhesive 
components available to the cell (by either ECM proteins in vivo or strategically placed by 
materials engineering in vitro) integrin clustering and SMAdh formation occurs 
(Cavalcanti-adam et al. 2007).  This in turn leads to downstream changes in phenotype, 
namely osteogenesis (Figure 5.2). Adhesion size is also thought to influence the 
differentiation of MSCs, those that are elongated and stable limit cell growth and 
encourage differentiation (comparatively, small adhesions promote cell migration) (Biggs 
et al. 2009). 
 
 
 
 Figure 5.2 – Intracellular Signalling for Osteogenic Differentiation. Osteogenic gene expression is 
activated in response to integrin clustering and subsequent signalling via FAK to ROCK activation which 
influences cell contractility.  This also promotes ERK signalling.  ERK can also be activated by the MAPK 
pathway, which is initiated by soluble mitogens. ERK is a prerequisite for osteogenic differentiation as it 
activates the transcription factor RUNX2 that is responsible for the activation of osteogenic specific genes 
(redrawn from (Khatiwala et al. 2009)). 
 
Adhesion to the surface is translated from clustering integrins to the nucleus via structural 
proteins (including FAK, talin and paxillin) during direct mechanotransduction (Mitra et 
al. 2005).   The clustering of integrins and recruitment of these proteins result in changing 
signalling cascades that influence cell morphology and end terminal differentiation 
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(McBeath et al. 2004).  As shown in Figure 5.2 clustering integrins activate ROCK via 
FAK and RhoA.  McBeath et al. correlated the expression of ROCK to increased cell 
spreading (McBeath et al. 2004).  Cells cultured on areas of fibronectin created by large 
PDMS stamps (10,000 µm
2
) exhibited increase ROCK expression and osteogenic 
phenotype, even in the presence of adipogenic differentiation factors (McBeath et al. 
2004).  The expression of ROCK can also result in the expression of ERK signalling.  ERK 
is a mitogen activated protein kinase (MAPK), the last effector of the MAPK pathway 
(activated by mitogens rather than mechanotransduction) (Khatiwala et al. 2009). ERK is 
responsible for the activation of the transcription factor runt-related transcription factor 2, 
RUNX2, (also known as core-binding factor alpha 1 (CBFA1) an activator of osteo- 
specific genes (osteocalcin (OCN), bone sialoprotein (BSP) and alkaline phosphatase 
(ALP)) (Ducy 2000).  ERK deficient cells are incapable of osteogenic differentiation, with 
very limited mineralisation and bone marker formation demonstrating that ERK expression 
is a precursor to osteogenesis (Lai et al. 2001). Similarly, the inhibition of ROCK by 
disruption of cell shape (treatment with blebbistatin and cytochalasin) abrogated 
RUNX2/CBFA activation and therefore osteogenic differentiation is dependent on several 
downstream factors as discussed above (McBeath et al. 2004).   RUNX2/CBFA is the main 
transcription factor for osteogenic activation.  CBFA
-/- 
mice are osteoblast deficient, lack 
mineralisation and have limited vascularisation of the marrow (Otto et al. 1997). Terminal 
osteogenesis is marked by mineralisation which is crucial for mature bone formation (Stein 
& Lian 1993). The bone ECM is mineralised by calcium (from hydroxyapatite) and 
inorganic phosphates that in turn facilitate skeletal development and contributes to the 
mechanical properties of bone (Staines et al. 2012; Shekaran & García 2011).  The 
interplay of bone deposition and mineralisation is constantly regulated in conjunction with 
bone resorption by osteoclasts to maintain bone mass (Shekaran & García 2011).   
 
5.1.2  Metabolomics 
There is a wealth of genomic and proteomic information that has been generated to allude 
to cellular processes (Fiehn 2001).  However, metabolomic analysis provides a 
complementary method to these techniques by providing a way to view the end process of 
gene expression, active cellular responses (Fiehn 2001).  Metabolomics can be stratified 
into targeted and untargeted approach.  As the name suggests, a targeted approach is 
applied to identify a specific metabolic pathway or a group of metabolites.  In comparison, 
an untargeted approach refers to identification of the entirety of small molecules present in 
that data set.  In this Chapter, we use an untargeted approach on MSCs seeded on DIGE-D 
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surfaces at week 3 to allude to how metabolically active cells are when cultured on 
different surfaces.  If they are active, then this would suggest a differentiating phenotype 
conversely down regulation of metabolites suggest a quiescent phenotype.   
 
5.1.3 Aims 
The objective for this chapter was to determine cell phenotype in response to surface 
chemistry.  Due to the observation that there was differential adhesion regulation and 
increasing MMP-2 secretion on DIGE-D and DIGE-E specifically (Chapter 4), we 
concentrated our work to encompass DIGE-D/E controls only in comparison to glass for 
the experiments carried out in this chapter. We initially determined self-renewal in 
response to the surface, then observed cell behaviour over longer term cultures 
 
5.2 Methods  
5.2.1 Supplier Information 
Table 5.1 – Supplier Information.  List of reagents used in Chapter 5.   
Technique Reagent Supplier 
In-cell Western 
CellTag™ 700 stain LI-COR, USA 
Goat anti-mouse  LI-COR, USA 
Stro-1 antibody Santa Cruz, USA 
OPN antibody Sigma –Aldrich, USA 
OCN antibody Sigma –Aldrich, USA 
ALP antibody Abcam, UK 
qRT-PCR 
RNeasy Micro Kit  Invitrogen, UK 
GAPDH antibody Sigma-Aldrich, USA 
Superscript II reverse transcription 
kit 
Invitrogen, UK 
 
5.2.2 ICW 
Supernatant was removed from the wells and samples were rinsed in PBS.  Cells were then 
fixed for 15 min at 37 °C and permeabilised at 4 °C for 4 minutes.  Perm buffer was 
removed and milk protein (1 % milk protein in 1x PBS) was added at 37 °C for 1.5 hours 
on a shaker after which, the primary antibody (1/100) in PBS/BSA was added and 
incubated at 37 °C for 2.5 hours.  Samples were washed 5 x 5 min in tween, then the 
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secondary antibody (1/800) and CellTag
™
 (1/500) (both diluted in milk protein) were 
added for 1 hour at room temperature.  Washing was carried out on a shaker 5 x in Tween 
for 5 min each at room temperature.  Coverslips were removed and dried on white paper 
then inverted into a new 24 well plate.  ICW was performed using a LI-COR Odyssey plate 
reader and data was analysed using Odyssey SA software.  List of primary and secondary 
antibodies are shown in Table 5.2.  Data was analysed by normalising the protein of 
interest over the total number of cells. 
 
Table 5.2 – Antibodies used for ICW. 
Marker Type Primary Antibodies Secondary 
Antibody 
Control 
Marker Raised in 
Self-renewal Stro-1 Mouse 
monoclonal IgG 
 
Goat anti-mouse 
IgG 
CellTag™ 700 
stain Osteogenic OPN 
OCN 
ALP 
 
5.2.3 von Kossa 
P2 (Stro-1 selected, University of Southampton) were cultured on controls for the time 
stated in the text.  Cells were rinsed in 1x PBS then fixed with fixative.  A 5 % solution of 
silver nitrate in dH2O was added to samples and was placed under UV for 30 min.  
Samples were rinsed twice in dH2O then under running tepid water. 5 % solution of 
sodium thiosulphate in dH2O was added for 10 min then samples were rinsed in dH2O.  
Samples were then counterstained with nuclear fast red (0.1 g nuclear fast red, 5 g 
aluminium sulphate in 100 mL dH2O) for 10 min and rinsed in dH2O followed by rinsing 
in 70 % ethanol.  Images were taken using a Zeiss Axiophot fluorescence camera with an 
Evolution QEi digital monochromatic CCD camera and Q-capture imaging software and 
analysed using Fiji (free download from NIH).    
 
5.2.4 qRT-PCR 
RNA was extracted from cells using RNeasy Micro Kit.  RNA was reverse transcribed into 
cDNA using Superscript II reverse transcription kit.  qRT-PCR was carried out using PCR 
7500 machine (Applied Biosystems, UK) using relative comparative method.  
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as reference controls 
(n=3). Gene expression was expressed as a fold change after normalising to GAPDH. 
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Table 5.3 - Primers used for qRT-PCR. 
Target Primer 
CD63 
Back 5'-ATCCCACAGCCCACAGTAAC-3' 
Forward 5'-GCTGTGGGGCTGCTAACTAC-3'; 
Sox9 
Back 5’-CGGCAGGTACTGGTCAAACT-3' 
Forward 5’-AGACAGCCCCCTATCGACTT-3' 
PPARγ 
Back 5’CTGCAGTAGCTGCACGTGTT-3' 
Forward 5’-TGTGAAGCCCATTGAAGACA-3' 
Col 1a 
Back 5'-AGGTGAAGCGGCTGTTGCC-3' 
Forward 5'-GCTCCGACCCTGCCGATGTG-3’ 
 
5.2.5 Metabolomic Analysis  
Culture medium was removed from wells and the cells rinsed in chilled sterile PBS.  
The PBS was then removed from wells and 150 µl chilled extraction buffer (1:3:1 
Chloroform:Methanol:Water (v/v)) was added.  The plate was placed on rotary shaker 
on ice at 4 
o
C for 1 hour.  Extracted metabolites were placed in Eppendorf tubes and 
centrifuged for 3 minutes at 13000 g at 4 
o
C. A pooled sample (5 µl from each sample 
combined) was also included for analysis.  The supernatant was analysed using liquid 
chromatography separation with a ZIC-pHILIC 150 mm x 4.6 mm, 5 µm column 
(Merck Sequant), operated by an UltiMate liquid chromatography system (Dionex, 
Camberly, Surrey).  Mass spectrometry was performed using an Orbitrap Exactive 
(Thermo Fischer Scientific, Hemel Hempstead, UK) with mass range m/z 70-1400 in 
polarity switching mode at the Glasgow Polyomics facility (Creek et al. 2011).  
Metabolite identification was carried out using IDEOM analysis pipeline and analysed 
metaboanalyst 
10
. 
  
                                                 
10
 http://www.metaboanalyst.ca 
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5.3 Results 
5.3.1 Self-Renewal 
It was hypothesised that the presence of the PEG blocking group in conjunction with 
RGD peptides would induce self-renewal response in MSCs, consistent with the work 
presented in Roberts et al. (Roberts et al. 2016).  We stained the MSCs for Stro-1, a 
MSC surface marker of self-renewal using ICW (Lv et al. 2014).  ICW is an 
immunohistochemical technique that shows the proportion of the marker to be 
investigated in terms of the whole cell population. Unfortunately, as there was no 
positive control, data was interpreted relative to the values obtained for other controls.  
We analysed Stro-1 expression over 4 weeks.  We found similarity between all 
controls, showing a decreasing trend in Stro-1 expression over time (weeks 1 - 4) 
(Figure 5.3).  This phenotype could be due to increasing differentiation and therefore 
loss of stem cell phenotype.  As the glass control exhibits no behavioural cue to 
promote MSC differentiation in a targeted way, we could postulate that there is 
unspecific differentiation.  This effect is maintained at week 3 on the DIGE-D surface 
which is comparable to that of week 2. It could also be possible that cleavage of the 
sequence has occurred at week 3 and that exposure of RGD is stimulating 
differentiation (Figure 5.1).  This could explain the decrease in Stro-1 expression for 
DIGE-E and DIGE-D which is significantly different at week 4 (in comparison to week 
1 values for both p<0.0001).  Stro-1 expression decreases with specialisation and 
therefore self-renewal is not promoted on any control as Stro-1 expression decreases 
over time (Arpornmaeklong et al. 2009). It was expected that Stro-1 would be 
maintained for 21 days in response to PEG as described in Roberts et al.(Roberts et al. 
2016).  We can speculate that this is due to increasing distance from the RGD peptide 
as the enzyme recognition sequence is double the length tested previously. From the 
data presented in this Figure, we cannot say definitively that the decreasing Stro-1 
expression indicates a heterogeneous population of progenitor cells.  However, MSCs 
behave similarly between week 2 and 3 on DIGE-D suggesting a more comparative 
phenotype on this surface for these times.    
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Figure 5.3 – Stro-1 Expression Over 4 Weeks. For all controls, Stro-1 expression decreases from week 
1 – 4. Graph shows differences in comparison to week 1 for that control.  Graph shows mean  SD, n=3 
where *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Statistical analysis calculated by ANOVA and 
completed in respect to week 1. 
 
5.3.2 Early Markers of Osteogenesis 
To determine if the loss of Stro-1 was in response to increasing osteogenesis, we 
looked at the expression of RUNX2.  RUNX2 expression was minimal on glass for 
both time points tested suggesting that glass was not promoting osteoblastic 
differentiation (both DIGE-D and DIGE-E were statistically different for both time 
points tested in comparison: p<0.05 and p<0.01 respectively).  At day 7, there was 
significantly different expression of RUNX2 in response to the surface chemistries in 
comparison to glass. Surprisingly for DIGE-E this was more pronounced (p<0.05) 
suggesting an upregulation of RUNX2 on this surface.   The expression of RUNX2 at 
day 7 for the DIGE-D surface was more comparable to the glass control suggesting that 
osteogenesis at this stage was not promoted by RGD which was surprising due to the 
results presented in Chapter 4.  
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Figure 5.4 – RUNX2 Expression After 24 Hours and 7 Days. ICW analysis of RUNX2 expression as 
an initial response to the surface. There is an increasing trend for RUNX2 expression after 7 days in 
response to surface chemistry as expression of RUNX2 is significantly different to that of day 7 glass for 
both DIGE controls. Graph shows mean  SD, n=3 where *p<0.05, statistics analysed by ANOVA and 
completed in respect to glass. 
 
5.3.3 Metabolite Analysis, Week 3 
In previous studies (Roberts et al. 2016) we utilised metabolomics to understand how 
active cells were i.e. does the uncapping of the PEG blocking group result in the 
upregulation of the metabolome indicating cellular differentiation?  In those studies, we 
identified that there were some differences in the unswitched (blocking group in place) 
and switched controls (RGD exposed) (Roberts et al. 2016). This experiment was 
repeated for this Thesis, although it was conducted comparing DIGE-D and DIGE-E 
surfaces. We performed an untargeted metabolomics screen to understand the secretion 
of metabolites for both DIGE-D and DIGE-E controls in comparison to glass at week 3 
(osteogenic time point 0, Figure 5.1).  This was employed to understand how 
metabolically active the cells were, indicating the uncapping of PEG and subsequent 
cell differentiation in response to peptides. Metabolomics data was firstly analysed 
using MetaboAnalyst 3.0, a web based tool for metabolomic interpretation (Xia & 
Wishart 2011). Using MetaboAnalyst, we identified similarities between data sets when 
expressed as PCA plots (principal component analysis).  Samples with distinct clusters 
indicate differences in each sample set whereas those with overlap indicate a more 
similar dataset (Fiehn 2001; Robinson et al. 2005).  Variation is determined by 
principal component (PC) and is usually plotted using first and second components, 
PC1 and PC2 where those with the most variance first (Robinson et al. 2005).   Figure 
  132 
5.5 shows data for Glass (blue), DIGE-D (red) and DIGE-E (green) surfaces where 
there was an overlap between samples. Overall, there was similar behaviour on all 
surfaces and in addition there may be more variation of DIGE surfaces than glass (more 
spread across both axis). DIGE-E samples, display more variance on the PC1 axis that 
spans the most variation (73.4 %).  In comparison, DIGE-D data sets were spread over 
PC2 axis indicating less variation between triplicates (21.9 %).   
 
Figure 5.5 - PCA Plot for DIGE-D and DIGE-E at Week 3.  Metabolomics data was uploaded to 
Metaboanalyst and a PCA plot generated.  Data shows overlap in metabolite expression from cells from 
both samples indicating MSC phenotype at 3 weeks is similar.  Data labels are coloured where red = 
DIGE-D, green = DIGE-E, blue = glass (n=3). 
We then separated the metabolites into categories (lipids, nucleotides, carbohydrates 
and amino acids) then performed a PCA analysis (Figure 5.6).  For lipids, there was a 
significant overlap for all data points from both controls, with glass controls the most 
tightly clustered.  DIGE-D and DIGE-E were much more spread.  DIGE-E showing 
more variation over PC1 (96.8 %) than DIGE-D where PC2 totalled just 1 %.  
Comparatively, glass controls exhibit more variation when looking at other metabolite 
types than there was for lipids.  Overall, the behaviour of DIGE surface act similarly 
for all metabolites.  DIGE-E samples appear to be more spread over PC1 and DIGE-D 
samples are spread over PC2.  This suggests that there is less variation for DIGE-D 
controls than DIGE-E.  For all parameters tested, there is no distinct clustering of 
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metabolites indicating a degree overlap of all metabolites for both controls and 
variation between the triplicates tested.  PCA plots reveal the similarities between data 
sets, not the regulation of the metabolites in those sets.   
 
Figure 5.6 – PCA Plots per Metabolite Group.  Data was separated into metabolite type (lipid, 
nucleotide, carbohydrate and amino acid) and expressed as PCA plot using MetaboAnalyst.  Data shows 
that there is a degree of overlap for all metabolites tested, indicating similarities in expression in all 
metabolite subgroups. Data labels are coloured where blue = glass, green = DIGE-D and red = DIGE-E, 
n=3. 
 
The metabolites were then statistically evaluated using the IDEOM file where a T Test 
was carried out in comparison to the glass control.  Few metabolites that were 
identified as statistically different also had high confidence in their identification.  
Identification of metabolites was based on the retention time from the separation phase 
and the mass and intensity as calculated by the mass spectrophotometry (Sumner et al. 
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2007).  If a metabolite has been matched to a standard, then it could be described as an 
authenticated metabolite and given a high confidence score on IDEOM (Sumner et al. 
2007). Otherwise it is an annotated metabolite and therefore has a lower confidence 
score. Metabolites with a statistical difference but with low confidence scores were 
excluded.  Applying these parameters revealed few identified metabolites with 
statistical significance as consistent with Figures 5.5 & 5.6. 
 
When comparing DIGE-E to glass, 3 metabolites were identified as statistically 
significant; octadecanoic acid, taurine and phenylacetaldehyde, which are involved in 
fatty acid biosynthesis, bile acid metabolism (lipid metabolism) and phenylalanine 
metabolism (amino acid metabolism) respectively.  Conversely comparing DIGE-D to 
glass reveals two metabolites that were statistically different. Both of which were 
classified as members of the amino acid metabolism pathway; L-Citrulline and N-
Dimethyl-2-aminoethylphosphonate, which are involved in the arginine and proline 
pathway and the aminophosphonate metabolism pathway respectively.   
 
It should be noted that during the execution of this experiment there was some level of 
extraction solvent evaporation prior to analysis. This therefore limits the reliability of 
the experiments and the quantification of the identified metabolites. Due to this 
limitation and the few metabolites that were identified, there is not enough data to 
comment on the peptides effects on these metabolites.  
 
5.3.4 Differentiation, Week 4 - 6 
Cell culture was then extended to 6 weeks to observe phenotypic changes in response 
to increased MMP-2 secretion and cleavage of the surface (Section 5.5.1).  To 
understand if the decrease in Stro-1 (Figure 5.3) correlates to increasing specialisation, 
we looked at osteogenic makers at 4 weeks using an ICW (Figure 5.7).  We found that 
ALP is upregulated on all controls at week 4 and was significantly different to that of 
OCN and osteopontin (OPN, p<0.0001 for all controls).  ALP is an early marker of 
osteogenesis and would be expected to be secreted before OPN and OCN in 
differentiating cells (Stein & Lian 1993).  It was not expected that all surfaces would 
promote similar levels of ALP with no one surface is actively promoting ALP over the 
other chemistries.  Furthermore, it was thought that osteogenesis had not occurred at 
this time point as OPN and OCN are mature markers of osteogenesis which were 
expressed at minimal levels. (Stein & Lian 1993)  
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Figure 5.7– 4-week ICW of Bone Markers.  ICW was performed for ALP, OCN and OPN.  Results 
show there is similar expression for each marker across all controls indicating that this time point is 
insufficient for osteogenesis.  Graph shows mean  SD, n=3.  Statistics calculated by ANOVA, where 
ALP controls are statistically significant with respect to OCN = # and OPN = § (**** p < 0.0001 for 
both # and §), ns observed between controls for ALP expression. 
 
We then analysed samples for evidence of mineralisation at 4 weeks using von Kossa 
staining.  As stated in the introduction of this chapter, mineralisation represents 
terminal bone formation (Shekaran & García 2011).  Mineralisation of MSCs can be 
observed using von Kossa staining where silver ions react with phosphate to create 
silver phosphate which is then degraded to silver in response to light that can be 
observed by microscopy (Bills et al. 1971).  For von Kossa analysis, cells are treated 
with silver nitrate that is deposited, replacing calcium in the mineralised part of bone.   
It is then reduced by a strong light to be visualised as metallic silver (Bills et al. 1971).  
Figure 5.8 shows no mineralisation was observed on any controls at week 4 which was 
expected due to the results in the previous Figure (Figure 5.7). 
 
Figure 5.8 – Von Kossa Staining at 4 Weeks. A) Glass B) DIGE-D C) DIGE-E. There is little 
mineralisation observed on all controls.  Scale bar = 100 µm, n=15 (frames). 
 
We then extended the culture time to 6 weeks and repeated the above experiments.  
There was a change in the presentation of osteogenic markers at 6 weeks as determined 
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by ICW specifically, OPN was upregulated after 6 weeks (Figure 5.9).  Further, OPN 
secretion on DIGE-D surfaces was statistically increased in comparison to Glass and 
DIGE-E surfaces (p<0.05 and p<0.01, respectively). OPN is also expressed at a much 
higher level than that of OCN and ALP. It is known that ALP is an early marker of 
osteogenesis,  which is replaced with OPN and then OCN with extended culture (Stein 
& Lian 1993), and thus the change of makers between 4 and 6 weeks was not 
unexpected.  Due to the markers following the expected pattern of expression, it was 
thought that cleavage had occurred.  It was surprising that this trend was reproduced in 
all coverslip preparations, although OPN expression at 6 weeks did increase 
specifically on the DIGE-D surface.   It is possible that if cultures were extended to 8 
weeks, then we would have seen a further change in expression.   
 
Figure 5.9 – 6-Week ICW of Bone Markers.  ICW was performed at 6 weeks using the osteogenic 
markers ALP, OCN and OPN.  Data shows increases in OPN staining, specifically for DIGE-D control.  
This suggests that the osteogenic phenotype was induced by presentation of RGD.  OPN expression was 
statistically different to OCN and ALP.  Graph shows mean  SD, n=3.  Statistics calculated by 
ANOVA, where * p<0.05 and **p<0.01. Concentrations of ALP (#) and OCN (§) were statistically 
different from concentration of OPN for that control # and § = p < 0.0001. 
 
This was repeating using qRT-PCR at 4 & 6 weeks.  OPN staining correlated with the 
results observed in Figure 5.9 where OPN was predominately expressed on the DIGE-
D surface at 6 weeks (Figure 5.10A).  OCN followed a similar trend as shown in the 
previous figure (Figure 5.9) and was not expressed at comparable levels to that of OPN 
(Figure 5.10).  DIGE-D expression of OCN was comparable for both weeks tested and 
OCN expression was greatest at 4 weeks for the DIGE-E surface which was unexpected 
(Figure 5.10B).   
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Figure 5.10 – Osteogenic Markers at 4 and 6 Weeks.  For A) OPN and B) OCN (note difference in 
scale between A&B). A) OPN expression was significantly different to that of other controls at week 6.  
B) OCN expression was greatest on DIGE-E at week 4. Graph shows fold change in relation to glass 
control, mean  SD, n=3, statistics were calculated by ANOVA where * p<0.05, **p<0.01 and *** p < 
0.001. 
 
Due to increased OPN staining, it was thought that mineralisation of the DIGE-D 
sample would occur.  Mineralisation was tested at 6 weeks using von Kossa staining 
(Figure 5.11). We observed comparable average nodule size for both glass and DIGE-D 
(approximately 40 µm
2
, Figure 5.11D).  There was more consistency observed on 
DIGE-D with less variation in size observed between nodules whereas nodules 
observed on glass controls exhibited a large standard deviation (Figure 5.11D).  The 
DIGE-E surface presented few areas of staining and all less than 20 µm
2
. However, 
even though nodule size on DIGE-E was half that of DIGE-D, this was not statistically 
different and therefore we cannot say that any surface is promoting osteogenesis.  This 
result was unexpected after the increase in OPN shown at the same time point (Figure 
5.9 and 5.10).  After this extended culture time, with cleavage expected, this suggests 
that the DIGE-D peptide is not promoting the expected phenotype.   
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Figure 5.11 – Von Kossa Staining at 6 Weeks.  Images of A) Glass, B) DIGE-D, C) DIGE-E stained 
using von Kossa.  Image shows increased mineralization after 6 weeks of culture.  Scale bar = 100µm. 
D) Results of A-C were quantified showing a limitation of mineralisation on DIGE-E controls suggesting 
that this is not promoting osteogenic phenotype.  Glass and DIGE-D have similar average size nodules, 
however there is less deviation observed between nodules for DIGE-D suggesting a more synchronised 
population.  Graph shows average ± SD, n=15 (frames). 
 
5.3.5 Spontaneous Differentiation  
Using qRT-PCR, we tested the presence of differentiation and stem cell markers at 
weeks 4 and 6.  Figure 5.12 depicts fold change in comparison to glass, PEG21 diamine 
was also used as a control (treated glass with GOPTS then PEG diamine as per first 
stage of SPPS prior to amino acid addition).   
 
All markers were upregulated in comparison to glass (Figure 5.12).  Firstly we 
observed the Sox9 (Sry-related high mobility group box 9) marker, a cartilage specific 
transcription factor (Behringer et al. 1999) which is significantly upregulated at 6 
weeks for MSCs cultured on the PEG surface over time (p<0.05, Figure 5.12A).  Sox9 
expression was slightly greater on the DIGE-E surface than DIGE-D (3-fold compared 
to no change on glass).  We then looked at PPARγ (peroxisome proliferator activated 
receptor gamma), an adipose related transcription factor.  It was apparent from Figure 
5.12B that PPARγ expression was greatest on the DIGE-E surface at 4 weeks.  
However, this phenotype was not sustained at 6 weeks indicating the 4-week time point 
either marks the beginning of adipogenesis or is an artefact.  PPARγ was expressed at 
much lower degree for the other controls tested however, by week 6 PPARγ expression 
was negligible for all controls.   Expression of Collagen I (Col I) was also evaluated as 
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it comprises a significant amount of the bone matrix (Brodsky & Persikov 2005). 
Figure 5.12C shows a greater amount of collagen expression for all surfaces at 4 weeks 
in comparison to 6 weeks.  However, there is no increasing trend for collagen 
deposition over time on any surface.  This is expected as determined by Stein and Lian, 
Col-I expression is maximal at early stage culture (7 – 14 days) and decreases over time 
with matrix maturation and was consistent with results from Figure 5.7 – 5.10. (Stein & 
Lian 1993). 
 
Self-renewal was also tested by observing CD63 expression. CD63 expression for both 
PEG and DIGE-D controls was similar between the two-time points tested (Figure 
5.12C).  The results could suggest that PEG could support a degree of chondrogenic 
differentiation and DIGE-E might potentially support adipogenic differentiation 
however, this could also be the result of spontaneous differentiation.  However, we can 
confirm that DIGE-D surface chemistry was not promoting differentiation towards 
other phenotypes (adipogenesis or chondrogenesis). 
 
 
Figure 5.12 – Phenotype Determined by qRT-PCR.  Primers against A) Sox9 B) PPARγ C) COL I 
and D) CD63 were used and analysed at 4 and 6 weeks. Graph shows mean  SD, n=3, fold change in 
relation to glass control, statistics calculated using ANOVA, where *p<0.05. 
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5.4 Discussion  
Self-renewal was expected in response to the PEG group as we had observed 
previously with Roberts et al. (Roberts et al. 2016).  There was in general a decreasing 
abundance of Stro-1 for all controls tested over time and this demonstrates that the cell 
response to the peptide sequences is similar to that of glass at each week tested (Figure 
5.3).  As Stro-1 is lost with specialisation, this data further suggests that cells are not 
self-renewing.    Although the presence of peptide is therefore not accelerating Stro-1 
loss, it is also not enhancing it.  It would have been better to repeat the experiment with 
a different marker of self-renewal e.g. ALCAM.  The decrease in self-renewal could 
have also been correlated to other proliferative makers (to suggest transit amplification) 
or transcription factors that would indicate differentiation.  This was briefly looked at 
using RUNX2.  It was found that RUNX2 expression was not greatly increased at early 
time points and therefore osteogenesis at this stage cannot account for the quick loss of 
Stro-1 as determined by Figure 5.3.   
 
The lack of self-renewal was unexpected due to the Results from Roberts et al. The 
result in Figure 5.3 could be due to increasing chain length from A↓A used in Roberts 
et al. to GPAG↓L used in this work and therefore increasing distance from RGD 
(Roberts et al. 2016).  It was thought that the cells had an awareness of the RGD 
peptide beneath the PEG blocking group, which enabled an intermediate tension 
phenotype that is required for MSC self-renewal (Roberts et al. 2016).  There is a 
chance that the increased chain length was not promoting the same effect and thus 
potentially drives a fibroblastic population of cells (Dalby et al. 2018). 
 
An untargeted metabolomics screen was conducted.  From the data presented in Figure 
5.5 (PCA plots), we can determine that there is overlap between the samples suggesting 
a similarity between all controls.  This suggests that there was little variation between 
samples and when this data was striated into metabolite categories little variation was 
observed between metabolite classes (Figure 5.6). This result was confirmed when 
looking at those metabolites that were significantly different to glass as few identified 
compounds were different (p<0.05).  Due to the limitation of the experiment 
(evaporation of sample prior to analysis) this may not be representative of the cell 
metabolism and due to the expense of running the technique, the experiment was not 
repeated. Furthermore, if there was more time and availability of materials it would 
have been better to compare DIGE-D to LRGD, as this would have enable us to 
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understand the role of PEG in preventing access to RGD (unswitched sample in 
comparison to switched), and to understand metabolite regulation as an indication of a 
quiescent population.   
 
Differentiation of MSCs was not predicted to occur prior to PEG cleavage.  Cleavage 
was thought to be dependent on cell supernatant concentration of MMP-2, which is not 
sufficient until week 3 (Figure 5.1).  Further work should be done to understand the 
role of MMP-9, as it was shown in Chapter 3 that cleavage is obtained at 20 ng/ml 
MMP-2 but also at a much lower concentration (0.25 ng/ml) of MMP-9. A method to 
test uncapping in situ would have been beneficial, although challenging to do in the 
presence of cells. There is also a risk that secreted MMPs are acting locally and that 
there is variation across the surface with only a proportion of peptides being cleaved.  
From the data, we are unable to definitively say when cleavage has occurred, which 
will affect cell phenotype as a response.  
 
From the data presented, there was an indication that osteogenesis was beginning after 
4 weeks in culture and this appeared to be consistent with the original hypothesis.  
From the ICW data at weeks 4&6 (Figure 5.7 and 5.9), the DIGE-D sample seemed to 
follow the protein expression expected of differentiating cultures (Stein & Lian 1993).  
Moreover, OPN expression was seen to increase on DIGE-D surface at the 
transcriptional level (Figure 5.10).  However, when this was tested using Von Kossa 
staining, as an indicator of mineralisation (terminal stage of osteogenic differentiation, 
Figure 5.11), evaluation of areas of mineralisation revealed there was no statistically 
significant difference, which was surprising due to the previous data (Figure 5.7 – 
5.10).  This final result suggests that the DIGE-D is not promoting osteogenesis.  
 
The qRT-PCR data also suggests a lack of self-renewal in the MSC populations, 
although over long-term culture which wouldn’t be unexpected (lack of CD36 by 6 
weeks, Figure 5.12D). This could be due to differentiation by this time point, possibly 
in response to cleavage of the PEG cap. There is potentially a role of CD63 in 
osteogenesis.  It was suggested by Egea et al. that TIMP-1 co-localises with CD63 to 
prevent osteogenesis via the miRNA Let-7f promoting the knockdown of β-catenin/wnt 
signalling (Egea et al. 2012).  From the previous chapter, it was observed that there is 
an increase in TIMP-1 expression at week 3 (Figure 4.17C & 4.18) and so perhaps the 
increase in TIMP-1 could delay osteogenesis in addition to the restriction in adhesion 
due to the PEG cap.  However, if TIMP-1 is acting through this mechanism, and 
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expression remains high in cell supernatant over time, this could account for the delay 
of osteogenesis (Figure 5.11). To investigate this further, TIMP-1 expression should be 
tracked for the 4 and 6-week time points and correlated to the trend in osteogenesis.  
Co-localisation studies of CD63 and TIMP-1 could also be conducted.  
 
Further, it should be noted that DIGE-D does not support differentiation towards 
chondrogenic (Figure 5.12A) or adipogenic (Figure 5.12B) phenotypes and therefore, 
spontaneous differentiation was not expected on this surface. This alludes to a more 
synchronised population of cells in response to DIGE-D.  In comparison, various 
markers were observed on DIGE-E surface, this could be as a result of spontaneous 
differentiation.  More analysis should be done to understand the interplay of all 
phenotype markers from week 1 to week 6.  This would enable a better understanding 
the point at which differentiation begins and to account for the loss of Stro-1. 
 
5.5 Conclusion  
From the data presented in this Chapter there is a suggestion that DIGE-D is driving 
differentiation of MSCs in an osteoblastic lineage due to increased expression of bone 
makers however, this did not culminate in extensive mineralisation.  Extending the 
culture time would perhaps enhance this data however, this presents a challenge in that 
there would be an increasing risk of infection. There not enough evidence of self-
renewal and the results were not consistent with those presented in Robert’s et al. 
(probably due to increasing chain length) (Roberts et al. 2016).  Due to the increased 
proliferative and differentiation markers in response to DIGE-E and the lack of 
directive peptides, we suggest a fibroblastic population in response to this surface with 
increasing culture length.  In comparison, the specificity of osteogenic markers alone 
suggests that the DIGE-D surface is directing the cell population to osteoblastic cells 
specifically.
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6. Discussion 
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We are currently limited by the provision of adequate therapies to aid not only age-related 
illnesses, such as arthritis and osteoporosis, but also morbidity associated with organ 
donation (Ringe et al. 2002).  These conditions make regenerative therapies utilising stem 
cells attractive.  However, we are currently limited in the provision of high-quality stem 
cells and therefore high-quality terminal differentiated cells.  We have designed a surface 
using SPPS that was intended to provide dual functionality as a cell culture platform.   In 
this Chapter, we will discuss the benefits of regenerative medicine, the outcomes of the 
project, limitations of the system and assess further areas that could be investigated.   
 
6.1 Introduction 
Dynamic surface-based therapeutics are rapidly becoming the gold standard for 
biomaterials. These surfaces are thought to pave the way for the future of TE as they are 
better able to recapitulate the critical aspects of the ECM and thus drive phenotype 
development. The ECM is known to control cell behaviour as altering stiffness, 
topography and chemical composition leads to the activation of various genes and 
therefore control of cell behaviour. The in vivo ECM comprises an elaborate web of 
proteins, growth factors, physical and chemical cues which dictates a level of detail 
unmatched outside the biological world. However, materials are being designed in order to 
better control these aspects. Engineers and biologists are collaborating to develop more 
sophisticated surfaces that can change in response to a stimulus and therefore provide cells 
with abounding behavioural cues in an attempt to recreate the in vivo niche in vitro (Ulijn 
2006).   
 
As described in Chapter 1, current dynamic strategies involve using light, temperature, 
enzymes and hydrogels with tuneable stress relaxation to alter surface properties in a user 
defined spatiotemporal manner (Chaudhuri et al. 2016; Lee et al. 2015; Engler et al. 2006; 
Yamato, Utsumi, et al. 2001; Roberts et al. 2016).  The most successful materials have 
incorporated the RGD adhesive tripeptide which has not only satisfied cell adhesion for 
survival, but in the case of MSCs, has driven lineage specification. This thesis continues 
with this theme as an ERM was synthesised and hypothesised to provide two behavioural 
cues in one cell culture platform; self-renewal and differentiation.  The rationale was to 
maintain stem cell behaviour initially then, in response to enzyme expression by the MSC 
population, cleave the surface to allow differentiation to bone forming osteoblasts.  This 
type of technology could be beneficial in future therapeutics as a method to produce higher 
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quality bone cells for skeletal defects.  The method is advantageous as it is mimics the 
natural process of stem cell maturation in vivo. 
6.2 Regenerative Medicine   
In the last 100 years discoveries such as the biocompatibility of plastics and isolation of 
stem cells (Friedenstein et al. 1968), have rapidly progressed the potential of TE organs as 
therapeutics.  In this case, biomaterials must be adherent to allow cells to populate it 
otherwise the cells will die (Koh & Atala 2004; Chen et al. 1997).  In addition, the 
advantage of stem cells is that lots of cells can be generated from a single source and could 
provide a method to generate sufficient numbers of cells needed to seed the organs (Koh & 
Atala 2004). There are many challenges to TE; safety concerns, provision of an ethical 
source of cells and the complexity involved in creating those organs with specialized 
functions and highly ordered architectures (e.g. the heart) (Prestwich et al. 2012).  We 
aimed to aid the provision of high quality bone cells derived from stem cells thereby 
increasing the likelihood of meeting safety standards by providing a pure population of 
cells using materials engineering. Further utilising MSCs is again advantageous due to 
their immunoregulatory properties (Kode et al. 2009). 
 
The implementation of bioactive materials coupled with stem cell technologies for TE 
could have the potential to replace a disease or damaged tissue which would have a 
positive effect on the patient’s quality of life.  There would be other economic impacts that 
arise from this for example; reduction in health care costs due to less frequent hospital 
stays and consequently, reduced prescription of drugs to relieve symptoms.  This is 
particularly important to consider when faced with the problems of an ageing population 
because at present, health care provision cannot fully support this demographic.  TE might 
provide one method to overcome some of these challenges.  The work presented here could 
in future have an impact on this situation through the provision of bone cells from MSCs to 
repair skeletal defects.  
 
The bone architecture, is complex and materials solutions should consider both the unique 
shape (e.g. the jaw) and mechanical properties, particularly for load bearing sites (e.g. 
pelvis).  Shape can be created by 3D printing for example, which can tailor make scaffolds, 
in addition, mechanical properties are usually compensated for by utilising metals 
(Mironov et al. 2003; McNamara et al. 2011).  Traditional metal implants include titanium 
structures which ultimately weaken the bone marrow over time due to stress shielding 
effects, contributing to the revision rate of surgeries (Brydone et al. 2010; Sumner 2015).  
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The provision of bioactive implants could be one such method to reduce costs to the NHS 
(National Health Service).  Bioactive implants could reduce the number of restorative 
surgeries attributed to implant failure.  Readmission to hospital and multiple surgeries also 
increase the risk of hospital acquired infections which in turn contributes to antimicrobial 
resistance (Struelens 1998).  These factors have a detrimental effect on the general health 
and wellbeing of patients and particularly to geriatric patients. Surgical revisions may not 
be an option for some geriatric patients due to an increased risk undertaking surgeries with 
increasing patient age.  In addition, with increasing hospital stays there is obviously a cost 
to the NHS.   However, for older patients an extended stay (and therefore a reduction in 
their activity) equates to a loss of 5 % muscle mass per day according to a study 
commissioned by the national audit office 
11
.  The effect on the muscle contributes to loss 
of mobility which will ultimately put them at risk of more age-related fractures. The 
incorporation of bioactive implants seeded with stem cells therefore would be a better 
product than that of metal implants.  The need for revision would decrease which then 
reduces hospital stays, minimising the risk of infection that ultimately would reduce NHS 
costs and increase patient wellbeing.  
 
Another area of concern centres on the wait for organ donation.  Currently in the UK there 
are 6,500 patients waiting for a donation and approximately 500 patients die while waiting 
for a transplant 
12. Creation of “off the shelf” TE bioactive implants has been thought to be 
one such method to alleviate this. In this way, there would be no need for donors 
(assuming it was materials-based scaffold rather than a decellularised cadaveric scaffold).  
This is another area in which stem cells could be employed.  Provided there were sufficient 
cells available to create an allogeneic graft (phenotype maintained by materials 
engineering), then the wait for organs would be reduced.   
 
My thesis aims directly at this cell supply issue to find an approach that allows MSC 
expansion without loss of phenotype and then differentiation to bone forming osteoblasts 
for use in bone therapy.  The material, was designed to provide two stem cell phenotypes 
in one cell culture platform as a method to deliver the cells for potential therapeutics to 
meet the challenges that are described in this section. The outcomes of this work will be 
discussed in the following section. 
                                                 
11
 https://www.nao.org.uk/wp-content/uploads/2015/12/Discharging-older-patients-from-
hospital.pdf 
12
 https://www.nhsbt.nhs.uk/what-we-do/transplantation-services/organ-donation-and-
transplantation/ 
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6.3 Thesis discussion 
In this study, we present a dynamic cell controllable stimuli responsive material.  As 
presented in Chapter 1, enzymes as a stimulus are preferable for this application due to 
their efficacy in mild conditions (including cell culture conditions) (Bugg 2001).  Further, 
the use of short peptides has been shown previously to be sufficient to direct cell behaviour 
(Roberts et al. 2016; Zelzer, McNamara, et al. 2012).  Therefore, combining these 2 
elements together in the same platform hypothetically provides an ideal platform for stem 
cell growth.  The incorporation of PEG as a blocking group was also thought to be 
beneficial due to the biocompatibility of the polymer, particularly in comparison to Fmoc 
which was found to be susceptible to biofouling (Roberts et al. 2016).  The removal of this 
blocking group by cell secreted enzymes again provided another method of autonomy. 
Stimuli including light, temperature and electricity (Mosiewicz et al. 2013; Yamato et al. 
2002; Yeo et al. 2003) may not be as appropriate for cell culture as the stimuli is not 
natural in vivo.  This system was therefore designed to have biomimetic and biocompatible 
parameters. 
 
The objectives of the Thesis are presented in Section 1.10, this section will address how 
the results obtained have satisfied the original objectives:  
 
a) Understand the MMP profile of MSCs. 
The MMP profile was evaluated using ELISA, zymography and membrane assay, all of 
which confirmed MMP-2 is the primary MMP secreted by MSCs, as consistent with 
previous research (Morgunova et al. 1999).  Other MMPs were identified in MSC 
supernatant (MMP-9, MMP-3 and MMP-1, Figure 3.7-3.9) although it was originally 
thought that due to the increased concentration of MMP-2 in comparison to other MMPs 
identified, MMP-2 would be responsible for cleavage of the peptide. The concentration of 
MMP-2 remained consistent over many weeks when cells were cultured on glass (Figure 
3.8A). 
 
b) Design a peptide surface to be targeted by the MMP secreted by MSCs. 
Using bioinformatics methods, we identified the likely target sequence for MMP-2 
although it was noted that some redundancy with MMP-9 was expected (Chapter 3, 
Section 3.3.1).  It was thought the sequence GPAGLRGD was the most kinetically 
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favourable, as we have maintained specific amino acids at particular positions in line with 
the Schechter and Berger nomenclature.  This includes P at P3 and GL at P1P1’ for 
cleavage site, which have been noted to be important for MMP recognition and cleavage 
(Turk et al. 2001; Vartak & Gemeinhart 2007; Kridel et al. 2001). Due to the constraints of 
manual synthesis, multiple sequences were not tested for efficacy in response to MMP-2. 
Efficacy could have been improved by maintaining the prime side of the sequence and 
adding RGD to the consensus sequence instead of substituting it into the prime side.  It 
should also be acknowledged that enzymes in solution act differently to those tethered and 
in linear conformation, and therefore other sequences could have been explored to better 
understand efficiency (Ulijn 2006).   
 
c) Synthesise the surface utilising SPPS incorporating the sequence favourable for 
cleavage by MMPs and the cell adhesive peptide RGD. 
Manual SPPS was utilised for synthesis and characterised utilising the techniques 
available. This includes WCA, fluorescent spectroscopy and ToF-SIMS, which although 
have limitations (lack of specificity of WCA and fluorescent spectroscopy and the lack of 
ionization of particular amino acids during ToF-SIMS), are complementary.  We 
determined there was sufficient evidence to conclude that the surface had been synthesized 
(Chapter 3, Section 3.3.4).  This was expected due to the robustness of the technique 
(Piehler et al. 2000) and our experience of synthesis from previous studies (Roberts et al. 
2016; Todd et al. 2009; Zelzer, McNamara, et al. 2012). There could have been additional 
steps incorporated to maintain efficiency at all stages (Ninhydrin test) and prevent the 
presence of deletion peptides or peptides with the wrong sequences.  Manual synthesis of 
the sequence comprised many weeks which was limiting and will be further explored in 
Section 6.4. 
 
d) Understand the mechanism of action by enzymes on the surface 
By mimicking the cell secreted concentration of MMPs, we have shown that cleavage has 
occurred using ToF-SIMS on DIGE-D surfaces.  To conduct the ToF-SIMS experiment, 
cell supernatant concentration of MMPs from cells cultured on peptides sequences was 
utilised (Figure 4.14).  When applied to the surface, there was a reduction in the presence 
of full length peptide suggesting cleavage (Figure 3.20 and 3.21).  It was surprising that 
MMP-9 at a concentration of 0.25 ng/ml was as effective, if not better at cleavage than 
MMP-2 at a concentration of 20 ng/ml.  Unfortunately, this experiment was not conducted 
until the end of the PhD prior to which, the hypothesis was that MMP-2 alone was 
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responsible for cleavage.  Due to the increase in secretion of MMP-2 at week 3, this was 
thought to be osteogenic time point 0, where the PEG barrier to RGD peptides was 
presumed removed and could therefore allow differentiation.  It would have been better to 
follow up this experiment utilising differing concentrations of MMP in a dose-dependent 
manner to provide a broader picture of MMP action on the surface.  It was also assumed 
that the cell secreted concentration of MMP would be sufficient to trigger changes across 
the surface however, local action of MMPs could be possible.  The role of MT-MMPs was 
also not explored and therefore local action by these enzymes also cannot be ruled out.  
Local areas of peptide cleavage could result in an unsynchronised population of cells, 
which would not be applicable to clinical use.   
 
e) Analyse the phenotype of MSCs on the surface over time 
Early time point studies revealed changes in cell spreading and adhesions between 
controls.  This was enhanced on RGD and limited for RGE controls highlighting that RGE 
surfaces were indeed non-adherent (Figure 4.8).  However, those cells that did attach on 
the RGE surfaces, survived as after 1 week in culture, survival is similar for all controls 
tested (Figure 4.6 & 4.13).  Although there is differential cell morphology and adhesion, 
this did not relate to an increase in Stro-1 maintenance as expected (Figure 5.3).  This 
should have been repeated with other stem cell markers including ALCAM.  This was 
affected by the availability of materials and long-term cultures were prioritised.  This was 
an oversight and it would have been easier to concentrate efforts at earlier time points (1-3 
weeks) than late stage cultures (4-6 weeks).  It is with regret that not enough data was 
generated to satisfy the question of dual functionality of the surface.   
 
Cell differentiation was not enhanced on DIGE-D surfaces prior to 6 weeks in culture.  
Osteogenic differentiation was thought to be occurring due to the increase in markers such 
as ALP and OCN (Figure 5.7, 5.9, 5.10).  However, this did not result in increased 
mineralisation at 6 weeks, the marker of end terminal differentiation.  Furthermore, our 
data suggests that there are no other phenotypes observed on the DIGE-D surface 
(chondrogenic or adipogenic, Figure 5.12). Hypothetically, the culture period could be 
extended to understand if these indications could lead to mature bone cells.  This would 
extend to 8 weeks of culture where the risk of infection increases. 
 
Taken together, the surface is not promoting stem cell self-renewal nor enhancing 
differentiation in the manner that was expected.  Due to the risk of an unsynchronised 
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population coupled with the extended culture time, this system would not be utilised for 
the provision of high quality bone cells from a stem cell precursor. 
 
6.4 Limitations 
In terms of clinical translation, this concept, in this format, may not be feasible for the 
provision of cells for therapeutics.  If possible, the technology described in this work 
would be more suited to an allogeneic approach (provided it could be a cost-effective 
strategy) due to the duration of culture.  There are indications that the MSC population is 
specifically directed to osteogenic phenotypes therefore the incorporation of peptides is 
beneficial for the provision of higher quality bone cells. For patients with fractures, the 
turn around with potential autologous treatments should be a short as possible to provide 
the cells for treatment.  In this case, there is a need to create high quality bone cells 
quickly.  For allogeneic treatments, high quality bone cells could be stored in a biobank 
and utilised on request. However, the time taken to generate these cells, in this case, is at 
least 6 weeks which is not time effective for a therapeutic turnover.  In addition, increases 
the risk of infection of the culture.  This risk would again increase when scaling up to 
provide for demand.   
 
The creation of surfaces took at least one month’s synthesis manually and was limited by 
the number of vessels and space to create the amount of controls required.  Scale up would 
subsequently be a problem for manual SPPS, this would not be feasible for future health 
care strategies. An automated SPPS process could be perused if it was to be implemented 
as it has the advantage of speed and further increases in reproducibility between batches. 
 
It is argued that reversibility is preferable in a platform technology allowing cyclic 
applications of that technology (Xia & Jiang 2008).  We understand the limitations in that 
this system is not reversible however, in this setting we feel that as stem cell differentiation 
to bone is a “one way” system.  This material fits this purpose through promotion of end 
terminal differentiation.  A reversible system would however minimize single use 
materials and the reduction of waste which would have a better economic impact. 
 
The main advantage of this ERM was that the material would be responding to the 
demands of the cell population.  However, the uniformity of the switching was not fully 
explored and therefore poses the risk of an unsynchronised population.  It may be that the 
user-controlled system described in Robert et al. is therefore a better method to control 
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surface properties, thereby creating a defined ON/OFF switch that guarantees duality 
(Roberts et al. 2016).   
 
6.5 Future work 
Due to the limitations described in the previous section (namely availability of materials) 
there are several experiments that were not conducted.  Had the system been more high-
throughput, multiple stem cell markers could have been assessed for various time points.  
Specifically, markers of self-renewal, differentiation and proliferation should be assessed 
weekly for the duration of the culture (1 – 6 weeks).  This would be particularly relevant at 
the 3-week time point to test the original hypothesis.  For early stage cultures it would be 
prudent to look for other progenitor markers of MSCs including ALCAM and CD34 to 
confirm the same trend as observed for the Stro-1 data (Figure 5.3).  Furthermore, 
additional data on the colonisation of cells on the surface (proliferation) and the phenotype 
of these cells over the many weeks of culture, should also be assessed.    
 
Alternatively, to characterize phenotype in a high-throughput manner, we could spike 
supernatant with MMP-2 (on DIGE-D and DIGE-E surfaces in comparison to glass). Due 
to the length of time taken to achieve phenotypic changes there was difficulty pinpointing 
the exact time for early osteogenesis.  By speeding up the cleavage time point and 
decreasing controls, we could process more samples with more time points in a high-
throughput manner.  Using this method, we could also provide more evidence for cleavage 
of the surface.  Although applying this method would revert the system to the user applied 
stimulus that was utilised in Roberts et al. (Roberts et al. 2016).   
 
The role of MMPs should be more fully characterised with different concentrations of 
MMPs tested to understand potency.  An experiment could be designed where an Fmoc-
GPAG↓LRGD surface could be synthesized, treated with different MMPs at various 
concentrations then the presence of Fmoc analysed using fluorescent spectroscopy.  This 
would again allow a more high-throughput approach to the analysis of cleavage, as more 
samples can be run at less expense and has the added advantage that technique can be 
carried out in-house.  Moreover, we could apply small molecule inhibitors against MMPs 
to confirm which MMP is required for cleavage in the cell supernatant.   
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Additionally, the MSC secretome could be analysed to identify another enzyme that could 
be secreted at higher quantities at earlier time points (Kim et al. 2013). This would involve 
a change of sequence to accommodate this enzyme.  
 
The interplay of MMPs, TIMPs and phenotype could be further explored.  As stated in 
Figure 3.4 the activation of proMMP-2 is by MT-MMP1 (Visse & Nagase 2003).  MT1-
MMP can complex with the 1 integrin which increases secretion of MMP-2 and ALP 
signalling, therefore contributing to osteoblastic differentiation.  It would be worthwhile 
tracking the expression of MT-MMP1, particularly at the 3-week time point to determine if 
the increase in MMP-2 could be correlated with this mode of activation. And further to 
determine co-localisation of MMP-2 with the 1 integrin to substantiate this further 
(Karadag & Fisher 2006; Karadag et al. 2004).   
 
6.6 Conclusion 
There were numerous aims to the project.  We identified the most likely peptide sequence 
for cleavage based on the MMP profile of MSCs.  This was synthesised using a robust 
technique although there could be improvements to guarantee efficiency considering 
synthesis comprised many weeks manually.  While we did observe cleavage of this 
sequence by MMPs, more work should have been done to understand the potency of 
MMPs at different concentrations.  However, due to time taken for synthesis, access to 
ToF-SIMS and limited availability of the materials, this was not fully explored. Cellular 
phenotype was analysed initially as an indicator of viability then in long term culture for 
differentiation.  While we ascertained that cell survival was adequate on the expected 
surfaces and that there was some upregulation of osteogenic markers, MSC self-renewal 
could have been better understood. 
To guarantee a fully synchronised cell population at a more therapeutically relevant time 
point, other materials strategies should be explored.
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